var title_f3_13_3280="Template for dictation of placental findings";
var content_f3_13_3280=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F52233&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F52233&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 577px\">",
"   <div class=\"ttl\">",
"    Placental worksheet - template for dictation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 557px; height: 670px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_13_3280=[""].join("\n");
var outline_f3_13_3280=null;
var title_f3_13_3281="Passive Painful Arc Neer Test";
var content_f3_13_3281=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1124px;\">",
"  <div class=\"videoplayer\" h264=\"./images/EM/82879/Pass_painful_arc_Neer_video.mp4?title=Passive+Painful+Arc+Neer+Test\" style=\"width:480px;height:288px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Passive Painful Arc (Neer) Test",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 287px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The passive painful arc maneuver&nbsp;is used to assess the degree of shoulder impingement. It is performed by passively flexing the glenohumeral joint, while simultaneously preventing the patient from shrugging their shoulder.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stephen Simons, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_13_3281=[""].join("\n");
var outline_f3_13_3281=null;
var title_f3_13_3282="Two varices banded Endosc";
var content_f3_13_3282=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F54194&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F54194&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Esophageal varix band ligation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 277px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEVAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5+QEkLgHPHAzn0qxChGM89j/gajRSRyeM4wM/zq9DCSGA+baCQB/d7j61J1oktYC6jaoznk16N4L0PDLJg4IB2+3vWF4b0hriZDsO0EYH1Neu6BpoiUBRk4xXJVqdEzvw1G6uy9bEW9vtUAAenrXKeKtWCI6lu2Tn1/pXUa/MljAclOg+UHjNeNeINRMl1MA2RuPU8Yq6EbLmKxE7e7cqape73IjBPYeorKLNvBAO4HjPr/ntTZJSxJyT6g+4/SmoM4OSqjB3Dtmuhs4tyaJSRySR6EVMka7Qx6e/GabDHxsHpjHTIq7BCx2gAMQOc9iOn55/SovYuMLgsWQVGOwJx79TV22tjlW4Gefpnv8A/X6VasrTcoUjrzj1I7/hWjFakOuMdeuPzrJzOyFGyG2tt0UqSvb+taMFqc5I9ycVdsLEkEKPl7DHSr01usSlSoOMY7cVHNqbqGhWtkESmTIAA5471FPdEn5BgD25qOdzjaT+7B3ccZpIIDK2Nu7PrQlYq99LFmFGlbLZH155pfJZ3CBecYx64q/DamNQvbuTUtukbXsIf5FxuOBz/wDWoe2g0lcy73T5Y9rbGGBwSOBVXygp+Ygk+3IFbfiGRFdhbu3lAdB0FYE0m0hj1PIIpJStqN26A4UMQFIHQAj1/pTYlQTqxHJ5HsO9MDlh6tjP/wBb3qF28s7h29f51fkRtqdLBPAowqgnpkDFMmnRUIxhm5rGa4ZEXB5PJHtUT3JLgcjHpRyj51E6/wAFP9pubuL+JMPt+teqadKVi2tzxgZ9K8d8DXgg11t3S4jwDnIBH9K9Z0+7WWFNuAR39K8rER5Ztm9W86S0KHiiJ5NH1OJflJXI4rwHUCm9B1BwCVGegx/SvoDxASbS72HGYCc+leA6lCcqzE4cr256/wAq6cHszGovciw0i9jsJ38ssFYAnB6+tdbHrdhNpEkk0229ikPlqOjoQOx75zzXC+WvTkgHhD2qWAgoEfnb90Ec9a7Wl1MU7bG7ea3E0TgKGD/Lz61hyWBlxIhBGD8vT60k0BjCsy/K/K98/wD6quWtlMrLu3omcnPJI7VDklsVa5Sis5m3BU4UgnGOK1tNt0CyyYA29D/PipoICQxyNzDBz0+maIrY5VYT8xH5gdqlvmQ7W2LWl3N1perQalp0hgvLY7o2A+XkYKsO4OcHvzXd6n8QItcuIJHt1hkYFJIs5wFxg575Jb8hXnmdkg7HO33qlf3CWl0QJNsi4z3GPwprVWepnypS51oz2uyFlqdsHwQ33cY/Sua1vR/LkMkAAznIArnfD3jp7CbMSEhVwd44IxyB+Fbdt4iXUpnfgLJ/yzXsKFScfeiae2hJcs0YZuRAxR+GAAwRSzMkkWV54zk9hWzqGgR30E0to2117AckfT1rm5llsvvj5e9awlGbt1MKlN03dbGbdOqEMELE4HtVG9BOWQFSOBxz71s3CJMD3yc1SlgCgg989OlabHPI2PBmsrBMiSsVYDKsDkqa908CeKvt+6yvZF85eYz6r2r5jnQ25V4WZSvJx1rV0DxDPDdxyb9sqHhutFraoUvfhySPr4gMMEAg9jRXD/Dvxemt2vkzlRMnHBoq009zz505U3Y+HIEZiBzjIGOldFpFgZp40VQOP61nafAzspPPsK9N8DaNmSNivHYVjVnyxud9ClzSsdL4T0QQWyFlxkYyR+VdHcTR6fGXbAI6c1YzHZ2gA4459a848Xa3vDorcdDj/CuelT9o7s7q81TVkZ/jLXmupwqt0GFA78Y/+vXAXDFi3A44B7fXNWr65Mjnfnk88+nc1mvubb/ePG3Hau+3Y8yUmxNuTnB2tyAeScVYgTLYbDbh0HO76D0qOHl+Mg+v+ev1rSsoS78AZJye/wBfpUt2RUFdk1pbM+cJ+vSty0sAQS2QCevcVZ021VYy5VQW6e/pWtBAERcZyBj8KwlO56NGjYgjtVVOBjnOR1xU8UaqxboPXrVpITnOO2RioL7chwMbgMZPPNZq8jplFRLUdyIlwuQMcjPJFE8/mnk8+hPWskzM5/Hr6Y9jUwkJQFfXbx61dkkZq9ySUhsAZAORn3rc8P2LS8kE554HasRFy3r25rrfCzKHjRgv1NLRlJWZJqMIihO76ZFc40xEhYd+57V2niC3aSByuRt7j/PNcHeKY9w5GMkcU7alTWl0NvLsKu5uoB4zxmsO5uWHy8gjnAPtinXztuwSTkZUk9KzZjvDEAkDORnnr/j1q3qY9S9b3BUj5uccDr+NLcXBkYyNjg5J/oKzYWwQMYG3BI9KvMmUA6HoD6+39ahu2g0hI5mAAdmJAyST92pOXLKucjIYA1qaBoqanMEY7cr69B6U/VbSOKUxoq4TIODnPP8ASjmvohcjSuJ4dlWHWbN5CUJ+T0HPr/nvXrOlO0VwytxgEH0rxmGJjjIy364r0DwJqk17JLbXOXeFgqyZ5K4HB9a4sVTv7x2UJ3g6bOq8QW801lcwxn52iIA9cdq8N1O4+WGMlfLHIH9wg8817r4suDpuhvdr8zt+7UD3rwjXIVExDK0XHOO/Oc/jVYVNaGFR80EQbkkfovPynHPNWPJjMyRQuHB+Ykfw+9ZMIZY8szZYnZ/tD15rR00yWk7O3zh1xgDgV1SdjGKubVpa7SFmIcjpkfdqZyxJGCcA9OcD1qNZFeIuCc85Pep9Nn+zzK2Awxn6istWzTYz/MMZYsAM474AqB9SjjYmMkkcDArT1/7JcQpJajbkjeoHGR6CsAxGac7EPzHjGfm/+vWsY9zJtPYklvxdEomFXORjr+dNtEt0Yidd+Tnn+tDWZEYLKcgemM80Q7fM8t/4mxn0NaWVydSpfrufdHlMDgDtUNreT2r7vnGCDlT3q7NbbnCHAKknjAOB3H9Kg+wSmRyMjjnP8/0p3aM2kzvdB8ZRSWotpgUu0OQ6nAdf7p/xrd1aHT9WskltMBiuWTvmvIGikJ3qSCPukdq6rwxeuNsckpBPXj0rKVPmfMtzWFZxVnsJPby2Um05K8jk5FMkO9Mc8cZHT612N9o5utH+1IdwJxx1xXEzwSW8x3A+X0xnH1q4T5jKrT5dehTu4T/F3GRWRKjJIxUHHWunlAkh6An09fSsu4hA3AjgDAz7VpcwcTe+H/iF9M1SJySBgg+/FFchGzQzo3Kn3HbOaKenUqMml0Kvh2w+0ToCBtzXtHhmxFvCpUhTxjI61w3g7TkUq7cjgE46e1eied5FvkHoMkiuKo+eR00Y8iuZPi7UvJg2Kc8HgHp+PpXkWs3bSSEZDZbjHbP9OK6/xje7pNuSR0OPb1rz+5Jbdk9zx1BHrXbBcsbI4q83J3KkxwWBIxj9fTNNiBDDgDPJ7U8hgxwCQ2T1I96I1yQxXAxxwBim9TJLsSQxF2AOS2MH0+n9a6rRLEyEFhhQQSc1kaZDvcDqThuTXdaZbCOBVHJA781jUlY7cNSuxI4toChcDoAB0q1D8gwTycZNSpEGxgc8YxT54ljAYEcdO1c+7PTS5UOBCxFgBlsgYrKvGLkfMCtTGYtxkkDgf41Ayh+MDNXFcuxlK8mVBkMeuantULt33cdB3z1qVrbCtgN79qvWkYjjMhOGHb+9TkEVrqW9O09pZFEnyrmu60HSIccbWPQVw1nfhZQucL2x2rpLXXDAilWAPuOam9jRXex1t5pLz25hxhD1PpXlvi6BLK5eGIszbcNj37ivRY/EoNozyuA/Q/415f4ieWa6a4dS0UjHDYIVvoapNEWny+8c6NkrqJ8hUGAc/nVOaIAYXkdefSrgjCLJhsHdjB6mm4LPtA55I+nvV7GditHAu5A+AMY3D+VX7CFbhijMqlckse3HUfjTIrVp8MCFVTguQcA9skVpWGnZWOZm/duu4MB1OOn0qG9B2FtJGjcNC2wdMj/P+c0/5nclwxPf60rq0Lskcb3DLhmEaguBkAt9BkV2moeH7fRbtYLy8trl2ga4DwHcAB0XnuexocrbIainpexxOxkYErjuDjFdL8NJNviG6t5EzuQTxtj8CD+VW7uC0ls0WJB5o/eKQP8AWKcZx64x1960fBttYx+Jry6t8xo0UcCRMcnJPzH6cmufESvDU0jFxTa7HVeK7KKfQbyKUFljgMi7RnBBBzXg2rP5jqSC77Acn0POK+l9eiSz0+WSRd0Tr5bY6AEYNfPniTTDBeyQptaMD924HDJ2x6ntj2rOg+V2Zlh26tG67nPWFmt1O7KQYRwB0Of6VrpawQt86MGXgcd6ltYViRQq42jPPU1HLerArY5PXGMkVrq2aySS13GpNbiYI7D5ck457dqY1zAu5UJKdcA+tZssiTCc7SsznqD8oPcimRxHcrMcehUce5rpUepztvZF+NUJyG3Kf4R3/wAKmRmTiNQuzkH0qKGGRY0IGAehHT6VZLLuww5IH+frQO10ExecAv8AK3TgVWj08yq42HBzkDoauY3HBPBPertlKYm3OQVBwSe1CYuWzMprJ7dnMq8p0OKWaeMQ4RMs3BB/rXYailreWkqRqPP25jA/jHce57VxM8QD5Gcduf50+boS11MpSwPU9erdsdajjkaNR5QZSTu2+ntVyZN5wFDE8Y45xzUM0aGNCBjd97PGTRqRudX4X8QTOn2Elih+cDrgnirGsAFSsi7fQkd64/SpZrC7We3C71JXDDA54r1tI9P13wFpN75kKao8P+kRqfmMnfjr2PNEpOLukKKUvdZ5zbuUYoRjntT7iENGCOOMEentT9StBDK5HJJydvcUkEokjUn72PzrVamLunZmDewnljnr2orRv4P/AB47fSiluQ4nW6BaeXDHlRyc1sasfIs3LHkck57VJBEIIRlcAj6VzfjDU38po1B5AUEdT71y0o3kd1WXs4M4bX7jzbhuT6dec1zczfMpA+YnPP8AOr9/MGcE87ew5/IelZrHc5JOSRmu3ZHl3uxpXIU4GTjkc9asRJkjOMZ57/nUKjIPXjrj/GtSxhDspwdvUkcg1LlY0hHm2NTRYP3oLjock111uRgDcAKwrSLyl55OAMeg7VsWhJGAckrjjiuOq+x6+HjZamlaMokBxx1644zU+sjFssoTg/KD2xUcKbISSePpk5qlc3kjnY2SoGAPQVnTWtzpq7WMgs5cYYMCe3FXrZVC5LBmPQetNFqzxNJsyMZIHH/6qS3XB5YjHQgdq3vc5uSxadgF4yfr9ahkkLg565zjNPMTkLknLEqo65HqKjlj2xsuQScZPpUtlpX3KEk+J0IGMZBrXhk8yMnIGF4/MdKyGTa5c9c8c9Kmjl2xYPy47f596qK11DRbGheX4ih2qx3HoAeT2rOa6lnhSEyZUSYUE5APc4+mRVYBppdigH5txwCeO/TvWzbW9tHHIwQFmP7vcwIQf3s9/wCVN6aELXUyxp5eO7khct5K72BOCBUlnE0E0VzHsEiOybD8/PIO5fQ810otbeK2illzC7wvDLvG6a4LfdMan7vTknjGKqWcN3deZPottFAkQ8t7h2O3JGDlj04Jo33BpI0fCMltp9rf2GqWcE1u3MCTZZ4S2SSFH3gOOe3FZ6RrxHbpPcxxqEyq7d2F7/zrotCvNA8H3V7fpfte38kHkx4jD+QBgn5/uncTzg9APSsi5+KsNukkOm2Nla7pGkMu3zHJJJPByB1PToOBUcknqokuvZW3NHSNIvNa1EWum6XHbywR4lfcVU565OOT0ro5fBGsXCI++1DNhBl87lxxg46dsV5He/EnWZJ2mt764QjhfKYpj6BfrVA+N9YkGx9Svdq9T5zfmeetX7K+rZk8RK/u2+657W3hrxM0/ks8MjwRFU8tBgA4OCe2cfpV/RLLVrWykutRto1dmwzheF7KMfXj614HZ+PNbtpGMOr3kbO3IFwygn1PPf3rb0v4h66CYU1K5QkZCTP5i/Ug8deaiph+ZWT0Eq83pZHsnivWvM8NR6RGk0lzLGN7qeVA9frXB+IrR/sNnJOTHFFHsUoOPm6sa0NJ1xtaiguFWOK7RCt5Gozh8dRn+FucHtWxFpMGo2dvBcvKIcEMCcdT0zXn1K7paPdHp0adKlTT6PVnn3iDSr7QR9guox9qjZrh2zlm3fdB/wBng4+lYejRLqlw9vJIqXe8Hc/CspHJPpivo298KaR4hjWS8WQ3LKgaVWILBM7c9u5qGb4b6G19a3UETQvbtuG05DfX1rop13JXjG69TzJY2hpzO0uumh4feaKypBNHb+SjQEE9RIRwWB/pWb9gYKgG5BgEZ9a+ik8F2XmRRySNJYIXb7KwwoZurKRyD9OxNZ1x8PIJIbqGK5IR5EeFioyiqSdn6/j3q44htaIaxeHk9ZW+/wDr+tLnjV1bQ7wLYOqcYJGME/561VmhKM8bFWZWwWXnPAr15vhjKLeZlu1afcSgIwMY4BqtH8NLu2uhIksUqOoDqR69fx9xzVOs1vFr5Fe2oP7a/H/I8nVQSACfyre8L6RHqV0U1G4+zaYkMjy3LHGJRt2qfY5P5V1mp+Ab1Aj21rtKrtYA5BPriqVn4T1aYeWkLhAeh4z70vrMFo2VyxmuaMl63Rx9gssky4yuV3e4BPT/ABo1HT9gBHO4biRXdQ+ANWU5EIGe5IrUu/C16dKSO4tVjeIbAwOd2T1NWq0WgUoXtzL70eNx2hkcoc/ePOM4HvUEtr5TMh6qc47e9ehf2Jf+G/Ey3Mtt5zW67JE6rMjL/LnpXOf2eRKF2si5I5PO0nIGe5FCrJPVgqUpK61RzccWBjB45y35VctlnilCoxifj65HJH4jitaTTirYxnnnjr/jVqbTle2hkUMZgSkinnp0NUsREj2EhmuJbT3RFnjyWVWUKc4yoLL9Qc59Kwkha3dcnryMntXSabpsj+YxyREOSegBNS3el7kZscj0/lVKtBbCdCTOfniWSJj2xjHpRWhFaSqCpzgcdCPwoq/aroYui+qO214LbWjOQB6EjoPSvHfEV400rp1wePY16b8Q77biFCOF5x09a8e1SQs+c5BPGKdGHLHQnFS5pWMidwSSARk8/wD6qqg5IGAhPr7/AP6qklHbr/ng01FG7g8+vr7Vs/I4yeHll2ntnOelb+lxbiny9WyMmsO2GXByMnIJx6ev0rqtMgIC4Bz6cHNZVJcqOvDx5maMMZc468ZOa1LdNo4xz17U+wgBRR/d6k96nuAqrwPlHTJrkUuZ2PV5eVXQ17jbFt/AkDrVUKHY5GT3Pr/nioncqwyMnjjoKuWjDhn457Cqa7DhbZmjJbLa6KskikySybY16c4yT9BWG+cFVHGcD0A+taF/PJdRq2QIYQIxz0Bbrj1JqqFcrux8gOOv6URTitRzsyWF/JTc+CwAC+w680yeJRGJJCQzfcHWq8krEbQwI6DFRojzAAltoPyj09hT2EtdEQyE9W5JJHHSi1NubhI7wmOJgx3gfMDjj8O1aVvpN3f3iQWkLNjBY9l+uen41Pb6cYXF1LG0iSBiqYyW/hAHuSQc9OKPaIFSl1I9Et40vJpJU3QJiWKNvlMrYwEbr8uRWhEkdu9wsNtFNqUUSM8cCHyrYnjCj+JiSBgeuasTabKssSWLC5uI4wZ5kwUjkP8AACODtG3JHrUS3v8AYNvfQ2sipKWJmuwQfLxydh/DBPbtU86vqHs217qJ4FtfDg/tHxI5u9fciaO0ilANsB03ychMjOVAbPHSuA8YeP7vXZI7G02RWVsAkcdunlwRDbgBV55I9SazvH096uqNo8cTLcAhpGbPJZQ25ieSNrKeeTmsyw0iWOBI0YqhJYuwI69TjvXRCUOW61ucDpzlPVEKXMzMmWDBDgKeQ31/rSSiOSZyFhjYP91RwCedo9h0HpWhDoYaRzLIyx8D5eGcHPQ9ulTHRx5axsDvC84xkZ6n+lO5fsbbnOlHAZ8b8DoefypEnSM4bOACTx2FX7jSLmHeflQDAJMgGBVGfzPNC3Ee1W48wdM59f8AGqbM5U9dCyYklZHQg7hlQeRz6jvSh2tSp+ZWXgeo46061tpI2Qrny2O4FOTirt5blCQ2So6HGRjqCKN9URa2jL2h6s5KHzGWeMg70Pft9a9GsfGl1EmGjjLnhgOjepx2rx21DWmooxIKE7PbNdfabpFDOcN0xjHFc9WjGbvNHZRqStyp6f13PR7Xx9qkCt9mWBZf4WYZH0I716f4G8ZWniSBYLlBZawoPmWpbIYD+JD/ABL+o5+p+fYQI495IyT2q9ZmVJo5UJLo25GViGQ9iCOVPuKzp06cPhjoLE4OOIjroz6WvJ/sRLyRuYMZLrzt57iiPULZrZbhZUaAnHmA8A+h9K5HwV4yFzBFZa7MguSQiXDABZc9A3YHt6H61rXdmdBkuZ7a3WbRpxuubYLkxnu6juCOo9uK29it6bt+h4vsLS9nNe908/8Ag9jeguop1zFIrj1BzUu4GvMpZf7FtbVLe4lmsHMkscoXLNJnGw/7WCcj2yOlJH4tvdPhnS7ImMDhWdcY5APXuMEDPqCO1c06laFludDyuUlzU2enZpy4HTFee3HjhbYFJ4nDj29elWdJ8eWVyNtyhgcHHzHg+9TDFuDvKJjLLa6V7HdZpetZtrqFtdIGhmRgfQ1aEo/hIP0reOYQe5xSpSi7NEzojjDqrfUVmXPh/TLmTfJaR7vYYq/5g704SDNXKrh6vxJDhOpT1g2jGfwppD/8uoHuDUI8GaKB/wAezf8AfVdCGpcitI0aEtUjT63iF9t/ectP4I0xlP2dpoW9myPyrPk8EOmfKlRx6k4P8q7qilLBUnsrGkMxxEPtX9TzO58DXYJKJGw9nor0yipeBj0kzo/tet1S+4+U/Gt0XvJCzdPWvPrtyzHJB2g4J4/Gul8U3O+7kYk56E+wrjpyWLY9/wAPrXUlZWFUleRDKSQNxyV6kcZ55/8A1UikevA6f40rcZXHOee386kjUc5HIxwOcCghIsWaKsoOcnA4Iro7BmUgAnAPJB61i2sZIyBnPc/St+wspJdrKflUDB7Y9feuWrJbHqYWndXOhtblFgTO0fjmmXNxknJG481lMHhYqpxjAyOg9uaRXZj8wIIOfxrKOm51taWRbQNK+CcgnvwPU12trowXw95zDdK3t0H+TXG24IkTjJJPB/lXqCsf7HiXkDb+fvUyb50jSmtLnBSW0jOUTgE8YOOP896ZfvtVY16INoA/Wuos4oJbq3juZFgtp5GEsxH+qjUZJ+p5AzWH4ws7ey1u6tbC6F3bIU8qVe+QdykjglcDJ6HcOBWz06EuSvy/5/8ADGBGpL7nzj6Vs6Tam6uYreMZklO1UHY1TtQCwRzlcHnFdh8M44ftUt7cMix2zne5PCYB5rGo3bQpNQTl2O116yt/DvgsRog+0YBk2/ekYdF+ma8/gS68jyYpM6jLbm4lZhhYI26H2Zs8D610/iHXIbmG4vL8Mbe32TKjAhgu44A7Nvx06gYqlpttcaZokdxqBjfUb92uZgp3KxIIHPdVUkAdASKWkdEZYeNSMUp6yb1+f/A/qxBel9C0a20/TUY3dzHiWY8FFPOR6k+tcL4ha7tdE1C73Q2stnPAYT9/90CGMnOMFGAAxnJxkAZNd1fXaSLG0rhvs6Jbhj/BuY7FJ9znFebfFG4ilv8AQ9Mkc+UzGa5Yd/mG1T7HoaWHlCc7NaLc1xC5aVurZz+gWt3cedf3xkklvblp5JJOW56ZPqev0Ix0rqLe12lozEAqZb1B7fjRbSy/aER4VVCFIt1OACCcbR1xjkZyeTWoZbXckQYlgN/oR6/hXU2rkU6aUVEq/ZFkcbcE4JZiM54/+tisS6W4X52BDD+BfyIBrs7eJJyCo8tmQoSDjP07VlRaROZkLMTG6jII+YgdR7ccUKfRm88OrXRxmpwSQPH5coaKRFkIXoDzhTnoy9+3IrNghcu0cuPPzhht4Yep+o7V6XYeG7XUNN1G/FwkUdsXj+zTD9/IRj7q9xyeR6VXk8Oxxf6gLINoRiG5AxwcddvYE9+Kp67HGopuxxFg62c6I24QsckDoG7gH09q35dNQ25O35MEgdduemKvXehQy27II2Uggbc5z/tVW0eaaKWawnOTEu+Nu7j0+veqjpoyJwOW1eIodiAJ9nQRA4xjbnk+pOetaOnSZhj3EqGUMCOg47CrHiSzBjeVvl2qSWHTB/8A1VT0a3WSxjYMwJAJJ/Q5+mKmrF9BUGouzNwSlo3DEJs6Y5zn09at210y4DdVHBHXHt71nW8Z3qrgsynHNTXDiFCEY+eB8qryTn2rnSaOzn6G7bagZIir5ZCNrLjFeu/DXxS9zGmk6rLvuAP9Gmb/AJaqB90n+8P1H058RsraWWcSzMVPRUHQeufWun05wNixs0cyEOkikjaw6YNOFRxloYYnDrEQs9z1TxBpFrYxPC+9NIu5MsE/5dpezqewzgEdME15pqxktYVhliCgErtPRxk4b6HGfrmvYvDepxeItEK3cSmUDyriJuQT6/Q9a4nxLpLSrPbNh7nTgVUY5ktjyoHrtyfzronGLXMl6f1/WvqcmDry1pVPiW/+f5J/JnByyySKvnM64XGD7DGPyqmspHB/Dtj3ropoo3tIAX3MsQXcR1A6fX/Oa5+ZAjsPxwa5Wrne3bY0LDVrmyUG3laPrxng1sweNNQQDdITjkkHmuSkDeX5nVSSAffGf5VVMmCMZAxjrWMqEJ7oluL+LU9Eh8Z3xfJkIJ6DPFdFovi6W4BWXZuXrnivHlkKkbj8vX8+lXbW/ZAwUsec5rmlhUtYkypUKitKKPddO8Q2d2mTII37qxrYjnVxlGDD1BrwGDUnDbt5OTkgVrWWuz26745mA9nNQpV6T913Ry1cppy1pyt5M9tD08MDXmukeM5BIq3WGQ9Se1dbY+ILO6QFZNp9xiuunmUo6VEeXXy+rS6XXkb1FVo7hXGVcH8aK7Vj6TW5xODR8Ua3ctJcuQRjOawJnXcOPXkVd1RyZ2Bzk9c9qzJGxuOOF4+tdZ2t9SUALng9fu9h9KniXcfqPujuKqocrwCRkkc+9aFmpkcA4x6gdDSehUXc19Kty5Tcq5zy1dvBFstV2qFGOuO1c/o0Y3AkYwd2AK6O4c/Z9o4fHK1wVbuR7mGtGmY18CJfU9sccelMRAuCADjgCnSne555I7/0pyx8ZYH1GPSq2GnzEsW5QGzyOme1dhBrQk0+KDI3459xXFsp454bkc1JbSPvC8gH8CAKLK9zTVKxt6jcspbDY7cH9KyLctIN7fePOKfcu3mENgDpx39qS3VdgUKc/X9RTk9ASJOEHzxZJOB7Vs+FW2TXNgitImphVOCRtZQWyD2yVGfbNZtlp7alq1hZRzMv2i4SIt/dBPJFd/qMen6HrusNaRmNVCxwWq9AFYea4J+78uR+NZN30RV1fle+/wCRhaa7an4g0nTJAs1vbTPeXxHyqzj5Vye6qFHFbmrXwvr6WdIwkQxHAh7Rr0/Fup+lZ2iNH/Yl3qkY2SapdMiDGNkQ4GP+AhSfrTbpgYXERbeyHaQMkHHBrOrOyNKShG9aX9f8PsZUEW251BxPvNw6iUL0+XlVP0yT+Ncd8TjhNNulRWEM+x22gngbgueoHH+cV14ngeRm08s0YjjRtwx+9GTI3v8AeAz32+uc5V7p9vqVteWupAh541ELAEhXBA3N64GemDnrms8Km6t5y0/re3Y8p4PG1a0q2Jdo/Zj29bWWiMaC6dtnlgjLozFfvGM9fx5Nbd5En9p3MlpGUsoZvs0GMlTEvyxsT3LjBJPJJrHtLRrJvschEj248ontIOzj8zW5ZTSRtbRXBZobcMgABG453ZI7nPIz06Cumycrvc9anDZtHQ21kBBJJGh8wLiPJGGbuPw45q1HZG5ZYbRGeYxlXUj5Gm2ZMYborHnAbAyRzToC0V1bWZVTduVWBm4icv1J+mK62/S00O1uYdOWG4mSeO5u3dgXmmUgqiqOOCFyf4VB78jWMY7tmOJxM4NRp7vy0t+B59Zz/wBnatC18JP7PLCKZADHKrgE4BPIYHHynHGa6nwbc6fHqLai9rFFO7+T5Ty5Uhvma4YnhMsSMDOB0qzq+jfa/D1tqk863szRCWeZEAEzs3yBew2fMMnJIIyTiuMv7SSye52sHjkRlxjOXBIJI9z2rRRlFe9qmYc1PHR03WlhLyzNtKLdo2hmUN5a9CPmPH5Hj2zXKatA3mLNAPnV/lGMDgcj2rrElm1Lfhib5IlZTIdxLL0B79M1lXy77dCq5j3729ck9fpn9OKFFRXLHY0mnLWxy+oX32nT442dsfOoB4Ib0/H+hpmjIkNjEgI8wgZz/ez/AIYqvrasJVBxiQ7PTn1rlJ/EVxvlsLAeXvLQtcHnYBwSPf09atJ7HFUqKGrPQYw1yp2ybI84yBkn3H+P5Zq5b2kVvGBEoGO55J+vrXJ6b4ssvNEcqyQIAFUY3BRjoSK6mO+hmWMxspVlyrD09awnF9UaUa0Xsy5GxBGOB0IHGa2bZPKCsfvVg2lzFE5lnyUXkKAc57VZbVzOuI4yiNwS3UVw1pVHJRgtOpz4mti5Voww0fd6t/p6Hb+FtaTTdctbyYqYZG8mUkfdzxu/D19M133jaM2otdbgG9rYhJR2MTdSe2BmvEbWSOaKSCYnY/BVq9m8IajH4g8GiG8HmFN1ncZIHGOv5EV10rWdN9fzFiaSoVI1o7bPzPPtaVbDUHhsHDRKRJA5X5cEcjHovTFYt6HYO+MKeo9//r+lb95DK+nLHOwFxYStbS5Ppxn88VgNMVaaKRdyyKRyeh7c/nU31PRurdyic7WyeFx+eKqSx4wcAkjkE9Par8xzKSf4jkYGPxqjcnLheDzjI/nTtczb6EAfaeuMc4p0b7TnBPPrxUUrLGzKMNzjcDweag8w4POM/pTsZuTTNV7j5mKjkkdO3/16cLshSu7JzwR1rLjc7CxJGcZoaYAnPbPQ1HKNTsbf2xto2fKQuDmrEOpSZtwshV2cIBnjocc1zfnncnP5HJqW6u1QRyL/AAuBj+6aj2SZUazXU9Y0e/keFAHw4yrY9elFYGjySxzRLncsmHDA8HNFN4eKew+ZS1aPANTbMr4PGMgdh/8AWrPLfPjgFgM461b1AlnO4E45471SJJ3Ywp7Y9SOleqeE2SKcnJz16j/P6VqWA/fKdxwO/Uk1mxjGGwynnGetbGnghuBzxjbyPwqHYulqzq9FA3Kr5KjGcnPHWte9mG08ENznjtWNprGKRjg4471buZ2kA3cj/P8A9auCSfPdnvU9KdhkSB2x2HX1q0seCODntn1otgvlqzFfQk+uKnXlffoQTzV2LRAy5jYHJOPz/wDrVHt+bG3Jz24yfX0q6AMNjjI/IUx49sfGOO3pRcqyepmTyEuox83fPfmtG3QtGpVjnG7JqjL++IBGMcZxWpbR7kBzg4x170nJ7FQjc0dAu1tdctNRYDFrlgOmSRU19qE11balf3ZZS9wttz2GC8hx77QOKSwtsCOVojJCrqG4wG9jSXkTT6Po0cg+fULt5nXudzgY/ImpUlccoW1NaNFt7HT7RSCI4WlyOBmRif8A0DbTL+Ux2p2bWlchIw3A3McDJ7DJ6mp5grahclQRtk2KOwCgLx+VNmtftTyKwEkZGJFzwAa5ql1sd9JKMUmamtaNbaf5ENjHJItxGj3a+WWdHjJ+ZOOc5xgcEAHpWTf6PLYX1xBcRkSxjaS3CnPIK/l1Fdh4Zv57O8SW7dpobW1MCAjLEg5HPpg4z6AU7XbeC9NtcG7LWtjZ+TcXTKeVO1sgd2JUAL1y3Xsd1SjJc0N9NG/v6HlxxU6U/Z1FePV7/wBdFb/I8av1VdUMgjIaLG1wcZB4YY9eBzWwivcGR24F1MFJUcmRTu2jvzjd6E/Wq/iuyns7u2862dLhXeSRX6tBKAIsj1yjHPqSO2au6S8XkR+epD7UkEhO0ecuNrH2VgD+GDVWtOzZ2RXNHmS9PM3lnF1pWJEiacINuRuBIPUj19R7ClF9cz75r2TN3IwLk/eBA4OfXH6cVTtZg17exSfKs7b32cDeR/rF9AcdKmmAhuLaRiFaR/LlR+gA6Nn3HQ+9a6vbYJJR3IbjU2aOUkDzD+7YgY/P261Wj1Bo96Oyva+YGbjJZAOg96z78+XOWkUsiko45Axng1XikEIy3KglhTa1M76WN3atvfkWhG1yreaV/hP8I/Mk+uBS65bwW5aOBg8O35WYEb+eT/h71nW1zsgkEj/uiuSPenXdyr2aDzCyup2gng9uPqa0i7HNU00OI8Tp+7Y7uUO/PYY7n61x8Gk21y7y+VuYksFxkDPPT1/lXa6xatdiW3dXMsjgLGDhiQR19BW7aaM9tZqJFHnAEttAxuPam5dEcrpKWrPL59HiYHy7cxSDoF+7j0x6+/tUuk3VxperWck6S3NnHIPtMH/PWEclVYcqfRu1d1f6QZNxVW3s2FA659BXPXdlNbPIso8uRTsZf4h7H0+lHNdWOadFXvsamhXkesaTFfwgKktzJbLGWUSIVBYFlByAQD8x4J4znAq5FnZvC5J6c9h29a8/vknspjqdox8y3CidRwJIQw5P0/8Ar12mmX0d1Fvhlyz4IGeoPI/nWU49UaUpuPuy3NvT2xOC6Eeh3Zr034WXqDVr3TJDlLuHeo91PP57h+VeTwy+W65I611fhHUGs/E2i3CnAe5WF2/2WBz/ACFZfC7l11z03E6bX1lj17UYdgBvLQXGGHygquXYe+a4i5lG5HUYJAJNd78QIjH4hsvtDv5DvLC7KMsqOS/H5VwU+WJCrlgTgDrjPH6AZrNK0mbQlenF+QyeUuRubJUDH4jP86pXDhuCCUI4P+e1TSqVDbgynHcVTnVhCWOdoAGTWydyHcqPwQB29KhLg88Y6Y96dOCpO4ZQ9PpVNpdoYuRyMA45FVymLlrqW0cn5Rkk8j60wSDBIIJz+lVhLtICn5gPXpRuRSgZ8Zzu46cUrC5izPIIJHUP5kYHDgcEkA8fQ8fhUIuCU2PyAScg9jVG6ut0aAEjaOAenPP9agWctkDAwM8nqB2qorqRKZ7H4NvVl0aO3lw0kBwvYhPSiua8DXP2mRFRz8w5PoPeirlFHRQqPl1PIb4DzSGBIyepqquQQcZPTOP8KuXY3O/GR6H/AD64qou04JGASOhrpPHaHxbiAxGD1Iz+NbOndQc9BkE89fWsiIcqAenAzz0rW05/mwOeQCT/AAmoZtT31OtsEJjDKMY6gDGadMB5mNuB+uat+H7bzISRzxnimXcGx2OCCOea4LqUme5FWghkcpAAYZPBOf16VZSQEjH456is48EnnOec8CrunoGYBc57g1WiNY67E4Y7sIADjH1p7oSM7uOuO9T+ShJAXHBpkrbFxt568VPNdmnLZWZQRMOeRnPAI/WtfTxgBvToTzWY4G45wdvJPv8A/qrV01TIrDJJ6etRN2Lgruxs6lCsegs7ZDgfn/npUlun2nU/AkW5VSWRjkHoAuc1qarFG3h61DYII2v9BWZ4dK/8JL4FjYZUNKM9shDioi9L+RFWV4OS6X/BMdpzx+e63JPkLcXMjsh+cjzGAAzx2qa3MnkorFRK2MkZ257471mQAxtIGIyLi4U/9/nrTtgo8oEkjjHvUS+Nv1O3lSimaVhqcMWyJmkM858vyQCCzdFT0561uO8eh3iW2TLAsxeVB90seuPTHT9Oma5k2hucFW8ueOUSRuT6f1q3qeqRwyKZEdTMNuWPIwc/N9cYz70Rm4tps4atBVJpR1ve6/ryI/HF6mpX9nMIEkhRd258K8uCfkbHQL1GOAWJ6k155LqTSyG1cvuhll8rfwVUk7VOODxzXfaDpyX+swWVwwaG7ZpGdW/1W0ZEan1Of0rnPFejrBFcW8kTwXsMfnwzAcPJtwyY7EEnnkEc8VbrSrSba+fQ1g6dG1GD1ir/ANf1+BFpMjllLfLvXJ44we/6frV28nYqZlO5kQfIejL0yPpXL6PqgkTBO2WIgkL9B0H1BrWnulG5y2S7MyjPQH7w+mc1vRlpYuq09UQ38nnGYpnLgY47jp/M1kSyzOkCICCMr1zxmrsk28OGx1ynPIx0/maoNdGOV9v8a7QRzzjt/jWlrnM5o1FnEVrKkuBgAEkjJP8AnvWZqOoyRstsluzBf3kaKMFzjov+yD19aydX1Jot6nCyQkO/PJ9APTn+VPj8RQamolnUwX0THMY438Yyre/cYptqKszGKdSWh2OjRQWulx3F55UVzj9/gZbf6epqxqF3cTWvnWsXlR7hwfvN2yPX8Kz/AAy322++1X7KryAku65WEYJGB3PGP+BUt9Pc6tqsFhaKsdzIhaOLzMBQB80jnHyqo5J/nWTm2jsp0oQ1ZCt67wt5h3IR0wMqwP3SfWud1AyTGaVizfN8+4nnPAyfXitrQ4Evv7OjZjBBckyPPMcJCuCQz/iMD3IrmfEV09tMUKYR2YAZ6DcQD+ON30NXCpZ8rv8AicuIguhkXMhic/MTk8g9D7Eenan6HPFAggUkIrfLnkjPOM/XNVL2YbcnG5cjJ/U1mxymIgAkDgZz09fxNb2ujyptXudutxmTHmYwc59fatlLtltY3DfMk0bJ9Q3/ANeuDsr9nIUkbSTjviugW62aZJ5ZORt5H+8KynC+hcZ6H0D8WlVItFnx8xvGXPTI8tjnPtjFee2SCbVJU3bJFLH2PA4ruPizdRNpmhQbgZxc7mUnp+7b9a4TT5oLnUwslwYZZn8xZuykdP5GueKd/uLw2lKKfn+ZDqzqAhV1dAePUZ7VnRX6x6XeWrRhxKQylj9wj0/wpdVu/tM9xMyqrO7MQnChi3UD0rFmk2AlsYPrW6jfcc5WYy6l3kZPU5A9/wD61UXfaecZx6Z5p5kVmUOwVT1cDJUeoFLqAt97LaOZVyTnv2x+fP5VaRhe5XtmEl1BFI21XcKT1wCefrUF3chCerAcA9+vtVWZh0YkZ7dD/wDWqjJKxIbkZ5PYH3FNJEykWZJi2CSSM4Gee9VzcEjKg5z/APrB/Sqcso2PljuYkZ9DVaeZ9h2AZK8DPGf8atRMXM9G+Hl4z6gIo2GQQOOlFWfAVvaxz2t1bOQxQM6nqGxgnFFE4m1KStucLeoVkfrwcYJx+FUSDj5QTg54/QVraqmJDzn3H1FZshyMMQM/KTj9M1rY4mLEpUgDnGRzzn3Bq/YknAODk55J/rVW3jZ8kZyByBz7/hU8LdPmPb5scZqWnsVHR6HpvhG4EMADkkHjpinay8WS0eMgk8VjeGZx9n2/dHQ+31qxe8tnpzXB7NRk2j3qNRumkUZQWkPV8e1X9Och8nr6VTA5JxnOOfWrNtzICMYBolsdELo2pH+7k4bvn/P61Tdge3Uc/wD66fLINoC4weff6VA7EEdv5VHkbb7DSQYQzDJYkCtXRiG+XuRn9DWSpARtwzznGK2tDY7iowCeuKieiNaSuzr7mIS+FrXc2FdSpbsp9a5y0uPsDeD9W6wx3bDA7ZO1h/49W4JWl0FkXA8p+h7iuXuUK+Eb1XOf7P1FZCMfwHJ3D6kLWXTXsZ8mji+7/H/hzp761S21G+ReI/tMhVcckMdwJ/Fj0ot1j8sbSeOcds1d8QBX1SO4RvlvLOG6A7A42kD/AL5qijeX1xlT0xVtpu66/rqVSk50ovyRoxxg/MoOCMj+v9KzfEEHmeQ7oWXcqbV4ydw5rQtZNwBOOD3o1AiWAxgKSSCM+1RUWlkRTk4VEzLt5FttVf7MBEyyiWDBH7vaB0PXrnr6+1UvHetXOozW95uEd5bq0bcABl7jB9en41qalGlszSOpUIArjqQx6Vn65bW0lzCGwwYlm/FTg1HM4po6qKpzqRqNXdt/kcZp9jBd3f22xmWOSRCklrJwpxztOOe+Rj3qDUbo2cxV3JkhGXGCflcZX+YreudAglciIFWYDYynlT3NZb6YwaRC20upTj0xj8vSt6N1uZ4qzb5UcxqGsxwSsWbc46DI4HbJ796b4P1JNX1hobpdkCIxaQHGDjFY/iDQdioyNId3GM5JPPX24/lVbwnqZ8OXlwLuASQXBVicZZHHHA7rjrzxXdy3jozwpVHGpaWxp6zZTQxzJvJul/dlj/EffP8AP/69SW1rbrNaR29zE0srJCA2VAlKjIGeoGcZ6EjiuiFpa60sGoW9wgBXyyAOgzwCPr0NZmvaHdaVrUkd1AYyio8q8MUDAbX4PQ8Hjmp5ZSTaX/APQpSjE37SUW9ikSB0DDc7oe2DwMdM4xkU24nF7FAiqBdTQNFfTRkqjwMNsduQepU8sejDjmsexu5orPbNKhOdpI5yp7/0x71deYwwqEPI42j8+tRHmi9GXOonZmtcXcdra8kOyAMze/QDPYc1w+uNLfyAjJGeCeh/H1rS+wXurzjzgYI3AV8HHAOc/pU2umC1t0HAJ+UBVxwPatYxeyOStUVvM5aWzC22XYtL5gCqASCu07jx3zisi6kOxmUZJIwCccCtrStSMPiKyu3ChbVJTtcfKzNGy4P4En8KwJJFYfuiQifdU9Rkk/zJxWqTR5dSSZasiHYYyMfxAdvSuy8PW/8AaGp6Vpqg77y7jiKr6dTj8AK5DTowG2g5GeO3SvQvhtEn/CdabeTZEWnRyXhYeoAAH61nVvZ2Cmn2O9+JWofaNXgWM5Pn3Dnb2CMUH6VxU8gL/IB8oBOepq94juy+sKefMiUBm9HJ3N+vNYLXDnLth1OSxx/Soir6nTJ290nvGZh5ojYJnb04JHWs2eQkHORg9R0H+fWrMtwxtYUVyQCWdSOAc8EeoI61m3IQxKYicqAMN19z/LitErkSkkhyEEj5cgjofXr1qN5AYVCIFlUnc4bJb/PtVeOVo2zgkMdpHaie5AA2T7kUbgNvUnrj2ppGbZFNtIZWZgQBlTnn0/Wsq5JDAKCQOc9CDWlcSBQytCqrgZAHfr178VkzTgMduQxzg45//XVJGcmyB0lJHUjPbpz7+lOBVJ1yAAVAJ6fiP881G10X5AwTg59gKQt5pAPAXj2/CqSMm2eheB95fdHymAOCTxRT/hvI1q7yTKdsqlCCenp+XX8aKp2NabSWrMbW4gk7dj27c9xWKy/NwMZPXpmuk19R55GeRycD06HNc9INzDt3yRnr2p3MGrE1ljB+U7Dz25PfmjgSZHPOPWokkKxgcck4I5PFLk7iOduM7j2HqfxzSY0zq/DMwAZSck8enNbV9Fhs469gevvXK6Bc+VcLuYgHoOwrt7iWGS2+XGcYrjqP3rHr4b3oXuZKEAYGABx071LFw+QdpB4B5FMmYF+MnPOfQU6AkgqeSeq+lQ9Ed8E7k2VwAzd89KdINpD/AHs+tLDCQeeo7Y609k/u4wBjnvWbZsokfygAAErjBya0dKkCy4BHPJwMVlcKORjP8R9KtWLFXGcHnoaieqNKbtJHc6SVMzwyMFSQjkdge9Zq2Lf25qmnOvyXMDBc8iQphuPwBp1lKdybeQThsdK29fkfTtNs9UtUR1s7pLglh82MFWGf7pDcj6VzxnbQK94Tsuv59Cjp07X3giymdi0+kXHkSr/0ylxye+FyfyqKSUYIAOQO9S2T21h4l+xyqv8AY+tq0b88BZDuXn/ZdnFV7mOa1uJrW7IFxAxhk+XG4jow9j2pxlb3e39L8PyHSS5mu/vL0e/3O/3osRSMJIpEJxnBU8dR94/SpDKFkDLluRhcdMVnRH5gv8J68elW4yNxZh8x4obexpOCRbv2V0bblnbkg8hj/hWJdxC3tXkBDzOybVJ6DGDjPtmteRgYePvqev8ASsy9kSWZFJLFW3+nOaiXmPD3WnQl+6kZ+7nGD3Pp/WsW9IO9lPzBiQcY4/DpWlfTbbcqpAYjODwPeuaur1VjBDjk5Bz1+tdNFEVtEZ+pW8bSA9EPYfp/WuV1LT92VAUqSTggcHp+ANbt5ehY3wxDqQQR1wM/41nmUuAOoCnr39K7IS0PGrxTZy1jq82jXIwzRox7N9zPb6V2Fpri3Db2OJMbc4z7fl/kVzWr2KTx5QYXHBHv2+lYMD3Gmz7HyY+3PI55xWiV9UcsZypaPY7u6J8zzI3TDcFeNrHIweKu6ddIWkE6bZYzg8ZX6g9/p61xcOtxlR5kqqwGSWBz/kVL/byqpYspGRghscepp2KddPRHc3WrxRq2X+bjr0AHTFcTrepC5kIEjE5JJPp/Q1lXmrNO3zTNsI6L3rPebLkrgZ5APerUdDlnVV7lm4nwNkfXOSf6VDbkrIGwRzyFPJzTGYOOMHn14NXbKLc4yQQep9KZgm2zRtVJ2FOp7Z/WvS/hxGkdpJf35IhnLQggddnOP1rgtJsJ7yaGygjJnuCI4x1wScZ+gr0jxP5ek6XBptsoIRRbwgjqR99vxJP5VhU10O2jpqYq3cjrf3MRVre+dY5QSDypDAjuDkdR9OlQHaPOV24aNsdsHjijzIxb20EYO2LmRyPmLN1B9QD09qHfDsqtlTjjH1o0WxVrsz3yGCtlXGe2BVGbd8+35Tkd+PpWi0b7funpwO/0qnKjDDMPvLuRiOvvnv3q1daGctNTNn3EkkcE465x/wDXqGV8M5ZcgDHXH61pSRKysPuoxJz6f4cVlzhlOcFc8ZH9KtIykrdRguP4Fb5S2FX3PFU5XGSfU8moZiFcbRlhkk57dMfh/OoixIJ6lflx2p7GbZJNyATkg+g7fhSIVEwB5zwVx1J+lMWQ9SSSDkU612m4TA/iPQdBVozkel+CIVkjCq2QPlHPt70Vb8EwGKNfLbtkA8ZorGrKSeh20KcXG7Rj6/8A69gc/Q9PxrnJOeQOCcf5xXV+I4CsjEgjNcrOu5zkMWJ6D+VanFJ2epCrcdsk5/CpCw2kE5/2h/hUCnBzng8kD2NSZ29c9flPXHvQyUy7aTFHB255AwK6K3vWMeCze/HpXKoSpy2eOOea17LLAMBkBeh71z1lbU9PATv7p0MUqycDCkgZGc1ctogvXoOD7+grno5cElWOSOO/P/661re62rGDwQMfWuRybPZjBRZsJjaUJLcjDdxzSOuVIJz647VHA2UVj69SanC8ZIOPUCpSNdyjJhWBB556+tSQFQ+TkUkwIJBwcnpjkVGhIbAY9OMUb6DWmx1GnSfu1Ptyc10DTtc6HLbtgqFIYnoB6Vxun3G3GD7fSum01y8UnltywwU9u5ribcJnTWipRU+xlWgTVNCk0ttxutN3SxEfeaM9VH0xkfWuhmddc0O31gc3tmiwagq43OuMJLz154+hPpXJTzTaHrsOoWwPmRHIyDyCORg10+lXMemS6Xrdig/sjU42DxHBC/3oWHr1I/3TVSs9V/S/4DOepeDSjvuvO+6+a1Xn6Iq7QjZU49x9Kk4UD5TuJzj19q0tf0j+zJYpbY+Zptxhrd+uB18s+4zx7YHas0riHaBitLPY0hVjVipxejGyyfL16c8VTm2mRW654qSXnJA4HB9qqXRwAQAM9ql66HRBJalW+k+9gDGMDP8AhXG6lIwbAb5Sx+Wuju5flJDdOh9qwdVt/NO5h83U9q6Ka01OPEvqjCM+ZmZVBRsrzz6U1JASeeCcHn2xUV2JQTtIK55+nfH6UsKmXO5s8Fhn9K6U7Hlzs2PYqwwSGDcZHaqdxbqcFwB16jP1xVvkEjg9Rx36UoCmJuzew/T8a1i2jmlFMwbixjkQExqwOOlY93YIuQing5C4rqJwrY6sBgjnn/8AXWVqPMeF6c4yOnvW0WcdSnF7nO+XhuFK9OlPVG24bO7pjPX61O8QZiACfQAYqWCE7uAOSFGOw9aq5zez7C20O7tkEg5Nb+m22SVOMbh83oKqW9sAwwGwOmeTXW+DdHTV9atLe/8AMj0jcftUqfeOP4B7n9KzkzenA9N+BHhpd8vijVQIrWNSlmXHRR96TnseRz1zWVrGoWureKtT1Zoj9hjEi2kWPlMmAAxxz6kAetdd8QfEsJ0Wy0PQjHFA8Y83yxxDGOkY7cD+WK4/RbA6nd6baQMy2MB27j/d5PPsSax6XZ00uZO5Qi8NX2y0mnKwwXiM8dxIQVJRSdr+jnGMVgMuJASCpBOQT90+9d3rt/Etu8QAUq/zIB8g28ZA9K4xIXvJQwOBkkg96cW2XOysSMGltRuAOEC5HHTjmsq9D/u9xJVwdo7BR2rqTZiKJSELLggE9T2rmtTiMTspB6ZGRx9K0tYzfcxmm5PIA5y2M/hVW5wO5zjOPTHU/wAqRm/fYzk4xkdf85qrcTLgAgYx3PSrSMJOxnXLBpDlenJ7Z78UFMwuwIyMcjjPr+FRuPmGee+Bxnn+dODY4PXP3SOaZk2mIsf7v5SBxjp1NSWMTCVMnIHUCopMDp/DknPT8K2dDs2nYgLlGbJPZj/Sna7JXZHoXhI7Lbd3xyT2+lFWdGiMMcaMuAo5x3orGotTtp2tqO8Y2oS5kBXg8D/CvPp0KnHPXBP9M17h8StGFvcNIvG4ZPofr614tqa7JXXtnHTrWsdVqc1ZJSMyTgjHJzjinAqGx90A4I9B/k02THDcE8HJpyNhVHB2ngjI/wA+1NmKHLgYyeBkHJ/U+1dR4ctvOt2LERrnGG4z6ge/SuZDgkHJHAHXJNa+i3ht22LhVJ3fjWVSF1Y68LUcZo27u2xgoMv/ABYHX0p9vCSvPIzWvYxC7t/NCFh6g9TUcsYicA/pxivPas7M+l5lON0NtnEQJIyAcgHuf8K1ob6NLWSE4Kvxk9iO496zBEJmULxjkY7e1UriIwu0e7cF4XPPFJx6jpvoWbiXc5G7LDpUDEj7oII9e1XLSAGIFzkH1PvxUstquTtJ644PP4Uldq5WhBbyMNpzg+1dDpF5sKPnkHOP6VheRIiF2IGDUtrIY5DnO7OOO2KxrU21dHTRqKScJHVasp1eCSQD99GN2PU+lZOi6iLC1m0u7y2mzNnYf4G/vr6H6VPa3OR1Y8VNe6PJfIzWSkygZC5xnHNZ06nSRNWlGCs9lsdX4S1uK0sZdL1kC40+ViI5P4cf0P8AWoPEGkyaY6Swv9osJv8AUzgZwP7rf7Xv39q4jTtVe1geyuFPkNJuORhlPTI9MV0vh7xaul6bLpt4i31i7HaJDkbfQ+nNaLT3b6fkcMqU6VR1aS1e67+a7P8AMz5XBz69sVmXcjkfMM8YwO1bN3DZS25n0u4LKT81s/8ArIvcE/eA/P2rAvf3bYfIx2NCR6KkpRvEzbsllbawLAAr6VnXUpZieeFxg1dupOrAfw5wT2rMu8Srw3zLwK6II4K0jHuU80nYPmIyCPSqYbymUc9MLjk1bmJLnHUjof6VSuQyoSv3hnAH866F2PPqWWpIZDlWcDGMHsPzp9vKB8ueCSCemeKp7hjJXDYx8pxx3xSqxjHPzE8Z7dP8KtGErj70bMbV2qRWTNmRMcANzgn0q9NIZPlLDA6juf8A61MtoDI5HfJ//XV3sjGSbM6G1Y88gAcEdPpV6DT2fBwMnpgV0en6T5jKNpO87VAGSx9AByfoK9O8L/CW91GOG81hpNO0/G54iMXEoHQY/hB98H2pc6RlKCj703Y838J+ErvXpbp1cWen2ibry+flIR2RR/E57YrrNUubSxghs9GtjFtjG2LqV9XP+03Wu98b61pen6Gnh/w7bRQooCKiDhTkfM309a8/nkig/dwnzZiwka4b7ykcYX/Z4zjvmnzcyujSEWvIqawp0rTE0+GRWvJovMnkHOxn58sHvg8n6cYq7Jr8VroqWOmKYR5aiZ2GS7jv7Dnj685rDnQSKrPkuWO4k5zn/PWoLlhswuVC8DPtTautS1JokN3JMyhm3BG+Yuf0Nbelqiyqy7cn7vT+Vce7YZgONx6ZztFKl28I+WbZt6E5/E4quljO53gvbWOUpuBRcceoHBrkfFF9Fc3DvbYWPnC1mXV6QhCMck8kGsuWYs4Ybsn09PSixDnpYruQWPQe3XHbH9ao3AHmAttHY4q44OCOWUdPbFVZUbnnP49Pwq0YyuylNJhxvAUDHAPU0yRyYy3G7gBe7e+e1E2U3Ek/0xTIVLzLFkBmOB2yf8adjKRas42nfhRIM5YdfwxXf+E9KlYb8DYD0Axk1z+i6ZOLpAoxz8zLzjvXp9ja/wBn2ICnLtlhk9PSlJ8prSpt7iTp5ahe46n1opJZQ1q0kp+6Mn60VNmzVvsd/wDEGQ3Nsu7lcHjFeA+Io9k+BwP0r3jX50uLMDBJ2jB9cV4v4rhIaTsc9utTQndCxUeV6HJBmIy5+YHnI601CoJySD/9c00ncSeRn05J/OgncG2kA5zx/L/PFbaHJqixGQDwuO2B6dP51NbEIeDhc4BHPNVFOR1PBwB9evNSI21uOCOnH6/55pMuLtqeieF9fWy0s2pjUcFTnk5Pf8KfJch5dzk8HODXIaXc7VBHOOwPU/5/zmtaG4aZ9q5+mfzFefUhys+hw1TngkjoInAJAJDHrx1zUMqvdXQGCcEH6VNbQyCMnGB7/pUFrMIrp1GD83tzWMtTuhHlRtwWyJGihsnB4x0NSx2TyOqQgs5wAPem2rAndkkjoDVqO7ELKygZ6A+laK1iWylcwPFKYpsAhsYPUVWkjwcAZBGfpV4pNM11clRLu5ywzj3/AAqKazuVJdAXGBnB7+lE7bMUZS6EUUhikXLcY7GtvTdSe3KsjYZRlTWDG0awym7R/NdSqKOzdifam2ayTsIFcCQcAHjP/wBeuSrRW51wrKfuTN65sI9Xu3mVPnZSzgccjvXJaiktjIydsfn/AIVvRyT6bNGxcc/xLxj2qrq7peAO3L+oxyKzhKVPSRv7NT0X/BMFNSmgcSKeVOcDt6mtH+3IpkK3CY/DPH1rMe0kVHYRl0X1HFV2EbDbyg5zx2z2rVyjIcKcobqxqS2s1wvmQx/IfuEHqPpVZrOVz5bARsTglvf1p+mG3l3wyzGJACc7yBkdBxVXUdYeS8jclJFiHlq2zG5Qe4Hfv/OnzyJlQg3sX/8AhGo5W2zXBWRuF44+lUtT0C1tYeZ8465PX6VYXWkhsHjkjR5z0Y/w/wD68/pXOm7FxNm4DGHJC5788k5pRqz7jlhqK05Qh021nYbPMLjpJmtCPwvcXUiR2jB+nDjAH41p+GntllxOrYJ4+n1r0nS5rMKEgCbduST1qViZqVrmNfC0YRvyX9NPyPGb/wAJahYXEazw7y5IVkOc+1dB4X8CajdXka3IitYGOfNkOdv0Xufxr1+8tWmtt7YxtwOSDivNtWjurO8kWE3Che4J5rZVpT0TsebCjSlFyitV8/6+dz1XwxpPhXwVAt3d3UcupGPJlmILAf7Cjp/OszxB8QLjVjdR6Fbn7PbwtM8s3y/IOrD1PtXmNufMO4bnwByRxXVeH9Du9Ztbnykit7aMAy3FwPkBHTB/nitOdRio1Hp/Xqzg+qKMnWlr5vZfI5ryvPkgEZdZWDLdTsc7xkEHHYYByK29XhttEtUh8pHlZdwBXnkDBJ9DWz4i/sHw7pb6PbRf2jduElmv5sOd2cjZ2Xp0XjtXC65qtzqtwXunaR22qS3XaOgrWE3PpoNWUea2/wB/9eupj3Lkna3y5OQOmP8A61V5nTLlyD6kippMKdxY9c+/PFZ13PkY2jAJ3EV1Lsc7sULiYI4K9Fz+HPT61Te5G04J54IPQGob9t27PQDr1rKediFLMMgEEdv1qkjCUi+JgeDxk568Hj+hpxkCP0PTPr+JrLEx2kduw70SytkYIPvjrVJGPMuppO4+TCnb1J6j6UXSxxI0ayBye/Q1nwTMHxklc5xnuaVp2IOCMbcn/P40E3K9xxuOQBjvxkf0rV0DS5J5oJSCwJ4zyax5SM7nG3HVvQDk1658Fkt47S8l1iHzYZlJg+X7vIxj6Upy5IuQqUVUmkXtL0ybS7iVbiBoyV3jIzxjgVda4aR2DKAMZBrb1rVI9RkRQAVRAgPcn0rldZu0sbZ23BWbgseorCnOVRXkrHbUUKWkTA8S6p5du8KnHfOfyNFcjqNy085yCGOevY0V1x2PPm3J3PoC1l+12IUfM3Q/X2rifFOlSsrsAfXIFdF4Lm+0RRncOflOT+td5daHBNas5BbAyN3rXDCpyS5T0pQVSKbPlme3eOQllIGcfTFVym1jgDpgDHGPevR/HeiJa3DtEFTJxxx+P4+lcBNHs3Lt6Y6evrXYtVex581yuxEpOTtB9BnvTgCBsyWHA445+v8ASogdhAwNxx07f1qVWOdvQk5AzjI9qrXoQW7RyHyHBGMKRxW5p+TKsiDcOvvXNq2GBHQqO56f41vaJc7XVDgKflz2PtXNiKbauelgKyhKzOws7t5FEbAjsOP1pi2p+0eYx+X6cj3qS228bTj1xyBRcXPkMeM5GQK8/wAj6Raq5ZhlAbZjmpI5MOTke2fT/IqvAVmX7QXwV4HoapXVxm6IDfKODg8A1SehlLTRmvd6hI6usWUUjnA4NVZ9RuWYfvDkAKCP4vr70zdm2DYwRk5/CqkpwxH4YoWu4pO2xca/+0QlLnDMp+Rx+WDVE3jLInPO7GBwQaikbAAyMk5GfUVWkR/PjGzgrnnPJyMfpmrSVtTNybZvvaSXADOxYntu5x6Ug02ZBkNnjd161racTNbgogLqFH/16szQPGGRvy9a551FskehToJNNvUwIZ/JgkhZAPMGG3Vz14BHdbuCFbJyeCa6bU4+D03qOR1rmr8bWKkDcBxk9vSuSKs9D1nZx1Kd5dmeRT5aZYY/drjd1569f8KpFjtAAznnAHUf0p8gILD16Hjr6VNbQq7MXbg9s9v6VoZpJlSUsWIxliOOxJpLeMy3UUWTtLYbPp/nitCcJ84SLGD17/Q0y3LJLlMdc/N/jU8/Qv2Kep1eneGj5PmzzeWByM9K3dN06exdJGkJDHgg9a5y2vXuf3btyQBnrXQw3b21qse/fn1HGazdRTdmiatOpBcqe51Cam0qpGZAoUDjPP8A+qtOPSbLUhm8TbIP4wTXDNZzyKH3sHLAcHtXq2hwqdOgUn95gZJHp61cYSm9T57MEsLFSpvV9jmdR8EQzsZbXdFIRgsBjNRa8msnTre2lYraQKE+RMA4/iPqa9KB+VUICjtgU6a3t5f3UqK24c5Gatrl+I8aOaTTXtFex85Xayb335656cDt+ArNuI9qkHnt9a9217wLb3SM1mTGzAggAYxXG3/w4u41yjseOnGDXTHFKOjR1Rq0K/vRml6nkt2W5wRt7f8A16yLh8IAvbJ+lepXfw/1JQSqMw56kVxuu+D9Ts958j5SPmGQT9cV1wrQfUU8PN6wafozjNQigPlNbOVJX5stmsaWB1Y7gQ2OPY1q6naXED/vIXVgdw3cfjVZo38tWbJDc/Mef8/pXTF32PPnCSdpIzhG3LgfKT1zSOp3EYyq9TV66lCsE2bJP4tozj6e/wDWq77AWKkEHsT1/OtLs5mrCKMoARn2poIVCoYdKaMqCScZZTjofpTd4YA4HGe2BQidCOUbm2YGXwhAPZvft1/CvVfDc8draQqj42RDAXuTXmmlw+bfxodpDLyTzxjv7V6d4Z0YSRpOMspGQCO3vQ43Viqbalc1I5o8tI5xtGcZ4xXG+JdU+0zMsb7hnI57elbPjC+hgT7PEVEmckjufTntXF2yG4Z5Wz5afMzY4Hv6VMItbjq1L+6gijWGF5pucrtXPOPf/PpRVfULgMCqHKYwoHp/nmitUmc7kj0bwJqnllImb5xyM8mvZ9P1XzbTg5+XBz1r5m0e5MD5TIYY46dK9v8AB96l1bw5bAdOoOOa5JU/evY7qVXSxY8Q6QdRjkkWIPg5IxwRXknizQjp1zjaQmNyE8df89K+mLSGJrcqRnJyT74ry/4m2KNCXHSJs8joPStYzew6lNNNnhUg+bLLnPPTrTAduNx9vrVu/jaN2GM85PrnpVLLbsAgcjmtdziasWdu5d2QQO/ap7djHMpHTqMH/PWqinOAflAOTT0PGcdD1H8Q9B6VLRcXZ6HVWOp7Ahdyq/oPrU17qgYhE6kdB156VzcMpKYk5OPr/wDrqa3jLtuLk4GPbFcNWnyu6PocLiueKi90b0N3JGSjNhR096sW7i5lZ1wQe471lwW8s6o3AGBj6Zzya1tHiMcg83AI6fSsUjqlLUvsXWPBBxj7tRSMQAOTzwKu3UqEjaDuHXoKy5W7MePX+lNRJlLsNmkJYhSRg4NNjPDEMVO3GDzg1HNLskycNx07fSmCYEFh075/nmrM1vc6zw/dtKYRn587WJ9PU1v37GQZb5mVsZHevNNKvWtr0MrcHOc12tteq0YYnIYZya4KsOR+p69CarJS6ohv3DAlPujrxzisHU4CcsowMHjrzW07qznBA9cHAAqjfkQ27SjBUN1AyamMbHRKqkvQ5KUYLE4BH5D1xUSuwxt5YdBUly5CkHnjOB0GT0qoWwzKv1+nfP8AStpUnY5qeLTZaaXdkE5wMYBqSN/mBI7n8v68VSicE5HcccVYiyQoXtjJ9s4rCUGj0addM1LaQjAVs4HboK0lu92ABx1IJ71hhjjLHgc8Y49K0LYszjgcDk4zzWMoHUql0dv4fvTdXVtaM218HBPTivX9Ks9umeYZgzDjNeJad5YnQxxyMsYVztPzjBwTn8a99sdOih0oTXE6eWId4I4RBjO7PXpjOeK9PAU1O/Mj47iCrCDiou1+hXm1KG2sHN3z5Yzkc/5NM8O6zZanExEwEinBDYBrzDxF4iaYi3iZW9SMHBPr+VcOmr3FjdEwuUbcQ3cN3xUVvfacdUc8cppuk+eVpM+qo9rL1B9xTwgrwbw18Sbi2JinbIyODg16X4Z8b2OrMIndYpvQsMGqp4iEbRrQt5nj4jK61NOUPeS7f5HWtEp6qD+FUrvSrS5UiSFfyq+HVlBUgg9CDSEiuydOk1oedGc4O6djzvxJ4Is7pWAhBXrjj/CvMdf+HcKlvKg2nGMg4H8ulfRsiBhisPV7BiMryp7+lcDcqe1z2sLmTfuVkpev+Z8ka74IvLWXMA8xQc47/hXH3NnLbybXiZXHVcYr6y1zRZJlbAO7oeeK4LV/Bs0yHdAGB6nBJrSGPcfj1PV+oYXFLmpy5X2voeASIVP3Ttxn6elQqAoJYnJ716lqXgcqGEYdSccbTiuXv/CWp2w3JC0hPy/KDnOcf1rtpYqlU0TPPxGU16WtrryMzw3sN+gmxjofYV6VJrcGl6YUiYeYy4H1/wDr1x2o6O+issTL+9CASfKMZxyKx7meSUFWLHPHr/PrXUpXPOleno9yfULyTUJwWOQxPB7/AP6qbNKIrfyoujYLMO9QxsIhJIVw2PT8se9UJ5SxBAzzlcdPxoV+hhLTVkczOTuHrnk5oqvIV4HAOeCcHP8A9f0op3sZto3rN/LySVAHHB49K9I8Cas1vKIWfAHIryy1kCspXPHGen6Gug0i7+zTRuSQB0z39qiWqOmnKzPqHw/qMcsaDcu7HrXMfEV0msp0A5dTkj+dc14Y1vMSBTg44FbesRf2haMyZO4c98VyRbU/eO92nG6PC9VBaUsoI3kkAfX0rKwMg8bcgg9D712PiHS3t7l8rn5vXP8An/IrmZ7bKtgHrg5HWuy6Z58lqVVIDqvRhwfb2qxEeuQBzkH1quyg8Mw2nrnjH1qVc5yvboB396PUROhKkZPP3iT0xmrlueT6+x/zxVBWGMD5l9OueaVJvKxtwCOcdsVMoqSN6dRwdzs9OIWFdxBboPSpUlQT8YI6En17VhaffibaknGB61sCIyY2D3LHoK45QserSrKorl55FLNg55Hf8KrTnbychseucirX2YxIrId5xg7ahZS5+bAAPB9ai1zq5u5mPE0rHsP6+tMuW8tSM9v8mtOULCpY4U+h5/Kse4cSnCg9ew4H0pi8hiPl88jOM4rbsLpyjKDnbznP8v8ACsVUZDx1HIA5z6ZrV0yHykbzCQB19qzqRTRtRnySuXkuSrhlbHrmsvUrt5SFJ+QHHrg+taGqXEZ/1abQwAGPSueuC3mDDDkfNj9ainSs7s2r4hNcqNfQtKg1OOd7yQxf3cH/AD1rH1Kx+yTtEwDIT8rjgn/9XSrFpePBgdFP4cVZkkikDeafkI6ehPSui2ljjUznWcqSOcDPOOpqeGY4dAcZHHvTLhFaRguQF44PAqu20PkA44Bx7dcVm6akarEuOxvacy3VwsaAlsfkK6m3sI1Rd27PfHpXAafdvBco8OSxYJknt2zXrGjQebLGbkkZUEj+tcWIh7PY9XB4pzi3LodF8PNAsdZ1LUIdbAWCNUEMYbb5meS2fTgfLVvVfGtxY2GoaQhMqLPJBC/Q+WpK7P06+lZd1bSQ3CTRZ8sHjsM1z3imA28X2lMuJTyi8HJ9+31rooTekFoebi6KlJ15PmWll2aKd1qJjaU5y2MliMtzXLXdyXbA+UBsfhXYeKbCXTb9LO4CSLFbo0U8a4EkTd/qpAB+tcTfL+/ByWUZGDwa61BJ6HBOrJq7ZXmnZcuXxnrz3qay1i7tJo7m2kdJFPysD09RVO62Enghcj5Rx/Oq5YMjKrHaP1x71bpxkrM5lVad0e1eEfinKoWK7kw27Hzvlen0r0zTPHFjeMis6gnrgnH8q+Qc4cYOCfmB9fetGy1y80+QCOZmjU427jg+/wD9auKrg5LWk/kVbDVn++jZ91/kfbVrPHPGHicOp7ipJEDDGK8F+HHxDVgIS5PONhJz6Z69M17DY+ILW7TcpIPoamGJXL7OqrM87FZdUovmh70ejL8lnE3JQZqJ9PgdSCgpw1CFujUSXaBCQc+1Yy5L3icy9qtNTDvtDtZGP7lMfTpWfbeHLaHUbe4aBXELlyu3O7gj+tbhuvMkICkc/StC3XI6Y9ayiru6O361WpRs2eWeKPCMN40hFsNhJPK579+a8v8AEPgOOME20TROOo6ZNfVE1rHKpDKDn2rl9f8AD6zIxChu+cDNbqVWlqjuw+ZU61qeIV/M+QdT8P3NqSCvA4wOMVz9zbSREhkYEHA4/lX0/qXhf5jvjHPqBXMal4RglDboAPcEcV1Uswf20dVXKaFZXoTt6nzzIMZ6nHvRXqWr+AY3GLd9hIxxggD3FFdscZSavzHlVMmxMZWSueeQOS2wcbWAB/DitK1fBU7R3+tFFbNnDFanQ6JfSptkUnLHHXpXr/hS4eeMLLhgQAc9xRRXPXSudeGk+YyvGenQtJwNrHv+OK8yv7dI3O3gg9vxooqqLbjqTiFabSM+SFMhtoznj2OetUyo4UDHfP1//VRRWxzdGwY7TkjJwWBPbHNJA2W6DHtRRTsrEqTuWEPllSvUkfn610OmXL7tp5I43HrRRWVWKsddCpKLVmdTYTefafMuA3ygZ6VVYESvg4JXcSB+lFFcKVnY9xybVzL1IneFJzkgc+4FZ8TBs5HKqefpRRVdRLVamjbwq4j3biDjv61obRFBgDnHbiiioNFsjLu8+bySTnbn8Af61Qu/m5Yk8Z68+tFFaR6GMmyu1w83l7sDIJ49qQfMDu+6yg4+ozRRVWVzLmZVlHlFu+07hjikUb4xu524OD3OetFFKWi0C+g63YPMrEc/Ka9Usp2iS3lHLbQefeiiuHGLRHu5WrxkmdvBieydXHbdxVJrOGWB4ZV3xleh9DRRWVF6I59m10OO1qWR0itZH3w2gaOINyQDgn88CuWmjWaZ0PHfNFFd8G7Hn14pN2MG7XZMwJJ/Sq0ud4XgbuenT/OKKK6kec3qyluYyFAcdDnHb0qJndmJDYA4x7+tFFWYrXclt7ye0uxLbuUljJbcO/tivS/Cvie9ukiVtofg7xRRXNiKcZQbaO7A4ipGtGCejO/03Xb3IRnBA9q6zTb6a4KBzjIzx2oor56m9T2cxo04q8UdNplsrPkk59q6CONUUbRRRXv4GEXdtHxWKk3Ow4qDUUiKQQRxRRW+JhG17HPFmHqVvED9wcE4xXP3tnCeq54zRRXk2R7WEnJJanPXumwDJ570UUVNj6GjVm47n//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopy shows two varices in the distal esophagus that have been banded. The bands are indicated with the green arrows. The two strings in the right of the field control the trigger device used to deploy the bands.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Laurence Bailen, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_13_3282=[""].join("\n");
var outline_f3_13_3282=null;
var title_f3_13_3283="Mesosalpingeal vessel ligation";
var content_f3_13_3283=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F54391&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F54391&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 513px\">",
"   <div class=\"ttl\">",
"    Mesosalpingeal vessels",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 493px; height: 306px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Anatomy of vasculature for mesosalpingeal vessel ligation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_13_3283=[""].join("\n");
var outline_f3_13_3283=null;
var title_f3_13_3284="Ureteral endometriosis";
var content_f3_13_3284=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F54395&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F54395&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ureteral endometriosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 310px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    View of hydroureter prior to resection and ureteroneocystotomy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_13_3284=[""].join("\n");
var outline_f3_13_3284=null;
var title_f3_13_3285="Electrocardiographic diagnosis of left ventricular hypertrophy";
var content_f3_13_3285=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Electrocardiographic diagnosis of left ventricular hypertrophy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/13/3285/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/13/3285/contributors\">",
"     Ary L Goldberger, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/13/3285/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/13/3285/contributors\">",
"     David M Mirvis, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/13/3285/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/13/3285/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/13/3285/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Left ventricular hypertrophy (LVH) refers to an increase in the size of myocardial fibers in the main cardiac pumping chamber. Such hypertrophy is usually the response to a chronic volume or pressure load.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The two most important pressure overload states are systemic hypertension and aortic stenosis.",
"     </li>",
"     <li>",
"      The major conditions associated with left ventricular volume overload are aortic or mitral valve regurgitation and dilated cardiomyopathy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ventricular septal defects cause both right and left ventricular volume overload, while hypertrophic cardiomyopathy is an example of an inherited condition in which LVH (usually with asymmetric septal hypertrophy) occurs in the absence of any apparent hemodynamic pressure or volume overload. A physiologic type of hypertrophy with increase in wall thickness and left ventricular and diastolic volume may occur in trained athletes. The \"athletic heart\" is often associated with ECG voltage criteria for LVH.",
"   </p>",
"   <p>",
"    LVH is not an acute condition. It takes weeks and usually months to years to develop. Patients with LVH from any cause are at increased risk for major cardiovascular complications including congestive heart failure and cardiac arrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3285/abstract/1\">",
"     1",
"    </a>",
"    ]. These pathophysiologies may be fostered by the development of myocardial fibrosis in concert with LVH.",
"   </p>",
"   <p>",
"    The electrocardiogram is a useful but imperfect tool for detecting LVH. The utility of the ECG relates to its being relatively inexpensive and widely available. The limitations of the ECG relate to its moderate sensitivity or specificity depending upon which of the many proposed sets of criteria are applied [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3285/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Echocardiography is the procedure of choice for diagnosing LVH. It can also permit quantitation of LV mass and give important information about the etiology of LVH (such as aortic or mitral valve disease, or hypertrophic cardiomyopathy). However, the ECG may be used when echocardiography is unavailable or not cost effective [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3285/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL ELECTROCARDIOGRAPHIC FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Left ventricular hypertrophy and related changes can produce five major ECG findings: increased QRS voltage; increased QRS duration; left axis deviation; repolarization (ST-T) changes; and left atrial abnormality [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3285/abstract/2,5,6\">",
"     2,5,6",
"    </a>",
"    ]:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Increased QRS voltage",
"    </span>",
"    &nbsp;&mdash;&nbsp;An increase in left ventricular mass predictably will augment the amplitude of voltage generated by these fibers. This effect will, in turn, increase the amplitude of positive forces (R waves) recorded over the left chest leads and negative forces (S waves) recorded over the right chest leads. LVH will also increase the amplitude of R waves in those limb leads that record the projection of these positive forces (typically I and aVL with a horizontal or leftward QRS axis) (",
"    <a class=\"graphic graphic_waveform graphicRef69040 \" href=\"UTD.htm?41/58/42922\">",
"     waveform 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Increased QRS duration",
"    </span>",
"    &nbsp;&mdash;&nbsp;An increase in LV mass is often associated with widening of the QRS duration. This change may be subtle or may be associated with incomplete, or eventually complete, left bundle branch block (LBBB). On the other hand, most patients with LBBB have underlying LVH. In addition, some causes of LVH can lead to LBBB by other mechanisms such as calcification or fibrosis of the proximal ventricular conduction system, which lies close to the valve ring, in calcific aortic stenosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Left axis deviation",
"    </span>",
"    &nbsp;&mdash;&nbsp;LVH is usually associated with a horizontal or frankly leftward (&ge;-30&ordm;) QRS axis in the frontal plane leads. However, LVH may occur with a vertical QRS axis (or even rightward axis), especially in young adults or patients with biventricular hypertrophy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/31/16886?source=see_link\">",
"     \"Left anterior fascicular block\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Repolarization abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe LVH, especially due to a pressure load, is often associated with ST depressions and T wave inversions in leads with relatively tall R waves (",
"    <a class=\"graphic graphic_waveform graphicRef76497 \" href=\"UTD.htm?41/57/42906\">",
"     waveform 2",
"    </a>",
"    ). This pattern, formally referred to as LV \"strain\" (but best referred to as \"LVH with associated ST-T wave abnormalities\"), may be due to primary alteration in repolarization of hypertrophied muscle or to relative subendocardial ischemia.",
"   </p>",
"   <p>",
"    In a review of 886 hypertensive patients with LVH, these ST-T wave changes were present in 15 percent, were more common in those with coronary heart disease (29 versus 11 percent without coronary disease), and were associated with a greater left ventricular mass [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3285/abstract/7\">",
"     7",
"    </a>",
"    ]. In another report of patients without evidence of coronary disease, increasing magnitude of ST depression correlated with increasing LV mass and with increasing prevalence of LVH [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3285/abstract/8\">",
"     8",
"    </a>",
"    ]. However, the sensitivity and specificity of ST segment depression alone for detecting LVH were limited.",
"   </p>",
"   <p>",
"    A cellular basis for T wave inversion was suggested from an animal model of LVH which found regional differences in action potential characteristics [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3285/abstract/9\">",
"     9",
"    </a>",
"    ]. There was prolongation of the early repolarization phase of the action potential duration in the subepicardial and mid-myocardial layers; this phase was not altered in the subendocardium, but the plateau phase of the action potential was shortened. The net effect was an endocardial to epicardial sequence of repolarization, the reverse of normal.",
"   </p>",
"   <p>",
"    In comparison, LVH with a volume load state, particularly due to mitral or aortic regurgitation, is sometimes associated with prominent",
"    <strong>",
"     positive",
"    </strong>",
"    T waves in the lateral chest leads.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Left atrial abnormality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with LVH develop abnormalities in left atrial depolarization due to conduction delay or actual atrial enlargement. The two major markers of left atrial abnormal are increased duration of P waves (&ge;120 ms) in the limb leads",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    biphasic P waves with a prominent negative component (&ge;40 ms in duration",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    &ge;1 mV in depth) in V1. Biphasic P waves with a very prominent negative component may be a subtle but important clue to major abnormalities such as severe mitral regurgitation or dilated cardiomyopathy.",
"   </p>",
"   <p>",
"    The presence of a left atrial abnormality may be particularly helpful in the setting of a left bundle branch block. In a series of 220 patients with and without a left bundle branch block, 92 percent of those with a left atrial abnormality had LVH as established by echocardiography; the sensitivity, specificity, predictive valve, and accuracy were 80, 89, 88, and 78 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3285/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ELECTROCARDIOGRAPHIC DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The electrocardiographic diagnosis of LVH is quite reliable when very prominent voltage is seen in conjunction with left atrial and ST-T abnormalities, leftward axis, or widening of the QRS. As noted above, however, false negative and false positive diagnoses are not uncommon. Patients with LVH may fail to show voltage criteria, especially if they have only mild hypertrophy or underlying obstructive lung disease. The sensitivity is also reduced in women and in subjects with obesity [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3285/abstract/11\">",
"     11",
"    </a>",
"    ]. Right bundle branch block, when associated with decreased S waves in leads V1 and V2, may decrease the sensitivity of some voltage criteria for LVH. On the other hand, increased voltage is a common normal variant, particularly in young adult males [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3285/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The question of whether left anterior fascicular block (hemiblock) can simulate LVH in the limb leads (ie, tall R waves in I and aVL) is somewhat controversial among electrocardiographers and requires further study. Since arterial hypertension is one of the most common causes of left anterior fascicular block [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3285/abstract/12\">",
"     12",
"    </a>",
"    ] and also a major cause of LVH, these two findings often co-exist.",
"   </p>",
"   <p>",
"    Commonly used criteria are given below with estimates of their accuracy. Given the intrinsic limitations of the ECG and the many extracardiac factors which affect QRS voltage (eg, body habitus, pulmonary status, age, etc), it is not realistic to expect more than moderate accuracy from the ECG in diagnosing LVH [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3285/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following are the major criteria used in the electrocardiographic diagnosis of LVH [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3285/abstract/5\">",
"     5",
"    </a>",
"    ]. More complex mathematical models based upon the ECG are of limited use in predicting echocardiographic LV mass [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3285/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Sokolow-Lyon indices",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two criteria with these widely used indices:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sum of S wave in V1 and R wave in V5 or V6 &ge;3.5 mV (35 mm)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      R wave in aVL &ge;1.1 mV (11 mm); sometimes &ge;1.3 mV (13 mm) is used.",
"     </li>",
"    </ul>",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Romhilt-Estes point score system",
"    </span>",
"    &nbsp;&mdash;&nbsp;This index gives different weights to specific findings (",
"    <a class=\"graphic graphic_table graphicRef51012 \" href=\"UTD.htm?43/2/44075\">",
"     table 1",
"    </a>",
"    ). A score of 5 or more indicates \"definite\" LVH; a score of 4 indicates \"probable\" LVH. The upper limits of the QRS duration used in this system (90 ms) was from the pre-computerized measurement era. The upper limits of QRS duration by computerized measurements in adults is 100-110 ms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Cornell voltage criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;These more recent criteria are based upon echocardiographic correlative studies designed to detect a left ventricular mass index &gt;132",
"    <span class=\"nowrap\">",
"     g/m2",
"    </span>",
"    in men and &gt;109",
"    <span class=\"nowrap\">",
"     g/m2",
"    </span>",
"    in women [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3285/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      For men: S in V3 plus R in aVL &gt;2.8 mV (28 mm)",
"     </li>",
"     <li>",
"      For women: S in V3 + R in aVL &gt;2.0 mV (20 mm)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Accuracy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sensitivity and specificity of these criteria vary widely depending upon the populations studied, the \"gold standard\" employed (echocardiographic or magnetic resonance imaging LV mass versus necropsy measurements), and the severity of LVH. Overall, conservative estimates of the sensitivity of the various criteria for moderate to severe LVH is in the 30 to 60 percent range, with specificities in the 80 to 90 percent range [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3285/abstract/5,15\">",
"     5,15",
"    </a>",
"    ]. Although it is relatively insensitive, the ECG does have prognostic significance. Hypertensive patients with echocardiographically proven LVH who also meet ECG criteria have a greater left ventricular mass than those without the expected ECG changes [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3285/abstract/16\">",
"     16",
"    </a>",
"    ]. The left ventricular mass is highest in those with associated ST-T abnormalities (the formally termed so-called \"strain\" pattern).",
"   </p>",
"   <p>",
"    Serial monitoring of ECG voltage also may be helpful. In particular, changes in ECG voltage over time may reflect changes in left ventricular mass and correlate with cardiovascular risk (eg, regression of LVH with effective antihypertensive therapy). However, \"loss\" of LVH voltage criteria may also be due to alterations in lead placement or to factors that may be associated with decreased QRS voltage such as anasarca, pleural or pericardial effusion, weight gain, and increased severity of chronic obstructive pulmonary disease. Thus, regression of LVH is most accurately determined by echocardiography. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/34/17959?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinical implications and treatment of left ventricular hypertrophy in hypertension\", section on 'Effect of antihypertensive therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11754279\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Left ventricular hypertrophy (LVH) is an important finding since it usually reflects pressure",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      volume loads, or a hypertrophic cardiomyopathy variant.",
"     </li>",
"     <li>",
"      The ECG is relatively specific, but lacks sensitivity in diagnosing LVH. False positives are more common in young or thin individuals, whose voltage may exceed conventional thresholds. False negatives may occur with right bundle branch block, obesity, or chronic obstructive pulmonary disease.",
"     </li>",
"     <li>",
"      Different sets of criteria for LVH have been proposed, all with advantages and disadvantages. None is ideal.",
"     </li>",
"     <li>",
"      In addition to increasing QRS voltages, LVH may be associated with increased QRS duration (sometimes culminating in left bundle branch block), left atrial abnormality, leftward QRS axis and ST-T alterations (formerly called &ldquo;strain.&rdquo;)",
"     </li>",
"     <li>",
"      Because of its association with hypertension, cardiomyopathy, aortic or mitral valve disease, and myocardial fibrosis, the finding of LVH on ECG has adverse prognostic implications related to heart failure and atrial arrhythmogenesis.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3285/abstract/1\">",
"      Kannel WB, Dannenberg AL, Levy D. Population implications of electrocardiographic left ventricular hypertrophy. Am J Cardiol 1987; 60:85I.",
"     </a>",
"    </li>",
"    <li>",
"     Goldberger AL, Goldberger ZD, Shvilkin A. Goldberger's Clinical Electrocardiography: A Simplified Approach, 8th ed, Elsevier/Saunders, Philadelphia 2013.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3285/abstract/3\">",
"      Devereux RB. Is the electrocardiogram still useful for detection of left ventricular hypertrophy? Circulation 1990; 81:1144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3285/abstract/4\">",
"      de Vries SO, Heesen WF, Beltman FW, et al. Prediction of the left ventricular mass from the electrocardiogram in systemic hypertension. Am J Cardiol 1996; 77:974.",
"     </a>",
"    </li>",
"    <li>",
"     Mirvis, DM.. Electrocardiography: A Physiologic Approach, Mosby, St. Louis 1993.",
"    </li>",
"    <li>",
"     Mirvis, DM, Goldberger, AL. Electrocardiography. In: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 9th ed, Bonow, RO, Mann, DL, Zipes, DP, Libby, P (Eds), W.B. Saunders, Philadelphia 2011.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3285/abstract/7\">",
"      Okin PM, Devereux RB, Nieminen MS, et al. Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point. J Am Coll Cardiol 2001; 38:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3285/abstract/8\">",
"      Okin PM, Devereux RB, Fabsitz RR, et al. Quantitative assessment of electrocardiographic strain predicts increased left ventricular mass: the Strong Heart Study. J Am Coll Cardiol 2002; 40:1395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3285/abstract/9\">",
"      Shipsey SJ, Bryant SM, Hart G. Effects of hypertrophy on regional action potential characteristics in the rat left ventricle: a cellular basis for T-wave inversion? Circulation 1997; 96:2061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3285/abstract/10\">",
"      Mehta A, Jain AC, Mehta MC, Billie M. Usefulness of left atrial abnormality for predicting left ventricular hypertrophy in the presence of left bundle branch block. Am J Cardiol 2000; 85:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3285/abstract/11\">",
"      Levy D, Labib SB, Anderson KM, et al. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 1990; 81:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3285/abstract/12\">",
"      Elizari MV, Acunzo RS, Ferreiro M. Hemiblocks revisited. Circulation 2007; 115:1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3285/abstract/13\">",
"      Rautaharju PM, Manolio TA, Siscovick D, et al. Utility of new electrocardiographic models for left ventricular mass in older adults. The Cardiovascular Health Study Collaborative Research Group. Hypertension 1996; 28:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3285/abstract/14\">",
"      Casale PN, Devereux RB, Alonso DR, et al. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation 1987; 75:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3285/abstract/15\">",
"      Murphy ML, Thenabadu PN, de Soyza N, et al. Sensitivity of electrocardiographic criteria for left ventricular hypertrophy according to type of cardiac disease. Am J Cardiol 1985; 55:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3285/abstract/16\">",
"      Fragola PV, Colivicchi F, Fabrizi E, et al. Assessment of left ventricular hypertrophy in patients with essential hypertension. A rational basis for the electrocardiogram. Am J Hypertens 1993; 6:164.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2112 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-221.10.40.232-BF0A88A09A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_13_3285=[""].join("\n");
var outline_f3_13_3285=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11754279\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL ELECTROCARDIOGRAPHIC FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Increased QRS voltage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Increased QRS duration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Left axis deviation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Repolarization abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Left atrial abnormality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ELECTROCARDIOGRAPHIC DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Sokolow-Lyon indices",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Romhilt-Estes point score system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Cornell voltage criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Accuracy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11754279\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/2112\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/2112|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/2/44075\" title=\"table 1\">",
"      Romhilt Estes point score",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/2112|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?41/58/42922\" title=\"waveform 1\">",
"      LVH tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?41/57/42906\" title=\"waveform 2\">",
"      ECG ST-T changes with LVH tutorial",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/34/17959?source=related_link\">",
"      Clinical implications and treatment of left ventricular hypertrophy in hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/31/16886?source=related_link\">",
"      Left anterior fascicular block",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_13_3286="Non Hodgkins lymphoma PA";
var content_f3_13_3286=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F76321&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F76321&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Non-Hodgkin's lymphoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 358px; height: 343px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Non-Hodgkin's lymphoma involving the right upper lobe and the right middle lobe. Chest radiograph shows large opacities due to bilobar consolidation. The patient had undergone an open lung biopsy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAXMDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5WRGdgqKWY9ABk1N9juiMi2m/79mtHwggk8Q2qMMg7+2f4Gr0WLSYnOWj2/7tAHlQsLwni1uD/wBsz/hTxpl+elldH6RN/hXrqaRsHyYKj161cgWFQN0G4jrmgDxgaRqR6afeHnH+pbr+VP8A7D1b/oF33/gO/wDhXucUlssbhrNtpGCQ3H5VqRwWUqFYnaNs5UScc/WgD54/sTVc4/sy+/8AAd/8KU6FqwGTpd+B727/AOFfSR0vI6DnuvehLAINpAKn9KAPmj+ytR5/0C7/AO/Lf4UHS9QAybG7A/64t/hX0hc6Al0DJGAjd2xxVCXRVizGV57+poA+ezp16Bk2dyB/1yb/AApPsF3/AM+s/wD37Ney63pP2VwhXIblT6isv7GT1/AUAeX/ANn3v/Ppcf8Afpv8KUabfHpZXJ/7ZN/hXqK2pA5FWbe0JbOOKAPKU0bU3OE069Y+0DH+lWE8M68/3dE1RvpaSH+le46JYNnODn3ru7G2EEOCcsefp7UAfKw8KeIj00DVj/25yf4U/wD4RDxL/wBC7rH/AIBS/wDxNfWkK4OcZz2q6g3KCcLx0oA+Px4O8THp4d1n/wAAZf8A4mlHg3xOTx4c1r/wBl/+Jr7Ejz0HKj25qaJ8HnBoA+Nf+EM8Uf8AQt61/wCAEv8A8TUZ8J+Ih10DVx9bOT/4mvttVEiEAAjHFZU6gMRtAI/WgD47Hg/xMwyPDuskeosZf/iaevgvxSwyvhrWyPawl/8Aia+woZAhWPHDD5s1a09iwZQO+RQB8aHwV4qHXwzrf/gBL/8AE0w+DvEykA+HdZBPTNjLz/47X25IgZQqniqskOwgkL9KAPi3/hDvE+P+Rc1n/wAAZf8A4mkPhDxKBk+HtYA/68pf/ia+yLh+CD9Oec1kXt3FFnzCAfVj/SgD5MPhPxEOugauP+3OT/Co28M68v3tE1QfW0k/wr6dm8QWUbbS25fUdqhuNRtpNuWADdCD1oA+Y20LV0OH0u/U+ht3H9KjfSdRTG/T7tc+sLD+lfS1zaQXceEdQ/UCsa400q2yRAy+hHBFAHgH9mX/APz5XX/fpv8ACnJpGpOQE0+8YnoBCx/pXtz6Gd2+2BKk8x9T/wDXrqPD/h3aFeWM+aentQB85J4Z16THl6Jqbf7tpIf6VJ/wifiPn/iQavx/05yf/E19c2enJbAtgbyO3arDWgZlbbnaOKAPj/8A4RLxISAPD+r5/wCvKT/4mmy+FfEMQzLoOrIPVrOQf0r64uZfsa4AZnx1x0qg101yAt3Ekq54HTFAHyrB4W8QXDlLfQtVlcDJVLORjj14FSL4P8TMMr4d1kj2sZf/AImvqu1smhlM2nMA5XaUkQNwevXiuq1CWR5TdpqE5jknc+RHGqnZk4CtjgjjJPXtigD4pg8I+JLguIPD+sS7Dh9llI20++F4pZvCHiWCIyTeHtYjjBxueylAz9StfZ89lbxx6W91CkdsrN56xS/e3YIJGc54JNZOtCM+UuqXDXN7kmUo4ZMZXaWx1AXcNoweetAHx4dB1gZzpWoDHX/Rn/wpg0TVSMjTL4j/AK93/wAK+0Tt+12JjzIwD+UhmXKxlT9xhwi5/hbcfes3XLNmvWkaeWSZlG8SMrsuBgAuoCnjB4Ax0oA+PX0rUEzvsLtcesLD+lQSW08SlpIZUUd2QgV9Yy2TEMSeOua4b4p2+PBGpPk4Hl7R7eatAHgNFFFAHSfDuPzvGOnp6+Z/6Laval04AjaPrXjvwrXf490tcZ/1vH/bJ6+jI7FXILYDdCR3oA5xLHDYA6npVk6ZHIMMNrdjjmt42SAgsT9c1NHAgx8nPqTQBz0ejyE4IXy+mSOtWZNJMa7shh39q6a2hLkgqauxWAYZAwPSgDjbYTW7AQZxnBXqK3bOAXce4oqTDorcA1YNmkMjBYwSD1I4/wDr1BNFIxBZjkdPQUAWDbNFhFIwOvHWoLixWZcgfN6+lXbOQsm2Uc+verqwjqvbvQBxOq6WtxEIpR8wOQ2OlctLpjRSMsgww9uor1q5slmTGAGHesq+0pZl2uBvHRhQB5nJaYbhc+1aunaVkgzKQMdBXQf2K1tLmVMv1GemPWrlvY8EkZA5JoAZp1sNwCrhF56dK10VAeSM+9Z0l0kETGNwoH8WOvsDWW+qhA7qThc856mgDqN8YO1QS3t2p0U0ZYKXz656muDPiCRlKsxJJz/k0lpqMrvxIyEdCDQB6RDJET8sgz71aiwW5AOK4y0v5H/1h+Y98frW7YXhyMtkD17UAdNGAUwoAGKybsFJG6cdzVy3nV/uNx6VBeRiRhuJBzxmgDJuJgjli+09Kv6NJvY4/MnrSf2ZHLE7biSDkAVY0qBY5gMnHXFAGjGM/NyM+tRzhlZmLZJPp0H0q8UVQOBgnpWRqcz7mWIDGKAMHWL8W4ZYz8/Tce30ritXleQNvcjPU1v6vhXYE5bHJNc3qDK0R3naPrigDm7h9jleOnPOc1LbSRSIUYEFRlee3pVS6uIA2AS3PYdKqC8SKRT5ZJB596ANe3vHifAldMHoeQa6fS7lrh0hkCvuHy4Oea5SG2W5kXeHiUnO4jP6V2Gh2cUaEWjoWz8zvwQKAOk03RwriTGXJ4PpXQxWQRSVUbu+Kg0aYIio3I7v2rcRNwyD16Z5oAy1hLHJ6VFOc5WPOO9aF0hC/LnGecVRKYJz/wDroAy5IDzgkYJOTyOabsIGWwQPmAArSaLntz7VXkiw5HbvQBACee2egzV+zmbZtLZz2NVAgKgjB+lSxZUDqaALhtYbhiNvlufQZFUbjRlR8h1x14qXzGX7rYx6HFSQ3h4Rzx+hoAoLYJEuERcE56daFt88Dj9MVrbQy7o8jjoaIERsAgfhQBg3UYJ8sgY/rXB/GC32fD3VnHT90fp++SvTZrf524zXDfGqLZ8MdYyOgh/9HR0AfLFFFFAHY/CElfiJpJHUeb/6KevpqCE+WGyrf7oxXzP8HRu+I+kAjOfO/wDRL19T2Ee1yp6YoAbHCWHIytPjsIg2FZs/3cVbCnOB29KmO2FcnOP50AECRwrhucdhTxKvQdaqM5c5J47ClGSMGgB0mXbOcj0qvJEO469qse3GKcRk8kDvQBTSLY2QADnPSr1u42jd+NIsR6v19MYAqVVxjB5oAlEYYArjpxT1thIu4rz2NSRJ5qmNuBjGRwavbQFwOAP0oAx57JCMSgFR61yXiK4mijCWyMYj36fn6V2Gp3iAbAA3b/PrXGatFNK+8vuiP5D8KAOXvLgZVJZ1OOoXnFZeq3sUUARVdi3PJwMVtalZxv8APEvXn5elc1q9jOWjOOOmc0AUkvixIWMAdsGtCyuozywZSfTtVC3sgHHmOQDxhRmta3gjUARAYzzjmgDcsJXIBiKuB1Of0rorSbG1ZVKk8DPpWBZx4hyoBYnqOK07WZlJVju46Hk470AdPp+BJwcH/PNXb4sr7QNwPcGqFhho9y9Mc1cvG+bOPlx0oAfDJiJDjox71ctEAn3IOo71jRXBztKfKeRzWxprlicrjAoA05CAuPTpWTqH3G2nHJwa03ztGRyRnOKzL5SNx2nBORkUAcRrSybmyAAe5rg9aWbfh2LBugBr0nWISWZm4zx7VxOtqpQmMANjr3PNAHIvauQeM+1OitHAG6InBFaFrbzzN+4QsDx9K6DS9PEThpP3kg5A7LQAlhYSSiMyIyR4HJHJ+ldBaxlE8uJdqqMBcdT70xEkZy218Zx7flV6BjF13ZxzkUATWc7R9GIJ4Nb1hrMciiCUAr6j2rirrVI3LRoen3jjtT7OVWK+U2PY80AemxMsiBlIZD3/AMahmtjklFyuM89qxNKvJIyGDHn8q6WGRLiPMeQw5wKAKAhPTHfNV54MtkrWwY88jg+mMZFQTRAngZoAx9mACFLZPbtS7Nwznr6CrkkQC9MVEq89OMUAVnjz6Z6dKieI55z+FXmiJ+62OCBkZwe1DxewzQBXsGKOEclk9T2rRaAoxOODgj2ql5fPI/CtSzIlgKNyydD6igChJH8zHnB5rgPjguPhfrfBH+o/9Hx16W8ODkYDCvPfjrGF+FWuY4x5H/o+OgD5HooooA7f4LjPxL0YDP8Ay26f9cXr6rtRnnGMCvlT4LqH+JejqwyrecCPbyZK+srWMBQMdB0oAsRooO8n5VFU3JlfP8PUe1Xbk7Ylj6FvmYe1VgoPPpQAwJzTlQge3Ye9SDAZVyQzZwPUgZI/KpQvNAEJjwRjn3qVI+cj86cV59v51PDHz/Q0ACRAZ6YHPNSJFuPPTuasKmegH49qmCD6IOf/ANdAEIXy1+bgf54rPvdRChgx2jtipb653sypkBcDpj8R61zuoyKo+Z9xJzz2oAfKxmJIHXnNVTGA4yQefwrOnvWt3zIwRD0Hcj2FEGqxSY8kblz1c8j8KAH6jaLPzHmNhyeMggGsHVNOdIW80qADkEc1vTztNHy5I/SspPNSSbzWVkLfu154XAGDkdcgnv1oA5TYqkszx+yrn+dPjQMQqsP5VtXOnW8pO2FgWOSVqB9IEWGWQkgd15oAltDLGArAYxzg1tWabzkAegBrDhtJQcrKpA7EGtjTwyyAZGR6HNAHSWCGMoUJVTxitueIMc4XOM9KzbDnuTjv0rckXIXaAAVA/GgDPjhjZuIxnFalhCiZUDt0qO2hG4tgkDqa0IIgjH2FAD3UFVxge1Zd1HuYkjJ962wuBzyKoX+2O3aVRwB+RoA4PXoWaUruAQVyt3BaRgBmLMedp71v6vNJPLIBkg85PpWBcQSk5C5B4z3zQBQeUghIVEQ9B3q7ZRPIrFmOcUQ2Bd/3sqqF9OTV0tbwx7Vd/MYZ6c4oAhkcQwl3ZgE53g1l3GpyzBjFK6KOgB60y/ZZlffK+OgAXjNZM3lrGQs5zjuuKAJRqtwr4Lh+edwBrSstViZgHRo/9qPkfiDXLCJmbETqTmpovMiOCN3uDnFAHqWj3ZkTMcglHqDgj6iun067w4wwB9q8n0S4KpvV+p4IbvXZ6VqZIAnG7H8Q+9/9egD0eF1mj3KRn0oZN4OQc1i6deEFXRt6e3UV0KlZF3oRyOaAM6ZMrxggVVKBF6cj1rVlh2s7bnO85wx4XjoPQd/rmqUkZBYZ5IoApJIzJ8y7G7jOR+dSMuevJHfNPC4OMGhVAAB6epoAj2gMTn61LaEpOrZ9vwoKgfxZb3owcDjnPSgDQaNXXHGR2rzr4+QlfhLrxxgfuP8A0fHXorHKbhz/AFrz34+N/wAWi14HnHkc5/6eI6APjmiiigDufgiM/E/RR/12/wDRMlfW9qoUZOCe1fJPwRO34oaKf+u3/omSvraBicfXrQBHMd8zEjpxzQAc0KN0jHOcmpVX86AEVBuG4AnqD/WplXpTVwOxNS7QR74oAZGhLe3rVy3jI649qiiQ5wetXogPwFAD0XAx05yeKgvZBGu0dTzVossaBnPJ6D19awNQugpZpD16L3P/ANagCvdzcMdwVB3Ncvrt7sA+zjGT989RVnUrsuecnsB2/CsPUVeSAsQVA5560AYt3MWdiSS5OTzmobZ5EkMisV460tzKEG6NfmPHvVCS5ZTmVhGncMeaAOrsr6IoI5uWxkGr6yI2DGF254K1wa6rDG67d7+hzgVftdVcyfu0CY9KAOpumIjIwS1UQZDIpBJUjGc9KpxazJI5E+GUg5I4Iqa0voXcRuQsg/v8D8KANi2jDKuMD1q5aWolmCgd/SqyzKZcknJ/KtbTw27dgD3oA0bOJw3A+QdO5FbzJ90DAwMc+tZNipaRSN2Djt0rphGp5I7UAU7bKFlbAyOtX4Bvc9gB1pqwo5HAq9axhSdq4FAELZC49B1rG1HOJIyNquMj610sydQOD3rn9VQoWbr60AcDfWzK7bh8oPeqNyqCEvIRGq9Sa09WkjXdJI4CjsfSuN1fVopyURjhTwP8aAK093NdTNEgZUxjHdh70jTJHwGzjg85P41SMrp8wI3EHp/jVETgkqOHP8VAFnUJoEO1pHRiT2rAmuYlmG6ViOm0r1q3qCsVMzyREJww6H2rmp5/Ml3Ae2TQBrLcRPyJ0X0UnBFXrTeei7we681yruGJOfpmr9i8kW1kdlf2OMUAd1amJ4lDYGOp6HNbFiWDZjkJ46E81x9nqbblW4QTDjkcEfjXTabPCy5gcmT/AJ5scN/9egDqLC7aOcbXII9a7bQtQWQbScHuOxrzyzmV+GU++/qK6HTmaMhlJPt3oA7/AGgrg8elUZlK/KeMHrmpNPuRNCAfv49afIBKN6diR3GcUAZ7rhs9D3pMY4/LmrEg4Py8+9IqBiGoAg2HI9PTNIyjvU5ADKHwMnA560koHT0oAniJaIbutee/H0H/AIVFr3XgW/X/AK+I69Btxlcdf61wPx/z/wAKi1/j/n3/APSiOgD42ooooA7n4Jf8lP0X/tt/6Jkr63g4XkV8k/BH/kp+i/8Abb/0RJX1tF8qE4ycYyKAGRgH2z1qyF9elQxDBz/I1MDz6UAPCnB2gE9gTgVLtx/+qmoRuHY1Ix5/DtQA+BTnHGzrnvmr0a5HAAHSq0IzgDI96tM2yMtjGBQBV1O4EMWc8emeprir+V5JWK/MxOSTyK6LU5DLXOXQ3ZEeMdz6fWgChcSLFz95z39Kxb25hjINxIckfcHJP19Kn1HUBHmKAlnzzMf6Dt9a5W/lKMe79cGgCvqt48chEGyOJumOv4k1z8gkMrNkuf7xOc1qTbpRgjC9OazLmAwsCkhPoM0AQpPmPIHzdcH1rU0+4WRMbhuPTJrOjkRs74xkn0q/Zv8AZyjRqODngDmgDZjI83YiljwMim36MWOM47g9vf6Gte2nMtus0a7hkdKbbS7ZSJcSbicAjOKAF0a8aNAsr5HRQf4a6uzuZETKMWJ9axFS2KpiAZB4YHBxXR2ESSKvlkBscCgDpNGZnRRnD59OK6sHhcDqMEiuT0ZT5yqQQK6tMZUH8xQBLCmCPU9quwryOPrUNuvTODiriLg9cf1oAbIMZ6VzuvAmN8cnHSunccHIzWTqFoJSQV4IzyKAPF9ZjSSYpJk4OOtYN1pMW0yAM5/iUnAA/wA969O8SaGU3T2/DAfMuP5H1rjLiTykyF3NnBB/rQBzF5aPI3ysqIq4VBzj3zWJd2hjUSSSADB6Dp+tdhKYJ45XTMTgfMOxrjdddvmSNgBnkCgCjLbNcP5jS4jKYBY4rn2tykzh3DRj7oC4I/HPNblxxZwqTltx4B7VSaINJkspLDOM0AV7e1UgyOzY/hq0kRLARuc+460jPltqMvHHBFTW6jaG3KAD8xzQBatleEgldx9ewrSjnBwoOT7GqULvHMW+8D3XpWhAqScyIFY85HFAHR6RqTbhHODKox8x+8v49/xrr9OlztkjfzI84yO31rgbOEI37jLdiTxxXRaXcNC6lCdx4I7fjQB6Pp83KN0NdCCGjBXof0NcVp9xvxtABHYH+Vdbpc3nQlCfmAyKAEmUbs8nJxx2qAYVzntWg6HocZNUnXmgCI7UOVUbsYLHr9M9cUwnnj8afjnA/Co3HTHfvQBNb/UHiuE/aBK/8Ki10Ac4t/8A0ojruovvYPSuF/aB5+EevEdP3H/pRHQB8bUUUUAdz8Ef+SoaL9Zv/RL19aZIQjHOK+S/gj/yU/RcjPM3/ol6+sycJ9KAJIsHIHb2qVQcnOagiJHJOasxt6DBNAEobH4nBqVASwz19ai2g4zx68dangXJ7UAWYuAKZfOFUKSOmcZqeNct0461n30m522n260AZl2PlYbz1J+Y/dH4dq4/Wrv70cZwnf1b/wCtXQ390pBijPB+8fWuWvIQWYzAbsnv1/GgDnrwPIxwSB3Y1UcRiPrvfH3n4/Kr90WchFBJ/uKO1YV/LFbvukYu4/gU5x9TQBXunG0hmyeoxWe5JyW6eppLvUDKCAiIAeq9RWdMWcBtxbPWgC40kYIAdcdhU8N1Ggyylm/z2rHdXVucgYzSwNhh060Addpt6u9znYGB4Hf61v20AuAkqyqueOTzXFWU5WZSpK5BBHqKvLM0XypIY03ZABxQB2Em6E7CFUg8EHmt3RJTtBJ5rzuPWLlW2yBXx/F0NdX4c1ZZFzOpUjgY7UAer6M3mGM4HTmujt0Fc14XZXiDhtwI4NdXGRtBx+J70ATQxgMasKCeajiAAA6/jmphyefyoAHHHt61WmAx157VayMAAc1BJyOv60AYGox7kIwD+FeR+MJIbC9kRyMN8wxXrmryfI/JC9OK8D+ILifWZArZCrjA+tAGXJqZMm3BVHzjPPPauXuw+8g/NnnNXPm3HERJ6gHtT5rKRirqgKkE5z0oAzWX92ynICjtWY+AWPbFdHdQmFZEBRhjGeTzWTLYSALvkQMTnbjrQBmbRgk4HoO9CscDPQdBVia3YOQj7vU9BTGgCYaV93+yKALFndywMGjchu3cVv2N8shH2tcZ/jT/AANc4gO/iMgfmRV23l2t1IY9Ce1AHd2eDCWgAlQc7h2HuK2tMIZl8zjb0I6ivPtPuGjdTDJIr9mHHNdxpF0ksQS5KRXH94DAb2PpQB1NmXiZSDx/errdHu8tEVB64YelcjZsykLIMH0Irb09/LuEdW+XvQB2zqGy+T0qtKmH9R161PayBo0II6UTqQ/HQ0AZknDZ6CkKgYz0qxKnyk+npUJwwoAavXjGa4P4/kn4R69k/wDPA/X/AEiOu99s1wXx+/5JFruf+nfH/gRHQB8cUUUUAdz8Es/8LP0XHX99/wCiZK+r0J59PcV8n/BTj4m6L/22/wDRL19Wox2jIANAE6YyCcY6ZFWo+gH5VWj5PFWkXA7+tAEqkkgDoatwjHfntVaEfMMmrluu4njGBnntQBMSEj5POM4rA1CUqNijJPWty6fbCfTHSucvCAXY4LE/lQBk3X7vJBG4j8vpWFqbK0BeZlRB09T9BWvfOiLvcZx91fX/AOtXKajO8km+XDdhjsKAMXU795f3cY8lDyQp5b6mucvNpTamQ688963NRgyCyfLg5Hc1lXVjMcPIuMjjB/lQBhzEKcqcj6U1RIVDLnHXJrRnSKMZMYyeCD3qtKS6DA7cDHSgBhdZwscx2lRjI5qeGGIqE3AHPDY61R+YNyOfpR5m3ncAD1FAGxFCIpULjPPr0rRC27NyNqg8k84NZWmyRPE5Y7XTpjpVyKRxfOpXcrjAHX8aALz2OVDKAeST2FdJokKAKNhOcE471lQhksCrAlutdJ4btxPHHhsEdPrQB6R4ZT7PZr/DurrYeQCB161z1lEUWJOCVHODW/aglRkAUAXocAY9T1NTg4NQQjI5GCPWph90etADxyfSoZgQD6U9QQOc+/HWmyjsf50Ac14hPl2UrAjcRgE14JrKO95cSNuLjPIGc817v4rJ+zkA4rxTUQ0MtxCcEdQxHSgDk1IllIkO0AEnPFSM5jQKpYhMnIHYVBerErgpIZGc9BxUeoef5IIIIxg7c+lAEaTloJCFAVjgt3P0rMnkCE4cswzj1qO9dorFEjOATg1j72Zm5I7CgC27ux29CKbjnJY5HtzVMuyjAY+3vUizsMFsM30oA1IDsyzHr0APWrqBZHyygn1/pWPBNtOZACc9BWxp5jkYGSQxkcjI4/SgC7b2537ouV6BTW3p8gBCyghhzj1qnbgLwGBGf9ZjIrTgjQBfNdG75oA6XSdQKqI52yvRWPVa63TGI29CDyPeuAtomwDHhkBznOSPrXW6Dc5URMSFyACetAHoGlONqr6+/StGQFo+eo55/lWJp0hWRRnGCM5rcdgGxnOaAKrrkY9etVWXaxHWrsi4yAM1VlTLDpQBHjAHPB6V598fgR8I9eB/6d//AEojr0PaOffsOteefH85+Emu5GP9R/6PjoA+OaKKKAO4+Cn/ACU3Rv8Att/6Jkr6sj7cYr5S+Cxx8TNGP/Xb/wBEvX1ZG/zYGaALUXNW0PA659qqRgAknvjqeB9Ktx8EENn69qALUSjgsOhyMjvVqAEL06mq8Y46GrcQOcDg9aAIbp8ZyfwrnNQdUR3bgLW5dOHY45965bW5NzHbyoPIPrQBzepXJZyz5AP6VhyiVgSrDBPXsK2ZrffkyEgdl71QmSTIREYduRkke1AGcCY8hckngnHNZtzE6ghehOQSelaF88cBIMnmzDqqnhfrXP312875Y5UdAeBQBXnnhHErBnz1UVnlwXzGu0Hjceanl2zHLLtPqBVW8iMYG3LAjpQBDc2k6vgsCOzA8GqrwSYIwSRVtZpFj8vG4ZyBmpYXckMVVRnoelACaZZXMwPlqdijrjNanl+SIHyQxAySD71uaFJdRELEU8sLkAAZx71JPCt67uGwQPuE/rigCO3kndcI6t6gc5rvvCFsojgaVCrDn5q4C0gKgiIEn1BxXo/hkSi2j8xjyAAGoA7ewYs249e1dHa/w9T7YrlrFjgFDkeldLatlVHXjrQBprjA96fwBn371DF15BIx39am4YEH8hQADr2xUcxAB7cd6exI9MD9KgudwTv+VAHM+JmTyjuUe1eSa9btNMdqAgnnd0xXrusx+bgZGD+lcVq2n7y4jIU/T7xoA8uvNP2zllUYHIOOKq3VnMohZR1PIx613i2Um8JIAy54yvSnPpOZChj+VTgjtQB49q9ssTyhmZSD8qkfmc1iFVIxH0z+de3eIbWyns/skQgaRAQdyc/XpXll3pbxTMsJVlzjAB4oAxPIyBjG7rzTysajC/MehJ6Z9qum0MIx8rN/EQc1W8h25I+X0WgB9uEQBup9u1XEmwxOzO5cHPpVREI+ZkwB2qYAgAHJJ5FAGvptysGdnKkZIPT8q6KxuLW6bZEvly4/1bE4+oP9K5YQtCirMCHI3YA59q0tO2+ao2Fs9SxxQB2enNJAQu0EfSul0yMbvMVcEc4HrXKaVf8AmKqXGAvQOOCvsfaut0sNAqg9xkHqCKAOo0yXfjBIK9feuqiYvbqc4rjrT5WDpn3FdXYPui+negBzg9/zqvIvY45q5IMc44PSq8g9QPb1oAqE7e+K88+P5P8AwqbXc4/5YD/yYjr0NyVOOP8AGvO/j9/ySbXsf9MP/SiOgD47ooooA7b4Mf8AJStH/wC23/ol6+qoMbhnGcYzXyn8Gzj4kaP/ANtv/RL19U25wc9aANGM89OPX0q5BxgYxVGMkkAmtGAAYDA8+1AFqPGQAOAKsqdqEnjAPU1XiU59ulWJceUxB9KAMe/cqrdieAfSufmQqv7xixx1/rW1d/MxLZIHAHr71h6is0kUqwOqTYO1mG5FPbI70AZNypLEBQTnIPT8a57VLoYeO3ZyxHL+v0rZvbh5IFindc4wzrkAn19h7VzuoKoUlSAgH3h3oAwJl2H5mP8AM1TuHQYwfmB44zzV+VGdwEUgnPPXNVXs3bLECNfQ8k0AUWdpMqBtPrnFMa3kCDYCQc5Y9KvLboq4OM55yMn8qXcPlK5JXt70AZbWh9SDnqKmjskR/myQeR2wa0rVj5nzp8p5J9DWhFGs0m+VFEQ7k9aAH6LELVIzkANyynv9TWzFMJ5RiNFQc8LWJdyQbgkUqnb1X/69bfh795buj7SAQyMOcA9jQBq6ZaRM+/CqxPIA611mm27L95eh7Vz+mweY6+Uw2g8ketdrpEO6Ib8Zz3oAvWURD5I69RXQWkeMe1ULe3fCbNp5wc+ntWzAgA/woAlXO0AYzU2cA5pkfRc5qVRwSBxQAxhkdx/SorpSYjwM1Pgc0ki7lIoA5TUd3nDoQe2KyruyEq71HzD2rptRiAIKjHpWS4KklsrjqfWgDkruP/SEGzJJ5I4qy6xKAWT3b3FRazexwy5TGScZPbFVJLvzIwSFHNAHNeK4WDCWCMrI4PA7/hXJRW1zJGPtMZjkXIIxjI967TV4ZbuZJUBKqfvk4Uf59K5zVdRea58qCRSFJVpCPvkcflmgDm7nTU83cCoBPK5ziqc1uI3I+9j24q/d3lwlywmWNlXjGMiqctwowsq7foeTQAwDc4VIwcn+7k1IlqivnIjl9+g/Cn2uppGxWFgDj+7zTo5Y5nDsmcnj5v60AVnt50kLySeYufvZzVu1Dl8DBPfuAKuxzICFWGPaB7nFWliinclUEWepTjPtQBd0yIkq7YCg8DPJ/wDrV2Gk3WT5cmNh6YP3a5CK3EY+Q5UnqecVrWJ8vb8xJ9e1AHeWTlHUdq6rSOI+uVI4GelcRpU4lUAZ3KK7DSW5GSRnrQBsSYKfSq7jIGP0qdlzuzjPTPWqzEorZ5x6DNAFOcBSc9M5rzX4+Pn4U66Ov+oP/keOvTLtiVZexryz47n/AItbrg/64f8Ao+OgD5HooooA7L4QHHxF0g5xzLz/ANsnr6ot3BUeg6g18q/CRtvxC0kj1l/9FPX1DavgDGKANq2OT1HpWrAPQ9fasm07VqwtkcYoAuwYwWGDS3BHkNg89c0lvjH170t4G8lSABjJ569uKAMK6GTWBqc7fMoVSPWty7dYoztGMcAAdK5e8YENIVJx1oAybjO7kEZ6Lmsy5j8xmd23Adug+lbFyvmjLn5McjoTWTdM7SfIPlXhVX9KAMuddr7lPbqBWdM2SN/T2NaF7IsWS3bjaDWJfXDSZyQgHYdaAElZVbdkBh1APNQmcBJNgSMjncTkk+lUmb5WznPr/Sq/mHdnGeeaALwnmwZCzMh4z0Gas2Fz8xjcZWTg9yDWbJdySRbBxGvSMDpT7Jym5kJIx1PUUAaEkIDlWzkH6g10/hASfMqk47etYOhSvcyNHcp5iAckjqa9M8O2cEdis8aZ3ccjp2oAu2FqjM8qsqHjccdDXW6MX8kBvmGT0rAgSO3SRlIAxzWvoby+VgHPoG/xoA6uzYEhfQetake0g4wcHB+tZdgJMDeqhfUH9a04N5HzIB75zQBOo9BzTpPMELGBEeTIwHYge5P0pEJ47nsamXvQA04yQMYzxSEfIeKcSegJpG4HQ4+tAGbfIGHTk9xWFqKMiMR87fyrorpSSeOSePpWVdQkpkZyOtAHBa9bMtm8rRkcZU9g3vXMabJcXEZEqS4yOdpORXourWjvC6oM7uqnkGuYt92lu6xgqzcYYZAHpQBT1B4rWxKzuh3dAcde1ee/aITO5AVsE52jr612uvvHdAq+FGPvAc15xqVm1tfu3GCMlh0+tADbvzZlby0AY5we9YE0UqErcZ3ds1qx3kqlo1c89/Ws+acicI6kKT1I60AUWkKkqgx6kU+3dlfKkCpZkg83puB6EH+dKIzGwLKCDngD+dAGtp98wUiRdyH7x7/nXRWsYlZTbyAr1Cgc/SuQidz8oJA9PSr1tcfZpAUfc69weBQB2lp8shDKNmcEEZFX4oiMmJSFU8g9fw9axLDWVuSou1RD/wA9VGB+NdDaDa/RueeDxQBq6QxV1JyO+TXcafIfLDKCfYVxUKoXDRj94BkjFdTo83Kx57DigDrW/wBWrDHI71Wl5Jwc5/wqeP8A1QyG4/Ko5BjFAFGdQc569K8u+PYx8L9d69IP/R8derS4wcmvLv2gFH/CrNbI/wCmH/o+OgD4/ooooA6v4WEDx5peemZP/RT19O2rD5PWvmD4Ynb450s+hk/9FtX01YuWCEdKAOls+i8VqwKMZI596ybMnaM56VrW+SBxyaANGAHKqTzin3eCuOOODjnH1pIVw446Cn3f3CeDgZoA5TVW+YrnAHFc88WwAFiyjjLHJ61016q4LZ+b2rDlGWPA4BOT296AMSaPMjbMknJYngY9TWFqmojLJbMABwWArR1y6Z0aOMZhPfP3v/rVxV7IcnBwQw6dKAIrmTIJOWJ71lTBh6Yz61akuCi4bac8jA61CIWuE+Rck9PpQBDiQxN1J7VAY5GXAXIPHPArUttOLZ86URj0HJPtTktYemXOP73AoAzI4GVwFBLd62LGwLh1lRlI5yDjNWYljEfICntnrU4ZyqKgGCeDjmgDU0SyjRFdlCE8ggEiu+hgktLeNAGwRkH198YrC0C0ZbVFZXcgZYdq6C5kmZrdQoVVXnf3+lAFW7ul2rEVySfmJziuv8Ko8kZMiYOOlc9Bpy3EolwTjGB/Wuz8OxeWpUnPOOe1AG3bqcdOnar0YOB2/CoYkI/wqwq5xzk0ASKMZ/wqVTxTFHINSDnpkelACYPPHBpSDj5vT8KXGQfSlHTJzn0oApzjGB+NVjDnORwavSgHleAahC45OBQBl3FrySoGK5bX9N3fvFGGHOa7eRcFuv5daydRjR1PB3H9aAPHtQhJYxs2STyCw4NYWuWKNZnaUHZuxNdt4zsFtoGvFjm3KcnAAIFYOmix1DSZd7MZguDuHJH1oA8+XTIZJ9nnbe+Se9M1HSCkgEk6s7n5AeMjtW9d6WVut1v84XOSfSs0zbVMM0eY8kdct+dAGALF7cM8sahfrmonkJBxIOe2OlacrvG3ls27+6o7Cq91bAxBgoJbr6/WgCCJ0aPAkBbHOBU0KCPrjgdM9aoMvlZZfnx6danhuN/3Rtz04zmgDVtJAWDEAD+VdfoV75aKkpLxY4PQoa421kVpQcgHuBxXR6buABwvB6qOaAPQbIkEFnGwc7sjBFbtr8squv44rl9DuSIxHLgIeh/u109ouJVBBAoA7S2bdAjAnHWiXOcN1/SodM+a0IIBAP6VPKMp+PIzQBTlFeXftAf8kr13PrBj/v8Ax16nNyMdPwryz9oHP/Cq9cyO8HP/AG3joA+PqKKKAOn+Gv8AyO2m/WT/ANFtX0npLksi559K+bPhp/yO2m/9tP8A0W1fR+nHE0ZB70AdlY52LxWzbjgc/mKxtPOVHHPr0rbthkUAaMK9AM0zUCPIIPQ9alhHA646nmoNWbYFHqOfWgDnLhX8zgcmuf1t1MbJE3A6jP3j/hXQ37iJCc/Me57CuH1WfY7Z24x2PFAGBqbMpYlwvXjrXP3UsMjAmMtkZ+U4rdvoTPuKZyVyR61nLbxxfdA8wfw9t3rQBkrbxMN7B44x/e5P5Ug8tU/d7mX16VbkI3t5xTYeu0VRlMat+6Y7T1OOKAHFwWDH5MHnuKnimSaQKHAbu7DArMndNoXeB6kHrUSReYcmXKj88UAbPnWqtl5d46ExDr+NdLp0sSRK6IIoh/ERuP8A+uuJt4YwigF1JOOB1rqvtMTLBboWXGAFHc/TtQB0NnfvJchYGbYOcd2+tbuC1uJA7OR/tdBXLaTG0U8oU5AXHynAJ9K3JbkxW8cYIJC5JoAvQ6i8BEZcuF5AB/Su48OXcssYd8cDp0rzeO6Fw0NrDCic7mY/e/PtXofh9xGEAXgevWgDsoTuQGrKc9RVW1YMgJGKtR8Hk5yaAJQOeOfenj8DikHXOPenD1OKADPbv/KlAx70c8dz6Uv160AQSD5RUG3HNWpR0OMfSoG6n060AQN94Z/TmqNzbhxgjA9K0COcgEc1Ex2EjHPrQBz+oWKXELxSxhkYd6801LRX0ia4aFMQucbs8AHtivYblmyFCIc9icVg6vbi5gnhKqydOR1oA8O1AGIkxHL45xx+lYV8QjCT5cjqR6+ldJ4mtbnRbxzJCJbRidki8bT6GuNu5Ek+dGyHHIB6GgBt1dQSRAEDzAenc1XSUPGWVeB1XBJFVvMXcFkiJwf73SlKFgwgc/NwQev0oAmcMHDbFIPI96XykmfcdsR9VPT8KhtpSXaC4cYJ69atx26JJhW8wjv0zQA8xtAMqC3o/Y1uaTKVCmRQQR1PBzVS0QSsyhWAPVSeGA/rWlFYlSXjDYGOO9AHRafdbyNwBPTpXZ6TcedEOcsOh9q8/tJtjLj5D3x3rpdCuyJxgnjrx1/GgD1DQ3LQuD0HTmr7AbGBxxWRoTgE474ArXfg4OR3xQBTmHy4647V5V+0F/ySvXOnWD/0fHXqs2cE9a8q/aDx/wAKs1zkdYP/AEfHQB8e0UUUAdP8NOPG2m/WT/0W1fR1hkOvNfOPw0/5HbTfrJ/6Lavo+xXGznOPSgDrdPPyAnJzgcDP410VoOK52wPCnp7CugtDgcnmgDVhGQv061V1fnaxPAHWrduePWsvxA5S0ZhjduzkntQByOr3e+Qjdx+lc7eK0pIJG3rkVqXK+czbjgZ5NZsuIxiRv3YOOKAMGYlY8R5BJJ561nzxtMrDhW9uv/162NRRF3SB9ynoucE1zd3dNA7SJLiReAq9B/jQBnTgJG8kjqi54BHJrNnu2ddiSbV7gDGakvZZLlvnHsDj86qCEhgXzg8YoASOISuBvySeauxWhVC0mAnQY5pIBGqGTYdoyMZxSNO0hxjCDoM0ALukZtsO70rotAdbT99JmSYnByO9YqTtGoK8A9gK2tEtHnuVeT5U7lhwKAN+0uWnvMRDagXJGMc1swxbztZRhh1qjYQ28CkxYdS2N3pWs8bm5hCsSijOPagC1pGmKL9pcjYfau70qDBBydvpisDREZo0WMfLnOK7PT4Nh5PP8qANS1UCPnrV1V6DjnkVWgXCjAH4DFXEzwOmaAHKDnnPXsaeM/TFJz+PrTh6UAAo9KMfSlA9qAI5eozjGRioCPTPHU1Zf7tRFTyOc/XrQBAy446ZqGSPngdatlTkcYHvTCuDnqMUAUZYw2ARgiqEiEucqvz9q1ghKYc5OOo4z+FVngBY9sUAef8AivR4bmKRmjDQupDrjOD64r571rTLjRr10fLKSSknZh6V9Y3lpuLjg4BGD3zXmPjbw0t5azROu3+JSR37YoA8M3pOpVwPNXjOaghkaGfa5/8Ar1PfWUlldyQyod6k9ehFVirZEe7PHDZ4oAfOr28+5BkZyrAdvSr9k5aQN90AgtuqKzuJQVikVWVeu4dPcVLht3yuQrHmgDagOWDR52k54PWuh0qYR4LgsewzXF6dctDNsfcFPGK6KxmRxtV8ODwCelAG+6qVzAg3HmtPTZcIgIbjpng1kWG9XwwIJPBI5+tasMLGTegH+1jvQB6R4bnDWa72AO7HNdLMcAE4/OuN8NSBI0jIyrDBB9K68cqoA7YoAqzdD15/SvK/2gefhXrZHT9x/wCj469SnO1m9TXlv7QJ/wCLV63zn/Uf+j46APj2iiigDp/hp/yO2m/WT/0W1fSViOE5xXzb8NTjxtpp95P/AEW1fSFgWON2AvG3B5989qAOsshhQa3rdsJ1J79KwbLO0YBz7VuWnOAQOT+BoA2ISfMT7uzHPXOf8Kx9ZfeXUMMDitYsEjZueBgcdKxLw7twHJoA5W/AhkVE285IB6n1wPasa+kVVDSnc5/hFdFqYijj3yqpkAIQ4GR689QK4fUJ23ySSbsqMAds0AZeo3zJKVypGOcc5rDmCEM5UKueCO9Xr4ltzN8oA59axLnzJCGAwPSgB7urqFjQbyc7vQVFGEXJdOSeveliVIk3sCW7DPFRgtKy8nB74/lQBMQjIpUfKGxipo7VGTcY2RScAnmn2cO6QhF3KM9a3YLULbxvKdpLY45oAz7KxXzV2k7P4ie1bLFIT5YLZY4K+tBhReC6rH6kdfwqWC6t4kEyRlpz92RyOB6igC7b27Iu1m2qCPbHtXTR7DhlYtgD2BGP51yBkefflmDOclj3Fb1gx+xg7iTjAoA7HSrkCVI44x5aj6YrrbKUOFyAR15PSuH0eV0jRXwTjuOa7DS8MV2g8HvQB0MZyBn9KtJzyQTj061Uh6Z61bi4oAmHJzSgU3B6Dg/TNOHB9hQAv4Ud6MUtACHGPrxUbHk+tSHAHJ/WotwYnaCffPFACHjAFMY/Lgj6088k8Zx6Ux+OMAY7UARjAPyjBqFkBPGKm4BJznNRSDDAgYOe1AFK6izjrmsfULYyxuo79Qe9bs2QM5JzWddfeBHagDxTx74TW58+W3/dzLyo7N7V5isLBAvkBWU9Vr6X121SaMuQMj0rxvxZpptLsyx5AmJDegP/ANegDkZIPOhIRP369WHeqVszRExtzg556g1ovEdxeJsOB93PBqncQh5iSmDjODxigCSWQxnc/wAyN0OKu2xA2ypls84BrPhnjKASxludpG7FXIGWKIsgI+YEHrigDsNMuQ6qJNyseOTnFdLpimR1z06DtxXBafNuceW2w/xD1ru9JuP3CgcEj5SR2HagDrNOyjLtOFHT2rsraUSwIwIPHNcRYSAQAk/e+7XU6NIfKeI87ADxQBPdnDMOQDzXlfx/P/Fq9cBPP7j/ANHx16jeH5cn3HNeU/Hw/wDFrtbHB/1H/o+OgD5EooooA6X4cnb40049OX/9FtX0lpz/ACKfwr5o8Ats8W6ex7F//QGr6L0qZvLywXbxg9/xoA7XTjkAgfSt6yxvU+grmtKdXQFSCD3rpdPwSe3Hc0AaEsm21we9Yd3IoO9mOzbk5rVunBjCr78VyuuXJ8sKOVU4/H1oAytXuC8pYYweB3ArkNWIkkBU7SOntW1eXiujKWy4GOKwp3Vz9zOOQD2/GgDBuwxBQj5gck561RdBu5BVPcV0dxBHKmQRnoQOufb2qrNEIYiZVAkJyny9qAMaa1aQggEIvCgjr70+K3IbghiavSRu8W05AHzEnjFQyyhFUptOF7cYoAtF4bSJUXPmZwT1FWjeiGBVDJvXk57CsG03TTrucHJzuJ4FSX8u27IjKkg59etAFu4vXnbc5Ij9OhY1JDMrcMxLYwF7Zqgoluh8uflGCAO1XLOH5iZEdgD2GM0Ab1i7NAQ2DsGV/wAK29PZ1jQu5CYyQBWJYxlpFjgiIDkcH+Gt6dHjuo4IjuSPG70+n+fWgDrtNRZgssXyocY9RXW6amEB5JPrWD4cgHkqCvB5we1dPawkHB4xQBqQZKjJq+gwF449qpwIEwB6dKtxrhmPPzds0ASL7Y+lOHYUncd6UdRQAvWl9aTNKKABv8mozUhyBTMHINADM9c9qY44PHtUoH5Z5pH9cCgCA9CRnOKibGQSMGp2wBzj3qLA9SfegCvKDtP8qzbkAhiykDHTPNakobBxjNU54ywLAc0AYF2waJlABGOjV5v4qtlkSSOVTh/ukjpXpd9HkNgHIrjtWhW6do5MZP8AF/WgDxW5BtZ5EZc84PHXFWI4ElQBlG3qAD8wNT+JIJLS+Vjkrkq3HX3qhBMcBkZtwPAI/WgCLULCRULwp5gDcHHf3pmjq0Q+z3BMhd9zsegJ7D2HtW/bTG6gAcbSvBI4p4063WISiTy25O0jJb6UANtrf7K4G7LDoa2LK4ZLhWRiVJ6nIrCMu1lDcpnAPcVbhnRXVN+ex55FAHo9heLcqpB6cEe9dTpFz/pZB/jXFeYaNfmK4XngDkeo/wAa7TQ7o/bl9+5/nQB1d0f3cm3C856d68o+PT5+GWsjt+5/9HpXqkx3Bh6juK8m+O7Y+GusKc5Jh/8AR0dAHyhRRRQBu+CTjxPYn3f/ANAavoPSmDRL0/OvnfwiceIrQ+m7/wBANe+6M+Yo8cCgD0DTXyikkfhXT2BCwO3t3rktKY4QCumEgS2VFGTnB9qAC/nCQEE/fXGM9q46/l3xtGhHIwPb2rR8QagqzLhiQo2jP65rj9Ru2MrAEkeo45oAp3Uo3EbskdcHFU5JSVK5UORhcf4VFdMFJlODngE/570+1hkuG2QRPNck9V5x7UAPRMFeQHGC3oPX8fepZWDKC4w3QEnqP6V0Wk+FriX5tRkESDHyrz+ZrpbPw7Z28h8uBd2MFm5JoA8qOnahekLaW08qnqdu0fiTVu18FahI2yZkiy2TtyxJr2azsFTI2Dn25GPQ1bt9OQAnaMj17UAeYaX4ItYOZg8kinvwD+VasPg+zjcv5A3t1JFd+ttHH8pG4nv2FKLUGUxFSMY2v6+1AHFReHIU+7Gox0OKvf2BCefLXfjpjr712P2EY4XnI+UdqfHahQGlKovAyT+lAHJWfh1Y13hFyegI+7T10RT8569OetdmlvuztJwenFItnk9OvegChp8CxKgUY7c1vQqCAT07VQMSQnLttXOBn1rQhwFwORQBaRRwKtp09/5VVQ5x296sIM4IPH86AHjkdc04deOlIODjrQM57Y9qAHdvalPXn+dIKUdMCgBD+tNPuadimtwKAGkgn/61L3OfyqJjnn8qTdjIoAVxkjk4HYd6iYc/060pYYwajYgg0ARyHnpx37Yqo7ZOQePWrMp3DgZPvWfdNtYgjJPpQBSvkBDYOAw6k1xOpQssrvkcdRng12l2FkRlP159a5jU4C0m73zzQB594qsDLbyBF+ZhkHHQiuEtbd0nKyoxYcE+let3cYljKSHnqpHavPdfhW21B8EYbkKDjmgCqkyxSNnkggfL0Iq8pHmAqS2R0z0rBmuFUMVCkZOcnkcVDHqAA/dtls9Qe9AG5f5ADR4808FcYB+vv71QjuEQ8Aoyj7pPSlt78FPLm5yMgZ6GqN2okYNC2T39/wD69AG9b6gREGLAE9RjtXZ+DtS82UKSN0Y4yc5FeWR3QXGGG31963/Dupm1uVcEZzg+470Ae+wy+amSevBryf46n/i3usj0MX/o5K9F0i4ErBVztddw5rzf47N/xQOsDH8UX/o5KAPlqiiigDX8KHHiC0Pu3/oJr3XRn+ROegrwfwyca5an3b/0E17bojKUTIyMcj1oA9L0JtxQ9cDNbuoT+XaFtwyBgc+tc94dJ8kspUD7p4OfwqbxLd+XGIsnjnI7UAc/4hvAWReo2muUvLoEgKwL55I9ava7c7kV0J5O0Y+8a0vCmgGMrd3aBpP4UPIX/wCvQAuh+H5dQVZLsbExwnfH9K7rTNKhs0EcUSxx9MKOvvViziEacKWAGSF6n6VrW8KvhkI2thsgfeFACRw7UVTx9aswwhR82SexApkU0LXptfmaReuOinrWokPI4oAbBGBnOMn17VYVMZHYdzT4o8Hlh6fjVmJAePyyaAKjWkZDr5XMgOc9CenNSwRp1K4bGBx2qwgSSJipV1IIORwQMg5/WpbUpJFHJH8yOoKnBGR2680ANWLOM/lT2jU8EA/UfrUuML93npgUpXk7sEDoPSgCILuI4G31z1poXPUEHnvVgjPJ6dKXbzQBVaHcOQD655zUkaZ68ip9nFAQjHHGOaABBtzjg+9WF4AGc47k81Go5+lSjrkUALnBxinD86QUv4HNAC+9Ln0pPxwOvNKOmRigBDj86idc9alzikJ56UAVz19c9MUwqxAwD68VZbBGCOvb1pCTj2NAFZoyBycAfjQsSnqxIqxyOoGaZzjLEAevtQBEbaNjk89+tMe0hb7yZ/GrCg5LHAz0HpRgAHofrQBnPptocfuunuarTaRYOTm2U/Uk/wBa2GXnkEn+dNZMgkcUAYB0exQgrZw5B4ytZuraHp8mWaxgZhyD5Y4NdW6k9eT0qGeJSmMDNAHll14c0uaRt9lEN3/TMAVi3XgrRZCxFqiv6qSK9LubIB328Cs24smOXA+tAHj2p/D7JL2NxIMnoecVhaj4d1LTYy0kXmJjlk7Ad8da9xNowbdjA9D0qO4hWVCsqg574oA+bbnCkvGMr/Fjp9al02dpLmJg2cEAe1eo+LPBkF2jzWiCK5I4YDr9a8wi0+fTNUW3uIyjA8elAHtnhK+MnlDOTG2PwNc18e+PBGrDJ5MR/wDIqUeC7sx6xHC5xvBXH8qT47nzPh5qEn+3Gv8A5FSgD5cooooA0vDxxrNsfc/+gmvZdCl/dqQcivF9DONUgPuf5GvXdBfdHgjnGeaAPVtAYiCFORuXf+Oaw/FF+G1O9UE4RgOvQDitjRQubcgkbQPx46V5zqN9JLrVwFIZppGULnuTxQB0vhnTjqlyZ5FBjiPyA9zXodnaxhAqKuxRgewHasnwtZfZbGKIKTtGWIxyf0rqrdEjxtXGT2U0AS2kJUAdMetaEafK+GK8HBAzioIgu/GV9cE81dh4PGce9AEOm232dJ2lBYs+8MwG7PfnvyTWtEoz71V2q/lhyCynII4Gf89qvoFwCCDxjg54oAWEKxAxh8dMfyqXy8PuH3T8p4oQqGVc8nkD1qdAv3Tn+dAD1XPOMe1PA5OaRRz708DAxigBAMdOQKXbgnjqaXHp/OnYwenFACBcgdPrQAOemfSnLg5AzQB3PGP0oAFBzRjp/Klxz2x2zSj1/H6UAJt9+fapBz6VHGiooRFwo6DtUgGeTn6mgBR1PIwPSl+gpBx1I/Cl+hoAOMY6+oNKPfFICO3b0paAF7YpmOT2+lO5/wAikzknnpQAgGP/AK9IMsoLKVPoSDj8RSsQAR1+vemFjjPWgByqAXwWOTnBPA+lIyDOdufTnpSKxLELjH1qQcev0oAYVwO2aY/HU9KlI45OaYRlfegBhyPp9KafvH1p3PakyoYLuUNg4GaAIXDNIoAdVHzF1YYJ5G0jqRzn8uaZKBtPGRjGasHI64qJ/mTjOOnSgDKkiA4A+UDAqq0JYnIP41qyLtBLAn6daikXj0IFAGLPCrjBGPYcYrKmgMb7hnA710UqjeRzn6VRnjyCDyKAMN4g/Xn271yPi7wzHqVq8kSgXEeWRh612s0flNlRgd+KYYw6EHOOmaAPBdGvWtNWjlmJVo2AbPYg966X4zsH+G2r8E/6hwT/ANdU/wAay/iVpTaXqv2qNQIrg4OP71Xfi4/mfCy7kAPz29sTn/rpHQB8z0UUUAXNIONRh+p/ka9V8PSfKvJ9DXk1jIsN1G7nCr1P4V2+k+ItOt1Aludvf7jH+lAHvGmyhIgx4AQY/KvPdCtWvPE4YDcY3LDHr2/rVq1+InhtLRFfUiH2gEeRL/8AE1B4V8beFNPmnnutUCySMcf6PKePXhaAPbNLj2RIBj1JxWxGOcj6c15fa/FnwXGBu1oA/wDXrP8A/EVfi+MPgdf+Y7j/ALdJ/wD4igD0tFIX5Aue2RxVmCNCdyqATxnvivM0+MngQYZtfIPTi0n/AD/1dTp8Z/AKgD+3hjPIFncD/wBp0AeoRYwAzOe5BORVpA20dz2BHH515cnxr+HoIJ1/n1Flcf8AxurEfxw+HYPPiE4HpZXH/wAboA9Py3JVY8++akRiTggE9evSvMF+Ofw7CADxDnAxzY3H/wAbqQfHT4c4wfEXB6j7Dc//ABugD1JW4p4IOK8tX46/Dgf8zFj/ALcrn/43Sr8d/hz1/wCEj69f9Buf/jdAHqgxjHWlAB5wK8sHx4+HGP8AkYvzsbn/AON07/hfPw3/AOhjP/gDc/8AxugD1E+oJ47Cg9MivLv+F8/Dft4jx/243P8A8bpsXx6+HDJufxAY25BX7Fcn15/1f+c/hQB6ljPelwQDzzXl/wDwvr4b5/5GPp/043P/AMbpf+F8/DYAf8VH/wCSNz/8boA9QViMbsA/Wn5zzjmvLB8evhtnP/CRken+g3P/AMbp3/C+/htj/kYx/wCANz/8boA9Txn396d0PSvLB8fPhtnnxJ/5I3P/AMbpR8fPhr/0Mn/kjc//ABugD1LnHH60jAl0bceM5AJwfqO9eX/8L9+Gv/Qyf+SFz/8AG6P+F+/DXP8AyMn/AJIXP/xugD1Ln1xQ3XmvLf8Ahfvw1wf+Kk/8kbn/AON0x/j58N8HHiQ5P/Tjc/8AxugD1I845oIH4+prytfj38N8c+JP/JG5/wDjdOHx8+G3/Qyf+SNz/wDG6APTwMHNSfQYNeXf8L8+GvGfEmfX/Qbn/wCN0D4+fDUf8zJ/5I3P/wAboA9RA444NNIODgYavMD8fPhr/wBDJx/143P/AMbpv/C/PhtjnxHz3xY3P/xugD02RRICjYxxkA/lSnDHI/OvLJfjv8NSHK+IVDkdRYXIJOOMny+aVfj18OMAt4jG7HJFjc9f+/dAHqPrUbjBztya8x/4Xz8N/wDoYiP+3G5/+N0n/C+fhx1/4SM5H/Tjc/8AxugD0pxznoarSryB09PevO5Pjv8ADg9PEWff7Dc//G6rT/HL4duQB4hHHf7Dccf+Q6APQpMMDg5qpIvBBHNcE/xu+HjD/kP8/wDXlcf/ABuqh+NXgPB/4qLfx3srjP57P6UAdxcxgsRVKTKk5OSK4uT4z+BWB/4nuD/16XHP/jlULn4veCXI2a4SB/06TjP/AI5QBueNtLi1jRpInI3qNyt6GuD+LCtF8KJ0Y5ZYLdD9RKlar/FfwVIrK+sZUjBBtZjn/wAcriPif468Oa14PvtP0rUvPuJBGETyJFziRWPLKB0BoA8MooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_13_3286=[""].join("\n");
var outline_f3_13_3286=null;
var title_f3_13_3287="Hungry bone syndrome following parathyroidectomy";
var content_f3_13_3287=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hungry bone syndrome following parathyroidectomy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/13/3287/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/13/3287/contributors\">",
"     Michael Berkoben, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/13/3287/contributors\">",
"     L Darryl Quarles, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/13/3287/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/13/3287/contributors\">",
"     Stanley Goldfarb, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/13/3287/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/13/3287/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/13/3287/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypocalcemia is a common problem after parathyroidectomy or thyroidectomy. The fall in serum calcium is primarily due to functional or relative hypoparathyroidism, leading to reductions in bone reabsorption and increases in bone formation leading to an increased influx of calcium into bone, and, in patients without end-stage renal disease, increased calcium excretion and decreased intestinal calcium absorption due to reduced PTH-mediated renal 1,25(OH)",
"    <sub>",
"     2",
"    </sub>",
"    D production. A less frequent contributing factor is acute calcitonin release from the thyroid gland.",
"   </p>",
"   <p>",
"    The hypocalcemia is generally transient because the degree of bone disease is typically mild and normal parathyroid tissue recovers function quickly (usually within one week), even after long-term suppression.",
"   </p>",
"   <p>",
"    In some cases, however, the postoperative hypocalcemia is severe and prolonged despite normal or even elevated levels of parathyroid hormone (PTH). This phenomenon, called the",
"    <strong>",
"     hungry bone",
"    </strong>",
"    syndrome, most often occurs in patients who have developed bone disease preoperatively due to a chronic increase in bone resorption induced by high levels of PTH (osteitis fibrosa) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The underlying hyperparathyroidism can either be primary or secondary due to end-stage renal disease. In addition to parathyroidectomy, a less severe hypocalcemic syndrome can occur in patients with end-stage renal disease who are treated with calcimimetics, which reduce PTH secretion by modulating the calcium-sensing receptor in the parathyroid glands [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/3/9273?source=see_link\">",
"     \"Indications for parathyroidectomy in end-stage renal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to reduced serum calcium, reduced serum phosphate and increased serum potassium levels may be observed in hungry bone syndrome. The decreased serum calcium and phosphate and increased potassium likely reflect increased bone influx and efflux, respectively. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Clinical features'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Hungry bone syndrome has also been described after thyroidectomy in patients with hyperthyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. In such patients, the preoperative bone disease is due to high bone turnover induced by excess thyroid hormone. A less common cause is estrogen therapy in patients with metastatic prostate cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The postoperative hypocalcemia probably results from acute reversal of the PTH-induced contribution of bone to maintenance of the serum calcium concentration (",
"    <a class=\"graphic graphic_figure graphicRef67512 \" href=\"UTD.htm?8/10/8365\">",
"     figure 1",
"    </a>",
"    ). In the high turnover state associated with hyperparathyroidism, PTH increases bone formation and resorption with a net efflux of calcium from bone. Sudden withdrawal of PTH in such patients causes an imbalance between osteoblast-mediated bone formation and osteoclast-mediated bone resorption and perhaps other changes affecting calcium fluxes, leading to a marked net increase in bone uptake of calcium, phosphate, and magnesium [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/2\">",
"     2",
"    </a>",
"    ]. Thus, the hungry bone syndrome requires an abrupt decrease in PTH release that upsets the equilibrium between calcium efflux from bone and influx into the skeleton during bone remodeling.",
"   </p>",
"   <p>",
"    Similar mechanisms may be responsible for the hypocalcemia occasionally seen in patients with metastatic prostate cancer who have been treated with estrogen [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/6\">",
"     6",
"    </a>",
"    ]. The osteoblastic metastases act as a calcium sink and bone resorption increases to maintain the serum calcium concentration. Inhibition of bone resorption with estrogen unmasks the underlying elevation in bone calcium uptake.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lack of well-defined clinical criteria for the diagnosis of the hungry bone syndrome makes it difficult to determine its true incidence. In a report of 198 patients who underwent parathyroidectomy for primary hyperparathyroidism, the syndrome was considered present if the serum calcium concentration was below 8.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.13",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    and the serum phosphate concentration was below 3.0",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (0.96",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    on the third postoperative day [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/2\">",
"     2",
"    </a>",
"    ]. Thirteen percent of the patients fulfilled these criteria with a mean serum calcium of 8.2",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.05",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    and a mean serum phosphate concentration of 2.0",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (0.64",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"   </p>",
"   <p>",
"    The",
"    incidence of hungry bone syndrome following parathyroidectomy in patients with secondary hyperparathyroidism due to end-stage renal disease has not been carefully examined. In one study of 148 dialysis patients who underwent parathyroidectomy, hungry bone syndrome occurred in 20 percent, which was associated with a prolonged hospital stay [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33690?source=see_link\">",
"     \"Treatment of hyperphosphatemia in chronic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the above report of patients with primary hyperparathyroidism, the following were identified as predictive factors for the development of hungry bone syndrome (in descending order of importance) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Volume of the resected adenoma",
"     </li>",
"     <li>",
"      Preoperative blood urea nitrogen concentration",
"     </li>",
"     <li>",
"      Preoperative alkaline phosphatase concentration",
"     </li>",
"     <li>",
"      Older age",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Preoperative serum calcium and PTH levels did not provide additional predictive information.",
"   </p>",
"   <p>",
"    It is unclear whether these risk factors can be applied to patients with end-stage renal disease who undergo parathyroidectomy for secondary hyperparathyroidism. The postoperative fall in serum calcium has been correlated with the severity of bone disease seen on preoperative bone biopsy specimens [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical features of hungry bone syndrome are largely due to hypocalcemia and, to a lesser degree, hypophosphatemia, hypomagnesemia, and hyperkalemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Hypocalcemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypocalcemia, with or without its accompanying signs and symptoms, usually dominates the clinical picture. The serum calcium typically reaches a nadir two to four days postoperatively (",
"    <a class=\"graphic graphic_figure graphicRef67512 \" href=\"UTD.htm?8/10/8365\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/2\">",
"     2",
"    </a>",
"    ]. Tetany and seizures can occur, possibly leading to major bone fractures. Overt heart failure has also been described in patients with latent myocardial dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]; in these cases, cardiomegaly and pulmonary congestion resolved after normalization of the serum calcium. The duration of hypocalcemia is variable, and may last up to three months [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Hypophosphatemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The decrease in bone resorption and increase in bone formation that occurs after parathyroidectomy can also lead to hypophosphatemia. This primarily occurs in patients with primary rather than secondary hyperparathyroidism. In the latter disorder, the serum phosphorus falls from an initially high level to one that is usually still above the normal range (",
"    <a class=\"graphic graphic_figure graphicRef72139 \" href=\"UTD.htm?17/35/17982\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Hypomagnesemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypomagnesemia is also more prevalent among patients undergoing parathyroidectomy for primary hyperparathyroidism. The recognition and treatment of magnesium deficiency is important since hypomagnesemia can contribute to the development of refractory hypocalcemia by diminishing PTH secretion and inducing PTH resistance. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42580?source=see_link\">",
"     \"Signs and symptoms of magnesium depletion\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Hyperkalemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperkalemia occurs in up to 80 percent of dialysis patients undergoing parathyroidectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. The pathophysiology underlying this phenomenon is currently unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment is aimed at each of the abnormalities that can occur: hypocalcemia, hypomagnesemia, hypophosphatemia, and hyperkalemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Hypocalcemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Careful monitoring is required to prevent and treat symptomatic hypocalcemia, which can be potentially catastrophic. Thus, the serum calcium concentration should be measured two to four times per day for the first few postoperative days, the time of greatest risk (",
"    <a class=\"graphic graphic_figure graphicRef67512 \" href=\"UTD.htm?8/10/8365\">",
"     figure 1",
"    </a>",
"    ). The measurement of ionized calcium is preferred to total serum calcium since the total serum calcium concentration may not reliably predict the ionized calcium concentration, especially among patients with chronic kidney disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23685?source=see_link&amp;anchor=H701808710#H701808710\">",
"     \"Relation between total and ionized serum calcium concentration\", section on 'Measuring the serum calcium in patients with CKD'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Oral calcium supplementation (2 to 4 g of elemental calcium [50 to 100 mmol] per day) should be started as soon as the patient is able to swallow. If the serum phosphorus is normal or low, calcium should be administered between meals to maximize intestinal absorption and minimize phosphate binding.",
"   </p>",
"   <p>",
"    Intravenous calcium is indicated if the patient develops a rapid and progressive reduction in serum calcium or symptoms related to hypocalcemia, including frank or latent tetany (Chvostek's or Trousseau's sign), seizures, cardiac arrhythmias, laryngeal spasm, or either an ionized calcium concentration below 1.0",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    (4",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    or total serum calcium below 1.9",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    (7.5",
"    <span class=\"nowrap\">",
"     mg/dL),",
"    </span>",
"    all which can be life-threatening.",
"    <br/>",
"   </p>",
"   <p>",
"    Initially, intravenous calcium (1 to 2 g of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/11/18616?source=see_link\">",
"     calcium gluconate",
"    </a>",
"    , equivalent to 90 to 180 mg elemental calcium, in 50 mL of 5 percent dextrose) can be infused over 10 to 20 minutes. The calcium should not be given more rapidly, because of the risk of serious cardiac dysfunction, including systolic arrest [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/14\">",
"     14",
"    </a>",
"    ]. This dose of calcium gluconate will raise the serum calcium concentration for only two or three hours; as a result, it should be followed by a slow infusion of calcium in patients with persistent hypocalcemia.",
"   </p>",
"   <p>",
"    Either 10 percent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/11/18616?source=see_link\">",
"     calcium gluconate",
"    </a>",
"    (90 mg of elemental calcium per 10 mL) or 10 percent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15799?source=see_link\">",
"     calcium chloride",
"    </a>",
"    (270 mg of elemental calcium per 10 mL) can be used to prepare the infusion solution. Calcium gluconate is usually preferred because it is less likely to cause tissue necrosis if extravasated. Local vein irritation can occur with calcium solutions &gt;200",
"    <span class=\"nowrap\">",
"     mg/dl.",
"    </span>",
"   </p>",
"   <p>",
"    An intravenous solution containing 1",
"    <span class=\"nowrap\">",
"     mg/mL",
"    </span>",
"    of elemental",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/11/18616?source=see_link\">",
"     calcium gluconate",
"    </a>",
"    is prepared by adding 100 mL of 10 percent calcium gluconate (90 mg elemental calcium per 10 mL for a total of 900 mg elemental calcium) to 1000 mL of 5 percent dextrose in water. This solution is administered at an initial infusion rate of 50",
"    <span class=\"nowrap\">",
"     mL/h",
"    </span>",
"    (equivalent to 50",
"    <span class=\"nowrap\">",
"     mg/h).",
"    </span>",
"    The dose can be adjusted to maintain the ionized calcium concentration at the lower end of the normal range (4 to 5.6",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [1.1 to 1.4",
"    <span class=\"nowrap\">",
"     mmol/L]).",
"    </span>",
"    Patients typically require 0.5 to 2.0",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    of elemental calcium per hour.",
"   </p>",
"   <p>",
"    The infusion should be prepared with the following considerations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The calcium should be diluted in dextrose and water or saline, because concentrated calcium solutions are irritating to veins.",
"     </li>",
"     <li>",
"      The intravenous solution should not contain bicarbonate or phosphate, which can form insoluble calcium salts. If these anions are needed, another intravenous line (in another limb) should be used.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Vitamin D supplementation is also useful, particularly in patients on maintenance dialysis who are often vitamin D deficient if they have not been receiving some form of replacement therapy. In a placebo-controlled trial, for example, postoperative oral calcitriol in doses up to 4",
"    <span class=\"nowrap\">",
"     mcg/day",
"    </span>",
"    ameliorated the postoperative decline in the serum calcium concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38474?source=see_link\">",
"     \"Management of secondary hyperparathyroidism and mineral metabolism abnormalities in dialysis patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are no studies comparing the relative efficacy of oral and intravenous calcitriol administration. It is common practice to administer calcitriol intravenously at increased doses. The only concern with the use of high dose calcitriol is the potential to suppress the function and engraftment of autotransplanted parathyroid tissue. We give intravenous calcitriol, to all patients who are hypocalcemic following parathyroidectomy. Intravenous calcitriol is generally continued until the serum calcium has stabilized at a clinically safe concentration. Once the serum calcium is stable, the patient may be switched to oral calcitriol which is continued until the serum calcium concentration is normal (usually two to four weeks).",
"   </p>",
"   <p>",
"    Dialysis is another method of correcting the hypocalcemia. A high calcium bath (3.5",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    [1.75",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    can be used in patients undergoing hemodialysis. Alternatively, intravenous calcium can be administered during dialysis, thereby allowing an earlier switch to outpatient management. Similarly, one to three ampules of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/11/18616?source=see_link\">",
"     calcium gluconate",
"    </a>",
"    can be added to each bag of peritoneal dialysate in patients treated with continuous ambulatory peritoneal dialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Hypomagnesemia and hypophosphatemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The serum magnesium and phosphate concentrations should also be monitored, since significant hypomagnesemia and hypophosphatemia can occur in patients with primary hyperparathyroidism. The hypomagnesemia can contribute to the development of refractory hypocalcemia by diminishing PTH secretion and inducing PTH resistance. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42580?source=see_link\">",
"     \"Signs and symptoms of magnesium depletion\"",
"    </a>",
"    .) Thus, raising the serum magnesium concentration may contribute to correction of the hypocalcemia",
"   </p>",
"   <p>",
"    In contrast, the administration of phosphate to reverse hypophosphatemia is generally avoided in patients with hungry bone syndrome, since phosphate can combine with calcium and further reduce the plasma calcium concentration. Exceptions may be made for patients who have extremely low serum phosphate concentrations (ie, less than 0.5 to 1.0",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [0.16 to 032",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    in the setting of symptoms of hypophosphatemia such as severe muscle weakness or heart failure. Even under such circumstances, the administration of phosphate should be considered potentially hazardous because of the rapidity with which symptoms of resulting hypocalcemia may develop. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2167?source=see_link\">",
"     \"Diagnosis and treatment of hypophosphatemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Different changes in phosphate balance occur after parathyroidectomy in patients with primary hyperparathyroidism who do not have significant bone disease. These patients do not develop hungry bone syndrome and may have a rise in the plasma phosphate concentration due to reversal of PTH-induced phosphate loss in the urine.",
"   </p>",
"   <p>",
"    Clinically significant hypomagnesemia and hypophosphatemia are uncommon in patients with chronic renal failure undergoing parathyroidectomy. Serum phosphate values are typically elevated and fall toward the normal range after surgery (",
"    <a class=\"graphic graphic_figure graphicRef72139 \" href=\"UTD.htm?17/35/17982\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Hyperkalemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The serum potassium concentration should be closely followed in patients with end-stage renal disease. Such patients should be dialyzed on the first or second postoperative day, preferably with a no-heparin protocol.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the frequency of vitamin D deficiency in the hemodialysis population, most physicians recommend preoperative administration of calcitriol to all such patients if they are not already being treated with a vitamin D metabolite. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/58/32681?source=see_link\">",
"     \"Management of secondary hyperparathyroidism and mineral metabolism abnormalities in adult predialysis patients with chronic kidney disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38474?source=see_link\">",
"     \"Management of secondary hyperparathyroidism and mineral metabolism abnormalities in dialysis patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Intravenous calcitriol (2 mcg at the end of each hemodialysis treatment) begun three to five days prior to surgery and continued postoperatively may be helpful in preventing marked hypocalcemia. This regimen may also suppress bone remodeling and increase absorption of oral calcium, both of which can minimize the need for intravenous calcium postoperatively. Intravenous calcitriol is generally continued until the serum calcium has stabilized at a clinically safe concentration. Once the serum calcium is stable, the patient may be switched to oral calcitriol which is continued until the serum calcium concentration is normal (usually two to four weeks). Some authors also suggest starting oral calcium 2 to 3 grams per day two days prior to surgery, even in patients who are hypercalcemic [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/12\">",
"     12",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    Treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/23/26998?source=see_link\">",
"     cinacalcet",
"    </a>",
"    (alone or in combination with calcitriol) to suppress PTH levels and lower bone remodeling may attenuate the severity of hungry bone syndrome, but additional experience with this treatment is necessary before this is recommended.",
"    <br/>",
"   </p>",
"   <p>",
"    A few case reports and several retrospective studies have suggested a possible role for the preoperative administration of bisphosphonates as another preventive measure [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/16\">",
"     16",
"    </a>",
"    ]. In these reports, bisphosphonates were used to treat hypercalcemia in patients with severe primary and secondary hyperparathyroidism prior to parathyroidectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3287/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since bisphosphonates can reduce serum calcium levels, these anecdotal and apparently paradoxical observations require confirmation with a controlled randomized study. The fact that these patients did not develop postoperative hypocalcemia does",
"    <strong>",
"     not",
"    </strong>",
"    constitute enough evidence to justify the use of bisphosphonates prior to parathyroidectomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H512439998\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The hungry bone syndrome refers to severe and prolonged hypocalcemia which occurs after parathyroidectomy or less commonly, thyroidectomy, despite normal or even elevated levels of parathyroid hormone (PTH). A less severe hypocalcemic syndrome can occur in patients with end stage renal disease who are treated with calcimimetics. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Risk factors include the volume of the resected parathyroid adenoma, preoperative blood urea nitrogen concentration, preoperative alkaline phosphatase concentration and older age. It is unclear whether these risk factors can be applied to patients with end-stage renal disease who undergo parathyroidectomy for secondary hyperparathyroidism. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical features of hungry bone syndrome are largely due to hypocalcemia and, to a lesser degree, hypophosphatemia, hypomagnesemia, and hyperkalemia. Symptoms of hypocalcemia include tetany, seizures, cardiac arrhythmias, and laryngeal spasm. The hypomagnesemia can contribute to the development of refractory hypocalcemia by diminishing PTH secretion and inducing PTH resistance. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Careful monitoring of serum calcium is required to prevent and treat symptomatic hypocalcemia. Among patients who have a parathyroidectomy, we suggest measuring the serum calcium concentration two to four times per day for the first few postoperative days. The measurement of ionized calcium is preferred to total serum calcium. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Hypocalcemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypocalcemia may be treated with oral or intravenous calcium supplementation or by dialysis. For patients who have undergone parathyroidectomy, we suggest the following approaches. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Hypocalcemia'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Oral calcium supplementation (2 to 4 g of elemental calcium [50 to 100 mmol] per day) should be started as soon as the patient is able to swallow. If the serum phosphorus is normal or low, calcium should be administered between meals to maximize intestinal absorption and minimize phosphate binding.",
"     </li>",
"     <li>",
"      Intravenous calcium is indicated if the patient develops a rapid and progressive reduction in ionized serum calcium or symptoms related to hypocalcemia, including frank or latent tetany (Chvostek's or Trousseau's sign), seizures, cardiac arrhythmias, laryngeal spasm, or an ionized calcium concentration below 1.0",
"      <span class=\"nowrap\">",
"       mmol/L",
"      </span>",
"      (4",
"      <span class=\"nowrap\">",
"       mg/dL),",
"      </span>",
"      or total serum calcium below 7.5",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.9",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"      <br/>",
"      <br/>",
"      Initially, intravenous calcium (1 to 2 g of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/11/18616?source=see_link\">",
"       calcium gluconate",
"      </a>",
"      , equivalent to 90 to 180 mg elemental calcium, in 50 mL of 5 percent dextrose) can be infused over 10 to 20 minutes. This infusion should be followed by a slow infusion of calcium in patients with persistent hypocalcemia. An intravenous solution containing 1",
"      <span class=\"nowrap\">",
"       mg/mL",
"      </span>",
"      of elemental calcium gluconate may be prepared by adding 100 mL of 10 percent calcium gluconate (90 mg elemental calcium per 10 mL for a total of 900 mg elemental calcium) to 1000 mL of 5 percent dextrose in water. This solution is administered at an initial infusion rate of 50",
"      <span class=\"nowrap\">",
"       mL/h",
"      </span>",
"      (equivalent to 50",
"      <span class=\"nowrap\">",
"       mg/h).",
"      </span>",
"      The dose can be adjusted to maintain the ionized calcium concentration at the lower end of the normal range (4 to 5.6",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [1.1 to 1.4",
"      <span class=\"nowrap\">",
"       mmol/L]).",
"      </span>",
"      Patients typically require 0.5 to 2.0",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      of elemental calcium per hour.",
"     </li>",
"     <li>",
"      Dialysis may be used to correct hypocalcemia. The patient may be dialyzed against a high calcium bath (3.5",
"      <span class=\"nowrap\">",
"       mEq/L",
"      </span>",
"      [1.75",
"      <span class=\"nowrap\">",
"       mmol/L])",
"      </span>",
"      or intravenous calcium can be administered during dialysis.",
"      <br/>",
"      <br/>",
"      For patients who are on continuous ambulatory peritoneal dialysis, one to three ampules of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/11/18616?source=see_link\">",
"       calcium gluconate",
"      </a>",
"      can be added to each bag of peritoneal dialysate.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Serum phosphate and magnesium concentrations should be closely followed after parathyroidectomy. The correction of hypomagnesemia may contribute to correction of the hypocalcemia. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Hypomagnesemia and hypophosphatemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The administration of phosphate to reverse hypophosphatemia is generally avoided in patients with hungry bone syndrome, since phosphate can combine with calcium and further reduce the plasma calcium concentration. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2167?source=see_link\">",
"       \"Diagnosis and treatment of hypophosphatemia\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The serum potassium concentration should be closely followed in patients with end-stage renal disease. Such patients should be dialyzed on the first or second postoperative day, preferably with a no-heparin protocol. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Hyperkalemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For prevention of hungry bone syndrome, most physicians recommend preoperative administration of calcitriol to all such patients if they are not already being treated with a vitamin D metabolite. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Prevention'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Intravenous calcitriol (2 mcg at the end of each hemodialysis treatment) begun three to five days prior to surgery and continued postoperatively may be helpful in preventing marked hypocalcemia. This regimen may also suppress bone remodeling and increase absorption of oral calcium, both of which can minimize the need for intravenous calcium postoperatively. Some authors also suggest starting oral calcium 2 to 3 grams per day two days prior to surgery, even in patients who are hypercalcemic.",
"      <br/>",
"      <br/>",
"      Treatment with cinacalcet (alone or in combination with calcitriol) to suppress PTH levels and lower bone remodeling may attenuate the severity of hungry bone syndrome, but additional experience with this treatment is necessary before this is recommended. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Albright, F, Reifenstein, EC, Jr. The parathyroid glands and metabolic bone disease, Williams &amp; Wilkins, Baltimore, 1948.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3287/abstract/2\">",
"      Brasier AR, Nussbaum SR. Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery. Am J Med 1988; 84:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3287/abstract/3\">",
"      Goodman WG, Frazao JM, Goodkin DA, et al. A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism. Kidney Int 2000; 58:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3287/abstract/4\">",
"      DENT CE, HARPER CM. Hypoparathyroid tetany (following thyroidectomy) apparently resistant to vitamin D. Proc R Soc Med 1958; 51:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3287/abstract/5\">",
"      Jones RM, Davidson CM. Thyrotoxicosis and the hungry bone syndrome: a cause of postoperative tetany. J R Coll Surg Edinb 1987; 32:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3287/abstract/6\">",
"      Vogelgesang SA, McMillin JM. Hypocalcemia associated with estrogen therapy for metastatic adenocarcinoma of the prostate. J Urol 1988; 140:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3287/abstract/7\">",
"      Jofr&eacute; R, L&oacute;pez G&oacute;mez JM, Men&aacute;rguez J, et al. Parathyroidectomy: whom and when? Kidney Int Suppl 2003; :S97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3287/abstract/8\">",
"      Felsenfeld AJ, Gutman RA, Llach F, et al. Postparathyroidectomy hypocalcemia as an accurate indicator of preparathyroidectomy bone histology in the uremic patient. Miner Electrolyte Metab 1984; 10:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3287/abstract/9\">",
"      Falko JM, Bush CA, Tzagournis M, Thomas FB. Case report. Congestive heart failure complicating the hungry bone syndrome. Am J Med Sci 1976; 271:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3287/abstract/10\">",
"      Shinoda T, Aizawa T, Shirota T, et al. Exacerbation of latent heart failure by mild hypocalcemia after parathyroidectomy in a long-term hemodialysis patient. Nephron 1992; 60:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3287/abstract/11\">",
"      Benz RL, Schleifer CR, Teehan BP, et al. Successful treatment of postparathyroidectomy hypocalcemia using continuous ambulatory intraperitoneal calcium (CAIC) therapy. Perit Dial Int 1989; 9:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3287/abstract/12\">",
"      Cruz DN, Perazella MA. Biochemical aberrations in a dialysis patient following parathyroidectomy. Am J Kidney Dis 1997; 29:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3287/abstract/13\">",
"      Shpitz, B, Korzets, Z, Dinbar, A, et al. Immediate postoperative management of parathyroidectomized hemodialysis patients. Dial Transplant 1986; 15:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3287/abstract/14\">",
"      Tohme, JF, Bilezikian, JP. Diagnosis and treatment of hypocalcemic emergencies. The Endocrinologist 1996; 6:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3287/abstract/15\">",
"      Clair F, Leenhardt L, Bourdeau A, et al. Effect of calcitriol in the control of plasma calcium after parathyroidectomy. A placebo-controlled, double-blind study in chronic hemodialysis patients. Nephron 1987; 46:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3287/abstract/16\">",
"      Lee IT, Sheu WH, Tu ST, et al. Bisphosphonate pretreatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism. J Bone Miner Metab 2006; 24:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3287/abstract/17\">",
"      Kumar A, Ralston SH. Bisphosphonates prevent the hungry bone syndrome. Nephron 1996; 74:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3287/abstract/18\">",
"      Davenport A, Stearns MP. Administration of pamidronate helps prevent immediate postparathyroidectomy hungry bone syndrome. Nephrology (Carlton) 2007; 12:386.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2070 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-89.32.226.102-E9F4F161E5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_13_3287=[""].join("\n");
var outline_f3_13_3287=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H512439998\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Hypophosphatemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Hypomagnesemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Hyperkalemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Hypomagnesemia and hypophosphatemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Hyperkalemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H512439998\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/2070\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/2070|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/10/8365\" title=\"figure 1\">",
"      Hungry bone syndrome after PTX",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/35/17982\" title=\"figure 2\">",
"      Effects of parathyroidectomy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2167?source=related_link\">",
"      Diagnosis and treatment of hypophosphatemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/3/9273?source=related_link\">",
"      Indications for parathyroidectomy in end-stage renal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/58/32681?source=related_link\">",
"      Management of secondary hyperparathyroidism and mineral metabolism abnormalities in adult predialysis patients with chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38474?source=related_link\">",
"      Management of secondary hyperparathyroidism and mineral metabolism abnormalities in dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23685?source=related_link\">",
"      Relation between total and ionized serum calcium concentration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42580?source=related_link\">",
"      Signs and symptoms of magnesium depletion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33690?source=related_link\">",
"      Treatment of hyperphosphatemia in chronic kidney disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_13_3288="Epidemiology and environmental factors in inflammatory bowel disease in children and adolescents";
var content_f3_13_3288=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology and environmental factors in inflammatory bowel disease in children and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/13/3288/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/13/3288/contributors\">",
"     Leslie M Higuchi, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/13/3288/contributors\">",
"     Athos Bousvaros, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/13/3288/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/13/3288/contributors\">",
"     George D Ferry, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/13/3288/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/13/3288/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/13/3288/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 10, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammatory bowel disease (IBD) is comprised of two major disorders: ulcerative colitis (UC) and Crohn's disease (CD). UC affects the colon, whereas CD can involve any component of the gastrointestinal tract from the oral cavity to the anus. These disorders have distinct pathologic and clinical characteristics, but their pathogenesis remains poorly understood. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27401?source=see_link\">",
"     \"Immune and microbial mechanisms in the pathogenesis of inflammatory bowel disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The peak incidence of IBD occurs in patients between the ages of 15 and 25 years. Approximately 25 to 30 percent of patients with CD and 20 percent of patients with UC present before the age of 20 years [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/1\">",
"     1",
"    </a>",
"    ]. Both adults and children with IBD may present with similar clinical features; however, children can develop unique complications, including growth failure and delayed puberty. Clinicians caring for children and adolescents with one of these disorders must treat the underlying disease and its complications and must also carefully monitor linear growth, skeletal development, and puberty.",
"   </p>",
"   <p>",
"    The epidemiology and role of environmental factors in IBD in children and adolescents will be reviewed here. The clinical manifestations, diagnosis, and treatment of CD and UC in children and adolescents and the role of genetic factors are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/7/24693?source=see_link\">",
"     \"Clinical manifestations of Crohn's disease in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/34/4650?source=see_link\">",
"     \"Treatment of ulcerative colitis in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/25/27034?source=see_link\">",
"     \"Clinical features and diagnosis of inflammatory bowel disease in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/47/41722?source=see_link\">",
"     \"Overview of the management of Crohn's disease in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/26/44455?source=see_link\">",
"     \"Genetic factors in inflammatory bowel disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENETIC FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two issues related to genetic factors in IBD: factors that increase the susceptibility to inflammatory bowel disease (IBD); and genetic syndromes that are associated with an increased risk of IBD. These issues are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/26/44455?source=see_link\">",
"     \"Genetic factors in inflammatory bowel disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most children with inflammatory bowel disease (IBD) are diagnosed in late childhood and adolescence. However, both Crohn's disease (CD) and ulcerative colitis (UC) have been reported as early as in infancy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. Most information pertaining to the epidemiology of IBD is based upon adult studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Time trends in pediatric IBD",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of IBD in children appears to be increasing [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. In a report from Stockholm, Sweden, for example, the incidence of CD per 100,000 increased from 2.4 between 1990 and 1992 to 5.4 between 1996 and 1998, while the incidence of UC remained relatively stable [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/8\">",
"     8",
"    </a>",
"    ]. A study from Finland also suggests that the incidence of IBD in children doubled during a 15 year period [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/9\">",
"     9",
"    </a>",
"    ]. &nbsp;A study from Australia reported an 11-fold increase of UC over a 20 year period beginning in the 1990s [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/10\">",
"     10",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Geographic trends",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence and prevalence of IBD varies by geographic location. The global distribution of CD and UC are similar. Both occur more commonly in North America, the United Kingdom, and Scandinavia than in southern Europe, Asia, and Africa [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/1\">",
"     1",
"    </a>",
"    ]. There seems to be a north-to-south gradient with higher incidence rates of both CD and UC in northern locations, even within individual countries [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/17/7450?source=see_link&amp;anchor=H531100387#H531100387\">",
"     \"Definition, epidemiology, and risk factors in inflammatory bowel disease\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most incidence data for CD and UC in the pediatric population originate from geographic regions with higher rates of IBD. Given the significant rise in age-specific incidence in the teenage years, the reported incidence rates of pediatric CD and UC may vary secondary to differences in the age definition of the pediatric population for each study [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/14\">",
"     14",
"    </a>",
"    ]. As an example, a pediatric population limited to individuals younger than 15 years of age may yield a different incidence rate of CD and UC than a pediatric population defined as younger than 17 years of age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Racial and ethnic predisposition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial studies suggested a lower rate of IBD in non-Caucasian populations, but these results may reflect under-representation of non-Caucasians in the regions of study. Although the incidence of IBD among blacks in developing countries such as Africa is low [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/15\">",
"     15",
"    </a>",
"    ], data from urban areas of the United States suggest that rates are similar in African-American and Caucasian populations [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Both CD and UC occur more commonly among Jewish than non-Jewish peoples [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/18\">",
"     18",
"    </a>",
"    ]. The rates of IBD in Israel vary by the place of birth. The prevalence rates for CD among immigrants from Europe in the United States are higher than in patients of Jewish descent from Asia and Africa [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Although the prevalence of IBD tends to be higher overall, disease rates in people of Jewish origin vary by geographic region and parallel those of the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/21\">",
"     21",
"    </a>",
"    ]. The higher rates of IBD in those with Jewish origins across different countries support a genetic predisposition; yet, the geographic variation of IBD rates also suggest potential environmental factors that may influence such an inherited predisposition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Age-related characteristics",
"    </span>",
"    &nbsp;&mdash;&nbsp;As compared with adults, children with IBD appear to be more likely to present with extensive intestinal involvement and have rapid clinical progression [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. Children also are more likely to have a family history of IBD, suggesting a stronger genetic association for IBD presenting during childhood [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/26/44455?source=see_link\">",
"     \"Genetic factors in inflammatory bowel disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Data from a multicenter pediatric IBD registry provide a description of the characteristics of pediatric IBD according to age [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/25\">",
"     25",
"    </a>",
"    ]. This registry is comprised of six pediatric medical centers in different geographic areas of the United States. Between January 2000 and November 2002, 1370 children (0 to 17 years) with IBD were enrolled; both incident and prevalent cases were included. The following observations were made:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The mean age at diagnosis was 10.3 years; 15 percent of patients were diagnosed before age six years (6 percent before three years), 48 percent at 6 to 12 years, and 37 percent at 13 to 17 years.",
"     </li>",
"     <li>",
"      Family history (including both first-degree relatives and extended family) was positive for IBD in 29 percent of patients overall, and 44 percent of children with UC who were younger than three years.",
"     </li>",
"     <li>",
"      Isolated colonic disease, whether CD, UC, or indeterminate colitis, was more common among children younger than eight years than among older children.",
"     </li>",
"     <li>",
"      Among children younger than eight years, indeterminate colitis and UC were more frequent than CD (adjusted risk ratio 3.7 [95% CI 1.6-5.2] and 2.4 [95% CI 1.8-3.2], respectively).",
"     </li>",
"     <li>",
"      The proportion of cases of indeterminate colitis decreased with increasing age, from 33 percent in those diagnosed before three years of age to 9 percent among 13- to 17-year-olds, suggesting that indeterminate colitis may represent an evolving form of IBD that presents before definitive phenotype, or that current classification criteria to differentiate UC from CD may not be applicable to young children.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a large study using data from national insurance claims in the United States, IBD was far more prevalent in adolescents than in young children [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/26\">",
"     26",
"    </a>",
"    ]. Approximately 85 of every 100,000 adolescents aged 15 to 20 years old have UC. In contrast, only 2.3 of every 100,000 children under age five have UC. Similarly, the prevalence of CD in adolescents is 58 per 100,000, as compared with 5.4 per 100,000 in children under age five years. Because these data reflect prevalence, each age category includes incident cases diagnosed at a younger age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ENVIRONMENTAL FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lack of total concordance of disease among monozygotic twins and differences in rates of inflammatory bowel disease (IBD) among migrant populations support a role for environmental factors in the development of IBD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27401?source=see_link\">",
"     \"Immune and microbial mechanisms in the pathogenesis of inflammatory bowel disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/17/7450?source=see_link\">",
"     \"Definition, epidemiology, and risk factors in inflammatory bowel disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several environmental factors identified in the literature are listed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Perinatal and early exposures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The literature remains mixed as to the relationship of Crohn's disease (CD) or ulcerative colitis (UC) with breastfeeding exposure. Breastfeeding stimulates the development and maturation of the gastrointestinal mucosa of infants and may protect them from gastrointestinal infections in infancy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/27\">",
"     27",
"    </a>",
"    ]. Several studies suggest that IBD patients were less likely to have been breastfed as infants [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. In a study focusing on child-onset CD, children with CD were more than three times less likely to have been breastfed than their unaffected siblings [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/28\">",
"     28",
"    </a>",
"    ]. The same group found no association with breastfeeding practices and the risk of developing UC in childhood [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/31\">",
"     31",
"    </a>",
"    ]. However, another study examining early-onset IBD (less than 20 years at diagnosis) demonstrated no relationship between breastfeeding and either CD or UC [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/32\">",
"     32",
"    </a>",
"    ]. Retrospective studies have identified a high incidence of infantile cow's milk protein sensitivity in children with IBD. However, this finding may only reflect recall bias by the parents [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several authors have suggested that exposure to infections in the perinatal period or early life may contribute to the development of IBD. Individuals with CD or UC were more likely to have experienced a diarrheal illness during infancy when compared with their unaffected siblings [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/28,31\">",
"     28,31",
"    </a>",
"    ]. In addition, exposure during early childhood to antibiotics that target anaerobic bacteria increases the risk for IBD. This was shown in a large population study from the United Kingdom, in which anti-anaerobic antibiotic exposure increased the relative risk for IBD by 84 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/34\">",
"     34",
"    </a>",
"    ]. The risk was greatest for exposures before one year of age (adjusted hazard ratio 5.51, 95% CI 1.66-1.94), as compared with later in childhood or adolescence (hazard ratios 2.62 by age 5, and 1.57 by age 15). &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    Further studies suggest a role for viral infections as a risk factor for IBD development [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/35\">",
"     35",
"    </a>",
"    ]. The possibility of persistent measles infection in CD causing a chronic granulomatous vasculitis has been proposed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/36\">",
"     36",
"    </a>",
"    ]. However, the evidence for persistent measles infection in tissues of CD patients is mixed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. One study, for example, demonstrated an increased incidence of CD (all diagnosed before age of 30 years) but not UC among individuals born during measles epidemics in Sweden between 1945 and 1954 [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/39\">",
"     39",
"    </a>",
"    ]. In contrast, two studies from the United Kingdom did not find any association between the development of CD and birth during measles epidemics [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/40,41\">",
"     40,41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Conversely, some environmental factors may be protective against the development of IBD. Some studies suggest that contact with farm animals during early life reduces the likelihood of developing IBD [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. The effect sizes were small, and other studies concluded that pet exposure has the opposite effect [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/44\">",
"     44",
"    </a>",
"    ]. Nonetheless, the observations are consistent with the hypothesis that exposure to infectious pathogens early in life confers protection against some immune-mediated diseases (the \"hygiene hypothesis\") [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some of these risk factors or protective mechanisms may be mediated through changes in the gut flora. The correlation between IBD and specific microorganisms, and the association between IBD and exposures than alter gut flora are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/17/7450?source=see_link&amp;anchor=H531113796#H531113796\">",
"     \"Definition, epidemiology, and risk factors in inflammatory bowel disease\", section on 'Risk factors'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    There has been much controversy about the potential role of the measles vaccination and the development of CD. In one initial study, the relative risk for the development of CD and UC, was 3.0 and 2.5 respectively, in children who received the measles vaccine [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/46\">",
"     46",
"    </a>",
"    ]. These findings have been refuted in subsequent studies [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Diet",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the constant intestinal exposure to numerous luminal dietary antigens, it seems reasonable to postulate a relationship between diet and IBD. Ecological and case-control studies suggest an association between certain foods and development of IBD. An increase of refined sugar consumption has been associated with CD [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/49,50\">",
"     49,50",
"    </a>",
"    ], but not with UC [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/51\">",
"     51",
"    </a>",
"    ]. Other foods studied include margarine (which was associated with an increased risk of developing UC) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/52\">",
"     52",
"    </a>",
"    ], and decreased consumption of fruits and vegetables (which was associated with an increased risk of developing CD) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/50\">",
"     50",
"    </a>",
"    ]. However, methodological issues of these retrospectively designed studies, such as the collection of pre-illness diet, remain a problem with the interpretation of findings. As an example, the recalled dietary intake may reflect changes in the diet secondary to the effects of the disease itself, rather than the individual's dietary habits preceding the onset of disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/17/7450?source=see_link&amp;anchor=H9#H9\">",
"     \"Definition, epidemiology, and risk factors in inflammatory bowel disease\", section on 'Diet'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several reports have supported the treatment of IBD with fish oil preparations containing n-3 polyunsaturated fatty acids (PUFAs) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. The dietary intake of n-3 PUFAs may modulate immune responses by decreasing the production of cytokines [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/55\">",
"     55",
"    </a>",
"    ] and leukotriene B4 (LTB4), an inflammatory mediator with potent neutrophil chemotactic properties [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/56\">",
"     56",
"    </a>",
"    ]. Interestingly, the incidence rates of IBD are lower in Japan, a country with high fish consumption [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/57\">",
"     57",
"    </a>",
"    ]. In one report, a rising incidence of CD among the racially homogeneous population in Japan correlated with the ingestion of a \"Western\" diet containing increased n-6 PUFAs relative to n-3 PUFAs [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/58\">",
"     58",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/7/44152?source=see_link&amp;anchor=H642205784#H642205784\">",
"     \"Nutrition and dietary interventions in adults with inflammatory bowel disease\", section on 'Omega-3 polyunsaturated fatty acids'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking is associated with an estimated twofold increased risk for CD [",
"    <a class=\"abstract\" href=\"UTD.htm?3/13/3288/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. In contrast, current smokers have approximately one-half the risk of developing UC compared to nonsmokers. The evidence for an association between oral contraceptives (OCPs) and IBD is less clear than for smoking. Other reported associations include appendectomy and decreased risk for developing UC. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/17/7450?source=see_link&amp;anchor=H531113796#H531113796\">",
"     \"Definition, epidemiology, and risk factors in inflammatory bowel disease\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12781702\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The peak incidence of inflammatory bowel disease (IBD) occurs between the ages of 15 and 25 years; 25 to 30 percent of patients with Crohn&rsquo;s disease (CD) and 20 percent of patients with ulcerative colitis (UC) present before the age of 20 years. However, both CD and UC have been reported as early as in infancy. The incidence of CD in children appears to be increasing, but varies by geographic region and ethnicity. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      As compared with adults, children with IBD appear to present with more extensive intestinal involvement and have rapid clinical progression. Young children with CD are also more likely to have disease limited to the colon. Children also are more likely to have a family history of IBD (present in approximately 20 to 30 percent), suggesting a stronger genetic association for IBD presenting during childhood. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Age-related characteristics'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/26/44455?source=see_link\">",
"       \"Genetic factors in inflammatory bowel disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The lack of total concordance of disease among monozygotic twins and differences in rates of IBD among migrant populations support a role for environmental factors in the development of IBD. Proposed risk factors include lack of breastfeeding, viral infections, and several dietary factors. Smoking may have differential effects on the risk of CD and UC, and appendectomy may be protective. Studies examining these factors are retrospective and subject to recall bias, and none of these risk factors have been established. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Environmental factors'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/7/44152?source=see_link\">",
"       \"Nutrition and dietary interventions in adults with inflammatory bowel disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Mendeloff AI, Calkins BM. The epidemiology of idiopathic inflammatory bowel disease. In: Inflammatory Bowel Disease, Kirsner JB, Shorter RG (Eds), Lea &amp; Febiger, Philadelphia 1988. p.3.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/2\">",
"      Miller RC, Larsen E. Regional enteritis in early infancy. Am J Dis Child 1971; 122:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/3\">",
"      Chong SK, Blackshaw AJ, Morson BC, et al. Prospective study of colitis in infancy and early childhood. J Pediatr Gastroenterol Nutr 1986; 5:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/4\">",
"      Gryboski JD. Ulcerative colitis in children 10 years old or younger. J Pediatr Gastroenterol Nutr 1993; 17:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/5\">",
"      Barton JR, Gillon S, Ferguson A. Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three-fold rise in Crohn's disease. Gut 1989; 30:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/6\">",
"      Cosgrove M, Al-Atia RF, Jenkins HR. The epidemiology of paediatric inflammatory bowel disease. Arch Dis Child 1996; 74:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/7\">",
"      Armitage E, Drummond H, Ghosh S, Ferguson A. Incidence of juvenile-onset Crohn's disease in Scotland. Lancet 1999; 353:1496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/8\">",
"      Askling J, Grahnquist L, Ekbom A, Finkel Y. Incidence of paediatric Crohn's disease in Stockholm, Sweden. Lancet 1999; 354:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/9\">",
"      Turunen P, Kolho KL, Auvinen A, et al. Incidence of inflammatory bowel disease in Finnish children, 1987-2003. Inflamm Bowel Dis 2006; 12:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/10\">",
"      Schildkraut V, Alex G, Cameron DJ, et al. Sixty-year study of incidence of childhood ulcerative colitis finds eleven-fold increase beginning in 1990s. Inflamm Bowel Dis 2013; 19:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/11\">",
"      Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 1991; 100:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/12\">",
"      Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/13\">",
"      Khalili H, Huang ES, Ananthakrishnan AN, et al. Geographical variation and incidence of inflammatory bowel disease among US women. Gut 2012; 61:1686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/14\">",
"      Logan RF. Inflammatory bowel disease incidence: up, down or unchanged? Gut 1998; 42:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/15\">",
"      Mayberry J, Mann R. Inflammatory bowel disease in rural sub-Saharan Africa: rarity of diagnosis in patients attending mission hospitals. Digestion 1989; 44:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/16\">",
"      Calkins BM, Lilienfeld AM, Garland CF, Mendeloff AI. Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci 1984; 29:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/17\">",
"      Kurata JH, Kantor-Fish S, Frankl H, et al. Crohn's disease among ethnic groups in a large health maintenance organization. Gastroenterology 1992; 102:1940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/18\">",
"      ACHESON ED. The distribution of ulcerative colitis and regional enteritis in United States veterans with particular reference to the Jewish religion. Gut 1960; 1:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/19\">",
"      Fireman Z, Grossman A, Lilos P, et al. Epidemiology of Crohn's disease in the Jewish population of central Israel, 1970-1980. Am J Gastroenterol 1989; 84:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/20\">",
"      Niv Y, Torten D, Tamir A, Epstein L. Incidence and prevalence of ulcerative colitis in the upper Galilee, Northern Israel, 1967-1986. Am J Gastroenterol 1990; 85:1580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/21\">",
"      Gilat T, Grossman A, Fireman Z, et al. Inflammatory bowel disease in Jews. Front Gastrointes Res 1986; 11:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/22\">",
"      Van Limbergen J, Russell RK, Drummond HE, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008; 135:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/23\">",
"      Vernier-Massouille G, Balde M, Salleron J, et al. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology 2008; 135:1106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/24\">",
"      Kugathasan S, Baldassano RN, Bradfield JP, et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet 2008; 40:1211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/25\">",
"      Heyman MB, Kirschner BS, Gold BD, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr 2005; 146:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/26\">",
"      Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007; 5:1424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/27\">",
"      Davis MK. Breastfeeding and chronic disease in childhood and adolescence. Pediatr Clin North Am 2001; 48:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/28\">",
"      Koletzko S, Sherman P, Corey M, et al. Role of infant feeding practices in development of Crohn's disease in childhood. BMJ 1989; 298:1617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/29\">",
"      Corrao G, Tragnone A, Caprilli R, et al. Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC). Int J Epidemiol 1998; 27:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/30\">",
"      Michelow IC, Yantosca LM, Karpel M, Schmidt EV. Complex role of mannose-binding lectin in infectious diseases. J Pediatr 2009; 155:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/31\">",
"      Koletzko S, Griffiths A, Corey M, et al. Infant feeding practices and ulcerative colitis in childhood. BMJ 1991; 302:1580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/32\">",
"      Gilat T, Hacohen D, Lilos P, Langman MJ. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand J Gastroenterol 1987; 22:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/33\">",
"      Glassman MS, Newman LJ, Berezin S, Gryboski JD. Cow's milk protein sensitivity during infancy in patients with inflammatory bowel disease. Am J Gastroenterol 1990; 85:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/34\">",
"      Kronman MP, Zaoutis TE, Haynes K, et al. Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics 2012; 130:e794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/35\">",
"      Montgomery SM, Morris DL, Pounder RE, Wakefield AJ. Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology 1999; 116:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/36\">",
"      Wakefield AJ, Ekbom A, Dhillon AP, et al. Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology 1995; 108:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/37\">",
"      Wakefield AJ, Pittilo RM, Sim R, et al. Evidence of persistent measles virus infection in Crohn's disease. J Med Virol 1993; 39:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/38\">",
"      Haga Y, Funakoshi O, Kuroe K, et al. Absence of measles viral genomic sequence in intestinal tissues from Crohn's disease by nested polymerase chain reaction. Gut 1996; 38:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/39\">",
"      Ekbom A, Wakefield AJ, Zack M, Adami HO. Perinatal measles infection and subsequent Crohn's disease. Lancet 1994; 344:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/40\">",
"      Thompson NP, Pounder RE, Wakefield AJ. Perinatal and childhood risk factors for inflammatory bowel disease: a case-control study. Eur J Gastroenterol Hepatol 1995; 7:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/41\">",
"      Haslam N, Mayberry JF, Hawthorne AB, et al. Measles, month of birth, and Crohn's disease. Gut 2000; 47:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/42\">",
"      Radon K, Windstetter D, Poluda AL, et al. Contact with farm animals in early life and juvenile inflammatory bowel disease: a case-control study. Pediatrics 2007; 120:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/43\">",
"      Lashner BA, Loftus EV Jr. True or false? The hygiene hypothesis for Crohn's disease. Am J Gastroenterol 2006; 101:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/44\">",
"      Amre DK, Lambrette P, Law L, et al. Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn's disease: a case-control study. Am J Gastroenterol 2006; 101:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/45\">",
"      Gent AE, Hellier MD, Grace RH, et al. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994; 343:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/46\">",
"      Thompson NP, Montgomery SM, Pounder RE, Wakefield AJ. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet 1995; 345:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/47\">",
"      Feeney M, Ciegg A, Winwood P, Snook J. A case-control study of measles vaccination and inflammatory bowel disease. The East Dorset Gastroenterology Group. Lancet 1997; 350:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/48\">",
"      Davis RL, Kramarz P, Bohlke K, et al. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project. Arch Pediatr Adolesc Med 2001; 155:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/49\">",
"      Martini GA, Brandes JW. Increased consumption of refined carbohydrates in patients with Crohn's disease. Klin Wochenschr 1976; 54:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/50\">",
"      Thornton JR, Emmett PM, Heaton KW. Diet and Crohn's disease: characteristics of the pre-illness diet. Br Med J 1979; 2:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/51\">",
"      J&auml;rnerot G, J&auml;rnmark I, Nilsson K. Consumption of refined sugar by patients with Crohn's disease, ulcerative colitis, or irritable bowel syndrome. Scand J Gastroenterol 1983; 18:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/52\">",
"      A case-control study of ulcerative colitis in relation to dietary and other factors in Japan. The Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. J Gastroenterol 1995; 30 Suppl 8:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/53\">",
"      Belluzzi A, Brignola C, Campieri M, et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996; 334:1557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/54\">",
"      Stenson WF, Cort D, Rodgers J, et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 1992; 116:609.",
"     </a>",
"    </li>",
"    <li>",
"     Hartmann G, Endres S. n-3 polyunsaturated fatty acids and human cytokine synthesis. In: Handbook of Essential Fatty Acid Biology: Biochemistry, Physiology, and Behavioral Biology, Yehoda S, Mostofsky D (Eds), Humana Press, Totawa 1997. p.103.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/56\">",
"      Hillier K, Jewell R, Dorrell L, Smith CL. Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease. Gut 1991; 32:1151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/57\">",
"      Sonnenberg A. Geographic variation in the incidence of and mortality from inflammatory bowel disease. Dis Colon Rectum 1986; 29:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/58\">",
"      Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 1996; 63:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/59\">",
"      Vessey M, Jewell D, Smith A, et al. Chronic inflammatory bowel disease, cigarette smoking, and use of oral contraceptives: findings in a large cohort study of women of childbearing age. Br Med J (Clin Res Ed) 1986; 292:1101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/13/3288/abstract/60\">",
"      Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989; 34:1841.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5889 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-6C4A3AC97D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_13_3288=[""].join("\n");
var outline_f3_13_3288=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12781702\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENETIC FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Time trends in pediatric IBD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Geographic trends",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Racial and ethnic predisposition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Age-related characteristics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ENVIRONMENTAL FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Perinatal and early exposures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Diet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12781702\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/25/27034?source=related_link\">",
"      Clinical features and diagnosis of inflammatory bowel disease in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/7/24693?source=related_link\">",
"      Clinical manifestations of Crohn's disease in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/17/7450?source=related_link\">",
"      Definition, epidemiology, and risk factors in inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/26/44455?source=related_link\">",
"      Genetic factors in inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27401?source=related_link\">",
"      Immune and microbial mechanisms in the pathogenesis of inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/7/44152?source=related_link\">",
"      Nutrition and dietary interventions in adults with inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/47/41722?source=related_link\">",
"      Overview of the management of Crohn's disease in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/34/4650?source=related_link\">",
"      Treatment of ulcerative colitis in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_13_3289="Hydromorphone: Pediatric drug information";
var content_f3_13_3289=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Hydromorphone: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?24/48/25353?source=see_link\">",
"    see \"Hydromorphone: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?13/48/14086?source=see_link\">",
"    see \"Hydromorphone: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F180607\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Dilaudid-HP&reg;;",
"     </li>",
"     <li>",
"      Dilaudid&reg;;",
"     </li>",
"     <li>",
"      Exalgo&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F180608\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Dilaudid-HP&reg;;",
"     </li>",
"     <li>",
"      Dilaudid&reg;;",
"     </li>",
"     <li>",
"      Hydromorph Contin&reg;;",
"     </li>",
"     <li>",
"      Hydromorphone HP;",
"     </li>",
"     <li>",
"      Hydromorphone HP&reg; 10;",
"     </li>",
"     <li>",
"      Hydromorphone HP&reg; 20;",
"     </li>",
"     <li>",
"      Hydromorphone HP&reg; 50;",
"     </li>",
"     <li>",
"      Hydromorphone HP&reg; Forte;",
"     </li>",
"     <li>",
"      Hydromorphone Hydrochloride Injection, USP;",
"     </li>",
"     <li>",
"      Jurnista&trade;;",
"     </li>",
"     <li>",
"      PMS-Hydromorphone;",
"     </li>",
"     <li>",
"      Teva-Hydromorphone",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1053277\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Analgesic, Narcotic",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antitussive",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1053270\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?24/48/25353?source=see_link\">",
"      see \"Hydromorphone: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Antitussive:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 6-12 years: 0.5 mg every 3-4 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adolescents: 1 mg every 3-4 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Pain:",
"     </b>",
"     Doses should be titrated to appropriate analgesic effects, while minimizing adverse effects; when changing routes of administration, note that oral doses are less than one-half as effective as parenteral doses (may be only",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      5",
"     </sub>",
"     as effective):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants &gt;6 months who weigh &gt;10 kg (Friedrichsdorf, 2007; Zernikow, 2009):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Oral: Usual initial: 0.03 mg/kg/dose every 4 hours as needed; usual range: 0.03-0.06 mg/kg/dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     I.V.: Usual initial: 0.01 mg/kg/dose every 3-6 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Continuous I.V. infusion: Usual initial: 0.003-0.005 mg/kg/",
"     <b>",
"      hour",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &lt;50 kg and Adolescents &lt;50 kg:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Oral: 0.03-0.08 mg/kg/dose every 3-4 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     The American Pain Society (2008) recommends an initial oral dose of 0.06 mg/kg for severe pain in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     I.V.: 0.015 mg/kg/dose every 3-6 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Continuous I.V. infusion: Usual initial: 0.003-0.005 mg/kg/",
"     <b>",
"      hour",
"     </b>",
"     (maximum: 0.2 mg/",
"     <b>",
"      hour",
"     </b>",
"     ) (Friedrichsdorf, 2007; Zernikow, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Patient-controlled analgesia (PCA): Opiate-na&iuml;ve:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Children &ge;5 years:",
"     <b>",
"      Note:",
"     </b>",
"     PCA has been used in children as young as 5 years of age; however, clinicians need to assess children 5-8 years of age to determine if they are able to use the PCA device correctly. All patients should receive an initial loading dose of an analgesic (to attain adequate control of pain) before starting PCA for maintenance. Adjust doses, lockouts, and limits based on required loading dose, age, state of health, and presence of opioid tolerance. Use lower end of dosing range for opioid-na&iuml;ve. Assess patient and pain control at regular intervals and adjust settings if needed (American Pain Society, 2008):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Usual concentration: 0.2 mg/mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Demand dose: Usual initial: 0.003-0.004 mg/kg/dose; usual range: 0.003-0.005 mg/kg/dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Lockout: Usual initial: 5 doses/hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Lockout interval: Range: 6-10 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Usual basal rate: 0-0.004 mg/kg/",
"     <b>",
"      hour",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &gt;50 kg and Adolescents &gt;50 kg:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Oral: Initial: Opiate-na&iuml;ve: 1-2 mg/dose every 3-4 hours as needed; patients with prior opiate exposure may tolerate higher initial doses; usual adult dose: 2-4 mg/dose; doses up to 8 mg have been used in adults",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     I.V.: Initial: Opiate-na&iuml;ve: 0.2-0.6 mg/dose every 2-4 hours as needed; patients with prior opiate exposure may tolerate higher initial doses.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Patient-controlled analgesia (PCA):",
"     <b>",
"      Note:",
"     </b>",
"     All patients should receive an initial loading dose of an analgesic (to attain adequate control of pain) before starting PCA for maintenance. Adjust doses, lockouts, and limits based on required loading dose, age, state of health, and presence of opioid tolerance. Use lower end of dosing range for opioid-na&iuml;ve. Assess patient and pain control at regular intervals and adjust settings if needed (American Pain Society, 2008):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Usual concentration: 0.2 mg/mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Demand dose: Usual initial: 0.1-0.2 mg; usual range: 0.05-0.4 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Lockout interval: Usual initial: 6 minutes; usual range: 5-10 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     I.M., SubQ:",
"     <b>",
"      Note:",
"     </b>",
"     I.M. use may result in variable absorption and a lag time to peak effect.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Initial: Opiate-na&iuml;ve: 0.8-1 mg every 4-6 hours as needed; patients with prior opioid exposure may require higher initial doses; usual dosage range: 1-2 mg every 3-6 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Rectal: 3 mg (1 suppository) every 4-8 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Acute pain (moderate to severe):",
"     </b>",
"     <b>",
"      Note:",
"     </b>",
"     These are guidelines and do not represent the maximum doses that may be required in all patients. Doses should be titrated to provide adequate pain relief. When changing routes of administration, oral doses and parenteral doses are",
"     <b>",
"      NOT",
"     </b>",
"     equivalent; parenteral doses are up to 5 times more potent. Therefore, when administered parenterally, one-fifth of the oral dose will provide similar analgesia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Oral: Initial: Opiate-na&iuml;ve: 2-4 mg every 3-4 hours as needed; elderly/debilitated patients may require lower doses; patients with prior opiate exposure may require higher initial doses.",
"     <b>",
"      Note:",
"     </b>",
"     In adults with severe pain, the American Pain Society recommends an initial dose of 4-8 mg.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     I.V.: Initial: Opiate-na&iuml;ve: 0.2-0.6 mg every 2-3 hours as needed; patients with prior opiate exposure may require higher initial doses.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Continuous I.V. infusion: Usual dosage range: 0.5-1 mg/",
"     <b>",
"      hour",
"     </b>",
"     (based on 70 kg patient) or 7-15 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Patient-controlled analgesia (PCA):",
"     <b>",
"      Note:",
"     </b>",
"     Opiate-na&iuml;ve: Consider lower end of dosing range:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Usual concentration: 0.2 mg/mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Demand dose: Usual: 0.1-0.2 mg; range: 0.05-0.4 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Lockout interval: 5-10 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Epidural PCA (de Leon-Casasola, 1996; Liu, 2010; Smith, 2009):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Bolus dose: 0.4-1 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Infusion rate: 0.03-0.3 mg/",
"     <b>",
"      hour",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Demand dose: 0.02-0.05 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Lockout interval: 10-15 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     I.M., SubQ:",
"     <b>",
"      Note:",
"     </b>",
"     I.M. use may result in variable absorption and lag time to peak effect.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Initial: Opiate-na&iuml;ve: 0.8-1 mg every 4-6 hours as needed; patients with prior opiate exposure may require higher initial doses.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Usual dosage range: 1-2 mg every 4-6 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Rectal: 3 mg every 6-8 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Chronic pain:",
"     </b>",
"     <b>",
"      Note:",
"     </b>",
"     Patients taking opioids chronically may become tolerant and require doses higher than the usual dosage range to maintain the desired effect. Tolerance can be managed by appropriate dose titration. There is no optimal or maximal dose for hydromorphone in chronic pain. The appropriate dose is one that relieves pain throughout its dosing interval without causing unmanageable side effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Extended release formulation (Exalgo&reg;): Oral: Dose requires individualization: Dosing range: 8-64 mg every 24 hours. For use in opioid-tolerant patients only; discontinue all other extended release opioids when starting therapy. Suggested recommendations for converting to Exalgo&reg; from other analgesics are presented, but when selecting the initial dose, other characteristics (eg, patient status, degree of opioid tolerance, concurrent medications, type of pain, risk factors for addiction or diversion, etc) should also be considered.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Individualization  of dose: Pain relief and adverse events should be assessed frequently. Dose increases may occur not more often than every 3-4 days; consider titrating with increases of 25% to 50% of the current daily dose. If more than 2 doses of rescue medications are needed within 24 hours for 2 consecutive days, consider increasing the dose of Exalgo&reg;. Do not administer more frequently than every 24 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Discontinuing Exalgo&reg;: Taper by gradually decreasing the dose by 25% to 50% every 2-3 days to a dose of 8 mg every 24 hours before discontinuing therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Conversion  from other oral hydromorphone formulations to Exalgo&reg;: Start with the equivalent total daily dose of hydromorphone administered once daily. May titrate every 3-4 days until adequate pain relief with tolerable side effects have been achieved.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Conversion from other opioids to Exalgo&reg;: In general, start Exalgo&reg; at 50% of the calculated total daily dose every 24 hours. Titrate until adequate pain relief with tolerable side effects has been achieved. The following conversion ratios may be used to convert from",
"     <b>",
"      oral",
"     </b>",
"     opioid therapy to Exalgo&reg;.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Conversion ratios to Exalgo&reg; (see table): Select the opioid, sum the total daily dose, then multiply by the conversion ratio to calculate the approximate oral hydromorphone equivalent; start Exalgo&reg; at 50% of the calculated total daily dose every 24 hours. (",
"     <b>",
"      Note:",
"     </b>",
"     The conversion ratios and approximate equivalent doses in this conversion table are only to be used for the conversion from current opioid therapy to Exalgo&reg;).",
"    </p>",
"    <table border=\"1\" frame=\"border\" rules=\"all\">",
"     <caption style=\"text-align:center;\">",
"      Conversion Ratios to Exalgo&reg;",
"      <sup>",
"       1",
"      </sup>",
"     </caption>",
"     <col align=\"center\" width=\"100\">",
"     </col>",
"     <col align=\"center\" width=\"100\">",
"     </col>",
"     <col align=\"center\" width=\"100\">",
"     </col>",
"     <thead valign=\"middle\">",
"      <tr>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Previous Opioid",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Approximate Equivalent Oral Dose",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Oral Conversion Ratio",
"         <sup>",
"          2",
"         </sup>",
"        </p>",
"       </th>",
"      </tr>",
"     </thead>",
"     <tfoot>",
"      <tr>",
"       <td align=\"left\" colspan=\"3\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          1",
"         </sup>",
"         <i>",
"          Approximate",
"         </i>",
"         equivalent doses for conversion from current opioid therapy to Exalgo&reg;.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"3\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          2",
"         </sup>",
"         Ratio for converting oral opioid dose to approximate hydromorphone equivalent dose.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"3\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          3",
"         </sup>",
"         Monitor closely; ratio between methadone and other opioid agonists may vary widely as a function of previous drug exposure. Methadone has a long half-life and may accumulate in the plasma.",
"        </p>",
"       </td>",
"      </tr>",
"     </tfoot>",
"     <tbody valign=\"middle\">",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Hydromorphone",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         12 mg",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Codeine",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         200 mg",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.06",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Hydrocodone",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         30 mg",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.4",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Methadone",
"         <sup>",
"          3",
"         </sup>",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         20 mg",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.6",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Morphine",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         60 mg",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.2",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Oxycodone",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         30 mg",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.4",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Oxymorphone",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         20 mg",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.6",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     Conversion from transdermal fentanyl to Exalgo&reg;: Treatment with Exalgo&reg; can be started 18 hours after the removal of the transdermal fentanyl patch. For every fentanyl 25 mcg/hour transdermal dose, the equianalgesic dose of Exalgo&reg; is 12 mg every 24 hours. An appropriate starting dose is 50% of the calculated total daily dose given every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     <b>",
"      Dosing adjustment in renal impairment:",
"     </b>",
"     Decrease initial dose and monitor closely; for injection, manufacturer recommends",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      4",
"     </sub>",
"     to",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     initial dosage reductions. Adults: Exalgo&reg;:  If moderate impairment, start with a reduced dose and monitor closely. For severe impairment, consider use of an alternate analgesic with better dosing flexibility.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosing adjustment in hepatic impairment:",
"     </b>",
"     Decrease initial dose and monitor closely; for injection, manufacturer recommends",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      4",
"     </sub>",
"     to",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     initial dosage reductions. Adults: Dose adjustment should be considered. Exalgo&reg;: In patients with moderate to severe hepatic impairment, start with a reduced dose and monitor closely; consider use of an alternate analgesic with better dosing flexibility.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F180578\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution, as hydrochloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dilaudid-HP&reg;: 250 mg [contains natural rubber/natural latex in packaging, sodium metabisulfite]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride: 1 mg/mL (1 mL); 2 mg/mL (1 mL, 20 mL); 4 mg/mL (1 mL); 10 mg/mL (1 mL, 5 mL, 50 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dilaudid-HP&reg;: 10 mg/mL (50 mL) [contains natural rubber/natural latex in packaging, sodium metabisulfite]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dilaudid-HP&reg;: 10 mg/mL (1 mL, 5 mL) [contains sodium metabisulfite]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dilaudid&reg;: 1 mg/mL (1 mL); 2 mg/mL (1 mL); 4 mg/mL (1 mL) [contains sodium metabisulfite]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride [preservative free]: 10 mg/mL (1 mL, 5 mL, 50 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, oral, as hydrochloride: 1 mg/mL (473 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dilaudid&reg;: 1 mg/mL (473 mL) [contains sodium metabisulfite (may have trace amounts)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder, for prescription compounding, as hydrochloride: USP: 100% (972 mg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suppository, rectal, as hydrochloride: 3 mg (6s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as hydrochloride: 2 mg, 4 mg, 8 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dilaudid&reg;: 2 mg, 4 mg [contains sodium metabisulfite (may have trace amounts)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dilaudid&reg;: 8 mg [scored; contains sodium metabisulfite (may have trace amounts)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, extended release, oral, as hydrochloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Exalgo&reg;: 8 mg, 12 mg, 16 mg, 32 mg [contains sodium metabisulfite]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F180562\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes extended release tablet, powder for injection",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F180643\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-II",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F11238289\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Exalgo&reg;: As a requirement of the REMS program, healthcare providers who prescribe Exalgo&reg; need to receive training on the proper use and potential risks of Exalgo&reg;. For training, please refer to file://www.exalgorems.com. Prescribers will need retraining every 2 years or following any significant changes to the Exalgo&reg; REMS program.",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F10168465\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and as follows, must be dispensed with this medication:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Exalgo&reg;:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM204267.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM204267.pdf",
"     </a>",
"     . Medication guides are also available at file://www.exalgorems.com.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1053282\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Immediate release: Administer with food or milk to decrease GI upset.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Extended release tablets (Exalgo&reg;): Tablets should be swallowed whole; do not crush, break, chew, dissolve, or inject. May be taken with or without food.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Parenteral: I.V.: Administer via slow I.V. injection over at least 2-3 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rectal: Insert suppository rectally and retain",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F180649\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     LR, D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     NS, LR,",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Acetaminophen, acyclovir, allopurinol, amifostine, amikacin, amsacrine, anidulafungin, atropine, aztreonam, bivalirudin, caspofungin, cefepime, cefotaxime, cefoxitin, ceftazidime, cefuroxime, chloramphenicol, cisatracurium, cisplatin, cladribine, clindamycin, cyclophosphamide, cytarabine, dexmedetomidine, diltiazem, diphenhydramine, dobutamine, docetaxel, dopamine, doripenem, doxorubicin, doxorubicin liposome, doxycycline, epinephrine, erythromycin lactobionate, etoposide phosphate, famotidine, fenoldopam, fentanyl, filgrastim, fludarabine, foscarnet, furosemide, gemcitabine, gentamicin, granisetron, haloperidol, hetastarch in lactate electrolyte injection (Hextend&reg;), hydroxyzine, kanamycin, ketorolac, labetalol, levofloxacin, linezolid, lorazepam, magnesium sulfate, melphalan, methotrexate, methotrimeprazine, metoclopramide, metronidazole, micafungin, midazolam, milrinone, morphine, nafcillin, nicardipine, nitroglycerin, norepinephrine, ondansetron, oxacillin, oxaliplatin, paclitaxel, palonosetron, pemetrexed, penicillin G potassium, piperacillin, piperacillin/tazobactam, propofol, ranitidine, remifentanil, scopolamine, sulfamethoxazole/trimethoprim, tacrolimus, teniposide, thiotepa, tobramycin, vancomycin, vecuronium, vinorelbine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Amphotericin B cholesteryl sulfate complex, gallium nitrate, hyaluronidase, minocycline, pantoprazole, phenytoin, sargramostim, thiopental.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Ampicillin, cefazolin, cloxacillin, dexamethasone sodium phosphate, diazepam, heparin, phenobarbital.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Atropine, bupivacaine, ceftazidime, chlorpromazine, cimetidine, diphenhydramine, fentanyl, glycopyrrolate, hydroxyzine, lorazepam, methotrimeprazine, metoclopramide, midazolam, pentazocine, pentobarbital, potassium chloride, prochlorperazine mesylate, ranitidine, scopolamine, tetracaine, trimethobenzamide, ziconotide.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Ampicillin, diazepam, heparin, hyaluronidase, pantoprazole, phenobarbital, phenytoin.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Cefazolin, cloxacillin, dexamethasone sodium phosphate, dimenhydrinate, haloperidol, ketorolac, prochlorperazine edisylate, promethazine.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1053273\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral, parenteral: Store at 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F); protect from light. A slight yellow discoloration of injection has not been associated with a loss of potency; injection is stable for at least 24 hours when protected from light and stored at 25&deg;C in most common large volume parenteral solutions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rectal (suppository): Store in refrigerator.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1053281\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral (immediate release): Management of moderate to severe pain (FDA approved in adults); has also been used as an antitussive at lower doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral (extended release; Exalgo&reg;): For once-daily administration for the management of moderate to severe pain in",
"     <b>",
"      opioid-tolerant",
"     </b>",
"     patients who require continuous, around-the-clock analgesia for an extended period of time (FDA approved in adults). Should",
"     <b>",
"      NOT",
"     </b>",
"     be used as an as-needed analgesic or for management of acute or postoperative pain.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Parenteral: Management of moderate to severe pain (FDA approved in adults)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Parenteral (concentrated; Dilaudid-HP&reg; injection): Use in",
"     <b>",
"      opioid-tolerant",
"     </b>",
"     patients who require larger than usual doses of opioids for pain relief (FDA approved in adults)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Patients are considered to be opioid-tolerant if they have been taking oral morphine &ge;60 mg/day, fentanyl transdermal &ge;25 mcg/hour, oral oxycodone &ge;30 mg/day, oral hydromorphone &ge;8 mg/day, oral oxymorphone &ge;25 mg/day, or an equianalgesic dose of another opioid for &ge;1 week",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F180651\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Dilaudid&reg; may be confused with Demerol&reg;, Dilantin&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       HYDROmorphone may be confused with morphine; significant overdoses have occurred when hydromorphone products have been inadvertently administered instead of morphine sulfate. Commercially available prefilled syringes of both products looks similar and are often stored in close proximity to each other.",
"       <b>",
"        Note:",
"       </b>",
"       Hydromorphone 1 mg oral is approximately equal to morphine 4 mg oral; hydromorphone 1 mg I.V. is approximately equal to morphine 5 mg I.V.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Administration issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Dilaudid&reg;, Dilaudid-HP&reg;: Extreme caution should be taken to avoid confusing the highly-concentrated (Dilaudid-HP&reg;) injection with the less-concentrated (Dilaudid&reg;) injectable product.",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Exalgo&reg;: Extreme caution should be taken to avoid confusing the extended release Exalgo&reg; 8 mg tablets with immediate release hydromorphone 8 mg tablets.",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Significant differences exist between oral and I.V. dosing. Use caution when converting from one route of administration to another.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F180648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Bradycardia, extrasystoles, flushing of face, hyper-/hypotension, palpitation, peripheral edema, peripheral vasodilation, syncope, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Abnormal dreams, abnormal feelings, agitation, aggression, apprehension, attention disturbances, chills, coordination impaired, CNS depression, confusion, cognitive disorder, crying, dizziness, drowsiness, dysphoria, encephalopathy, euphoria, fatigue, hallucinations, headache, hyper-reflexia, hypo/hyperesthesia, hypothermia, increased intracranial pressure, insomnia, lightheadedness, listlessness, malaise, memory impairment, mental depression, mood alterations, nervousness, panic attacks, paranoia, psychomotor hyperactivity, restlessness, sedation, seizure, somnolence, suicide ideation, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Hyperhidrosis, pruritus, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Amylase decreased, dehydration, erectile dysfunction, fluid retention, hyperuricemia, hypogonadism, hypokalemia, libido decreased, sexual dysfunction, testosterone decreased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal distention, anal fissure, anorexia, appetite decreased/increased, bezoar (Exalgo&reg;), biliary tract spasm, constipation, diarrhea, diverticulum, diverticulitis, duodenitis, dysgeusia, dysphagia, eructation, flatulence, gastric emptying impaired, gastrointestinal motility disorder (Exalgo&reg;), gastroenteritis, hematochezia, ileus, intestinal obstruction (Exalgo&reg;), large intestine perforation (Exalgo&reg;), nausea, painful defecation, paralytic ileus, stomach cramps, taste perversion, vomiting, weight loss, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Dysuria, micturition disorder, ureteral spasm, urinary frequency, urinary hesitation, urinary retention, urinary tract spasm, urination decreased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: LFTs increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Pain at injection site (I.M.), wheal/flare over vein (I.V.)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, dysarthria, dyskinesia, muscle rigidity, muscle spasms, myalgia, myoclonus, paresthesia, trembling, tremor, uncoordinated muscle movements, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision, diplopia, dry eyes, miosis, nystagmus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Apnea, bronchospasm, dyspnea, hyperventilation, hypoxia, laryngospasm, oxygen saturation decreased, respiratory depression/distress, rhinorrhea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Antidiuretic effects, balance disorder, diaphoresis, difficulty walking, histamine release, physical and psychological dependence",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1053286\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to hydromorphone or any component; significant respiratory depression (especially in settings without resuscitative equipment or without adequate respiratory monitoring); severe CNS depression; patients with severe or acute asthma, paralytic ileus (known or suspected); pregnancy (prolonged use or high doses at term). Additional product-specific contraindications: Dilaudid&reg;: Obstetrical analgesia, hypersensitivity to known sulfite-containing medications; Dilaudid-HP&reg;: Opioid-nontolerant patients, obstetrical analgesia, hypersensitivity to known sulfite-containing medications; Exalgo&reg;: Opioid-nontolerant patients; pre-existing GI surgery or diseases resulting in narrowing of GI tract, loops in the GI tract, or GI obstruction; hypersensitivity to known sulfite-containing medications.",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1053269\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with hypersensitivity reactions to other phenanthrene derivative opioid agonists (morphine, hydrocodone, levorphanol, oxycodone, oxymorphone, codeine). Use with caution and reduce the initial dose in patients with significant liver, respiratory, or renal disease; hypothyroidism or myxedema; CNS depression or coma; respiratory depression; adrenocortical insufficiency; toxic psychosis; seizures; acute abdominal conditions; post-GI surgery; biliary tract disease; pancreatitis; prostatic hypertrophy or urethral stricture; acute alcoholism; delirium tremens; kyphoscoliosis and in debilitated patients. Use with extreme caution in patients with head injury, intracranial lesions, or elevated intracranial pressure; exaggerated elevation of ICP may occur. Seizures and myoclonus have been reported in severely compromised patients receiving high doses of parenteral hydromorphone. Use with caution in patients undergoing biliary tract surgery (narcotics may cause spasm of the sphincter of Oddi).",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1053268\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Respiratory depression may occur",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; use with extreme caution in patients with pre-existing respiratory depression, CNS depression, decreased respiratory reserve, hypoxia, hypercapnia, significant COPD, cor pulmonale, severe obesity, sleep apnea, myxedema, kyphoscoliosis or other skeletal disorders which may alter respiratory function; critical respiratory depression may occur, even at therapeutic dosages. Hypotension may occur, especially in hypovolemic patients or those receiving medications that compromise vasomotor tone (eg, general anesthetics, phenothiazines); use with extreme caution in patients with circulatory shock. Orthostatic hypotension may occur in ambulatory patients. Physical and psychological dependence may occur; abrupt discontinuation after prolonged use may result in withdrawal symptoms or seizures. Warn patient of possible impairment of alertness or physical coordination. Interactions with other CNS drugs may occur",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Healthcare provider should be alert to problems of abuse, misuse, addiction, and diversion",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Infants born to women physically dependent on opioids will also be physically dependent and may experience respiratory difficulties or opioid withdrawal symptoms.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Do not confuse the highly concentrated (Dilaudid-HP&reg;) injection with the less-concentrated (Dilaudid&reg;) injectable product",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; significant overdose or death could result. Injection (4 mg/mL, 10 mg/mL, and powder for reconstitution), oral liquid, and tablets may contain sodium metabisulfite, which may cause allergic reactions in susceptible individuals. Rubber stopper of multiple dose vials contains latex which may cause allergic reactions in susceptible individuals; avoid use in patients with allergy to latex.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Exalgo&reg; extended release tablets are for use only in opioid-tolerant patients",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; fatal respiratory depression may occur in patients who are not opioid-tolerant. Exalgo&reg; is indicated for the management of moderate to severe pain when around-the-clock pain control is needed for an extended time period; not for use as an as-needed analgesic or for the management of acute or postoperative pain. Tablets should be swallowed whole; do not crush, break, chew, dissolve, or inject",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; doing so may lead to rapid release and absorption of a potentially fatal dose of hydromorphone. Injection of the tablet excipients may be toxic and cause lethal complications. Accidental consumption of Exalgo&reg; extended release tablets may lead to fatal overdose, especially in children",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Tablets may be visible on abdominal x-rays, especially when digital enhancing techniques are used.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Exalgo&reg; extended release tablets are nondeformable; do not administer to patients with pre-existing severe gastrointestinal narrowing (eg, esophageal motility, small bowel inflammatory disease, short gut syndrome, history of peritonitis, cystic fibrosis, chronic intestinal pseudo-obstruction, Meckel&rsquo;s diverticulum); obstruction may occur. Exalgo&reg; is not recommended for use within 14 days of MAO inhibitors; severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299481\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F180571\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alvimopan: Analgesics (Opioid) may enhance the adverse/toxic effect of Alvimopan. This is most notable for patients receiving long-term (i.e., more than 7 days) opiates prior to alvimopan initiation.  Management: Alvimopan is contraindicated in patients receiving therapeutic doses of opioids for more than 7 consecutive days immediately prior to alvimopan initiation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ammonium Chloride: May increase the excretion of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May enhance the analgesic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotic Agents (Phenothiazines): May enhance the hypotensive effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Desmopressin: Analgesics (Opioid) may enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the adverse/toxic effect of HYDROmorphone.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mixed Agonist / Antagonist Opioids: May diminish the analgesic effect of Analgesics (Opioid). Management: Seek alternatives to mixed agonist/antagonist opioids in patients receiving pure opioid agonists, and monitor for symptoms of therapeutic failure/high dose requirements (or withdrawal in opioid-dependent patients) if patients receive these combinations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegvisomant: Analgesics (Opioid) may diminish the therapeutic effect of Pegvisomant.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: Analgesics (Opioid) may enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Succinylcholine: May enhance the bradycardic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Analgesics (Opioid) may enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1053289\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food does not significantly affect bioavailability of extended release capsules; food decreased the peak serum concentration by 25%, prolonged the time to peak by 0.8 hours, and increased the AUC of a single tablet dose by 35% (effects may not be clinically significant).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F180573\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F180588\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hydromorphone was teratogenic in some, but not all, animal studies; however, maternal toxicity was also reported. Hydromorphone crosses the placenta. Chronic opioid use during pregnancy may lead to a withdrawal syndrome in the neonate. Symptoms include irritability, hyperactivity, loss of sleep pattern, abnormal crying, tremor, vomiting, diarrhea, weight loss, or failure to gain weight.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1053276\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pain relief, respiratory rate, heart rate, blood pressure",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1053267\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Binds to opiate receptors in the CNS, causing inhibition of ascending pain pathways, altering the perception of and response to pain; causes cough suppression by direct central action in the medulla; produces generalized CNS depression",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1053284\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Analgesic effects:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: Immediate release formulations: Within 15-30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: Within 5 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maximum effect:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: Immediate release formulations: Within 30-90 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 10-20 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Oral: Immediate release formulations, I.V.: 4-5 hours; suppository may provide longer duration of effect",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1053285\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.: Variable",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: Rapidly absorbed; extensive first-pass effect",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 4 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: ~8% to 19%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Primarily in the liver via glucuronidation to inactive metabolites; &gt;95% is metabolized to hydromorphone-3-glucuronide; minor amounts as 6-hydroxy reduction metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Oral: 62%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: 2-3 hours; Exalgo&reg;: Apparent half-life: ~11 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: Oral: Immediate release: 30-60 minutes; Exalgo&reg;: 12-16 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: In urine, principally as glucuronide conjugates; minimal unchanged drug is excreted in urine (~7%) and feces (1%)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1053275\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?13/48/14086?source=see_link\">",
"      see \"Hydromorphone: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid alcohol, sedatives, tranquilizers, antihistamines, or pain medications without consulting prescriber. Hydromorphone may cause drowsiness and dizziness, impair vision, and impair ability to perform activities requiring mental alertness or physical coordination; may be habit-forming; avoid abrupt discontinuation after prolonged use. If oral liquid spills on skin, remove contaminated clothing and rinse area with cool water. Maintain adequate hydration, unless instructed to restrict fluid intake. May cause loss of appetite, nausea, or vomiting; or constipation (if unresolved, consult prescriber about use of stool softeners). Report chest pain, slow or rapid heartbeat, dizziness, or persistent headache; confusion or respiratory difficulties; or severe constipation. Do not let others use your hydromorphone products; severe adverse effects, including death, may occur.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Exalgo&reg;: Additional information: Read the patient Medication Guide that you receive with each prescription and refill of Exalgo&reg;. Exalgo&reg; tablets should be swallowed whole; do not crush, break, chew, dissolve, or inject. Insoluble shell of extended release tablet may appear in the stool (this is normal). Store in container dispensed in; keep away from heat and moisture.  Contact prescriber immediately if symptoms of gastrointestinal obstruction occur (eg, abdominal pain and distention, severe constipation, or vomiting).",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1053287\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Equianalgesic doses: Morphine 10 mg I.M. = hydromorphone 1.5 mg I.M.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Berde CB and Sethna NF, &ldquo;Analgesics for the Treatment of Pain in Children,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2002, 347(14):1094-103.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/13/3289/abstract-text/12362012/pubmed\" id=\"12362012\" target=\"_blank\">",
"        12362012",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Carr D, Jacox A, Chapman CR, et al, &ldquo;Clinical Practice Guideline Number 1: Acute Pain Management: Operative or Medical Procedures and Trauma,&rdquo; Rockville, Maryland: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, AHCPR Publication No 92-0032, 1992.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      de Leon-Casasola OA and Lema MJ, \"Postoperative Epidural Opioid Analgesia: What Are the Choices?\"",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 1996, 83(4):867-75.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/13/3289/abstract-text/8831337/pubmed\" id=\"8831337\" target=\"_blank\">",
"        8831337",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Friedrichsdorf SJ and Kang TI, \"The Management of Pain in Children With Life-Limiting Illnesses,\"",
"      <i>",
"       Pediatr Clin North Am",
"      </i>",
"      , 2007, 54(5):645-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/13/3289/abstract-text/17933616/pubmed\" id=\"17933616\" target=\"_blank\">",
"        17933616",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jacox A, Carr D, Payne R, et al, &ldquo;Clinical Practice Guideline Number 9: Management of Cancer Pain,&rdquo; Rockville, Maryland: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, AHCPR Publication No. 94-0592, 1994.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Liu SS, Bieltz M, Wukovits B, et al, \"Prospective Survey of Patient-Controlled Epidural Analgesia With Bupivacaine and Hydromorphone in 3736 Postoperative Orthopedic Patients,\"",
"      <i>",
"       Reg Anesth Pain Med",
"      </i>",
"      , 2010, 35(4):351-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/13/3289/abstract-text/20607876/pubmed\" id=\"20607876\" target=\"_blank\">",
"        20607876",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Phillips MS, \"Standardizing I.V. Infusion Concentrations: National Survey Results,\"",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2011, 68(22):2176-82.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/13/3289/abstract-text/22058104/pubmed\" id=\"22058104\" target=\"_blank\">",
"        22058104",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      \"Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain,\" 6th ed, Glenview, IL: American Pain Society, 2008.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Smith HS,",
"      <i>",
"       Current Therapy in Pain",
"      </i>",
"      , 1st ed, Philadelphia, PA: Saunders, 2009.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Zernikow B, Michel E, Craig F, et al, \"Pediatric Palliative Care: Use of Opioids for the Management of Pain,\"",
"      <i>",
"       Paediatr Drugs",
"      </i>",
"      , 2009, 11(2):129-51.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/13/3289/abstract-text/19301934/pubmed\" id=\"19301934\" target=\"_blank\">",
"        19301934",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13364 Version 44.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-52D7E7C181-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_13_3289=[""].join("\n");
var outline_f3_13_3289=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708907\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F180607\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F180608\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053277\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053270\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F180578\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F180562\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F180643\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11238289\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10168465\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053282\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F180649\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053273\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053281\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F180651\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F180648\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053286\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053269\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053268\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299481\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F180571\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053289\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F180573\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F180588\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053276\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053267\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053284\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053285\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053275\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053287\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13364\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13364|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?24/48/25353?source=related_link\">",
"      Hydromorphone: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?13/48/14086?source=related_link\">",
"      Hydromorphone: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_13_3290="Hypertrophic lichen planus lesion";
var content_f3_13_3290=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F54396%7EDERM%2F81589&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F54396%7EDERM%2F81589&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hypertrophic lichen planus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This scaly, hyperpigmented plaque is a lesion of hypertrophic lichen planus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hypertrophic lichen planus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 295px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hypertrophic lichen planus. Darkly pigmented hypertrophic lesions are present on the pretibial shaft.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_13_3290=[""].join("\n");
var outline_f3_13_3290=null;
var title_f3_13_3291="Indications preop consultation";
var content_f3_13_3291=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F55204&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F55204&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Indications for preoperative sleep consultation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       Strongly suspected OSAHS",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Assistance in integrating diagnostic sleep studies results into pre-operative risk assessment",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       CPAP non-compliance",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       CPAP technical problems",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Symptoms despite CPAP therapy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Changes in body weight since last CPAP adjustment",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       CPAP level determined in the remote past",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Reassessment of efficacy of non-CPAP treatment options",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_13_3291=[""].join("\n");
var outline_f3_13_3291=null;
var title_f3_13_3292="Various types of thromboelastograms";
var content_f3_13_3292=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F55087&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F55087&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Various types of thromboelastograms",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Native TEG",
"       </td>",
"       <td>",
"        Measures clot formation in the absence of a specific activator in either untreated whole blood or in citrated whole blood after recalcification.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rapid-TEG (rTEG)",
"       </td>",
"       <td>",
"        Tissue factor is used as the activator inducing clot formation via the extrinsic pathway. Compared with native TEG, rTEG gives a readout of clot characteristics within about 10 minutes. The corresponding RoTEM",
"        <sup>",
"         &reg;",
"        </sup>",
"        test is the EXTEM.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kaolin-TEG",
"       </td>",
"       <td>",
"        Phospholipid and kaolin are used to induce activation via the intrinsic pathway. The corresponding RoTEM",
"        <sup>",
"         &reg;",
"        </sup>",
"        test is the INTEM, which uses phospholipid and ellagic acid as activators.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Heparinase treatment",
"       </td>",
"       <td>",
"        Simultaneous measurements can be performed comparing heparinase-treated blood with untreated blood to identify the effects of endogenous heparan sulfates, exogenous heparin and heparinoids. The corresponding RoTEM",
"        <sup>",
"         &reg;",
"        </sup>",
"        assay is the HEPTEM.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Platelet mapping",
"       </td>",
"       <td>",
"        Platelet mapping assesses platelet function via the cyclooxygenase and ADP/P2 signaling pathways. The decrement in MA can be measured in the presence of platelet antagonists such as acetylsalicylic acid, dipyridamole, and clopidogrel and compared with the untreated MA.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fibrin function testing",
"       </td>",
"       <td>",
"        The RoTEM",
"        <sup>",
"         &reg;",
"        </sup>",
"        FIBTEM test activates the extrinsic pathway in the presence of cytochalasin D, which is a cytoskeletal inhibitor of platelet activity. This test qualitatively assesses fibrinogen levels since the clot formation in this test is attributable to fibrin polymerization alone.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     TEG: thromboelastogram; ADP/P2: adenosine diphosphate/P2 receptor; MA: maximal amplitude.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_13_3292=[""].join("\n");
var outline_f3_13_3292=null;
var title_f3_13_3293="Acidosis and K balance";
var content_f3_13_3293=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F57068&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F57068&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acidemia and the plasma potassium",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 273px; height: 264px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Change in the plasma K+ concentration in relation to the arterial pH in experimentally induced hydrochloric acidosis (HCl is a mineral acid) and lactic acidosis in dogs. Only HCl induced hyperkalemia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Perez GO, Oster JR, Vaamonde CA, Nephron 1981; 27:233.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_13_3293=[""].join("\n");
var outline_f3_13_3293=null;
var title_f3_13_3294="Contents: What's New";
var content_f3_13_3294=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      What's New",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     <strong>",
"      What's New",
"     </strong>",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			What's New",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <p>",
"      Our editors select a small number of the most important ",
"updates and share them with you via What's new. See these updates by clicking on the specialty ",
"you are interested in below. You may also type \"What's new\" into ",
"the search screen after you have logged in to UpToDate.",
"     </p>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds valign=\"top\" width=\"100%\">",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/62/6121\">",
"           Practice Changing UpDates",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/18/41253\">",
"           What's new in adult and pediatric emergency medicine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/23/24949\">",
"           What's new in allergy and immunology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/19/21817\">",
"           What's new in cardiovascular medicine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/51/27441\">",
"           What's new in dermatology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/27/12730\">",
"           What's new in drug therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/57/2961\">",
"           What's new in endocrinology and diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/52/26442\">",
"           What's new in family medicine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/3/44086\">",
"           What's new in gastroenterology and hepatology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/62/19431\">",
"           What's new in general surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/57/12180\">",
"           What's new in geriatrics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/46/22248\">",
"           What's new in hematology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/33/2581\">",
"           What's new in hospital medicine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/39/11897\">",
"           What's new in infectious diseases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/47/4855\">",
"           What's new in nephrology and hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/19/28981\">",
"           What's new in neurology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/35/30264\">",
"           What's new in obstetrics and gynecology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/43/11962\">",
"           What's new in oncology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/60/5066\">",
"           What's new in pediatrics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/47/21242\">",
"           What's new in primary care internal medicine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/5/12372\">",
"           What's new in psychiatry",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/63/31732\">",
"           What's new in pulmonary, critical care, and sleep medicine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/26/19873\">",
"           What's new in rheumatology",
"          </a>",
"         </li>",
"         <ul>",
"         </ul>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-2E45C987F4-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f3_13_3294=[""].join("\n");
var outline_f3_13_3294=null;
var title_f3_13_3295="Ossification in AS";
var content_f3_13_3295=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F66989&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F66989&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ankylosing spondylitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 244px; height: 323px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lateral view of the cervical spine in a patient with ankylosing spondylitis shows ossification of the anterior longitudinal ligament (arrows), which bridges adjacent vertebral bodies. This has resulted in bony fusion and ankylosis of the cervical vertebral bodies.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_13_3295=[""].join("\n");
var outline_f3_13_3295=null;
